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The Ryan White HIV/AIDS Program (RWHAP) provides HIV care to uninsured people 
living with HIV/AIDS (PLWHA). Although the RWHAP has helped PLWHA achieve a 
viral suppression rate of 84%, this does not meet the 90% target goals under the U.N. 90-
90-90 plan to end the AIDS epidemic. The Affordable Care Act (ACA) was enacted to 
enhance access and health status, but outcomes have not been measured for PLWHA. 
The purpose of this quantitative correlational cross-sectional study was to determine 
whether PLWHA enrolled in an ACA qualified health plan (ACAQHP) achieved 
improved health status compared to PLWHA enrolled in the RWHAP. Andersen’s 
behavioral model of health services use provided the theoretical framework for this study. 
Research questions addressed variables such as demographic factors, difficulty in paying 
out-of-pocket medical expenses, health status, coverage status, treatment compliance, and 
engagement in care. A purposeful convenience sample of weighted secondary data from 
30,670 PLWHA residing in Florida who participated in the 2015-2017 Medical 
Monitoring Project survey was used. Multiple linear regression only showed a 
statistically significant relationship between engagement in care and health status. Mann-
Whitney U tests indicated a statistically significant difference in treatment compliance 
and engagement in care, but not in health status between RWHAP and ACAQHP 
enrollees. Findings also showed that those enrolled in the ACAQHP had less difficulty in 
paying their health care expenses than those in the RWHAP. Study results may be used to 
encourage enrollment in an ACAQHP and improve health outcomes due to access to 
more affordable comprehensive services. 
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Chapter 1: Introduction to the Study 
Introduction 
HIV is a public health concern in the United States as approximately 1.1 million 
people are currently diagnosed with HIV and an additional 50,000 new cases are detected 
annually (McQuade, Raimondo, Phivilay-Bessette, Marak, & Loberti, 2015). The federal 
government created the Ryan White HIV/AIDS program (RWHAP) in 1990 to help 
people living with HIV/AIDS (PLWHA) receive necessary medical care (Health 
Resources and Services Administration [HRSA], 2016a). The RWHAP is the payer of 
last resort as it provides funding for the medical care for more than 500,000 enrollees and 
covers expenses related to HIV medical services, case management, support services, 
antiretroviral therapy (ART) medications, health insurance premiums, coinsurance, 
copayments, and deductibles after all other sources of insurance coverage have been 
exhausted (Morin, 2015).  
The Affordable Care Act (ACA) was passed into law in 2010 to improve 
insurance access and benefit quality of medical care for the underinsured and uninsured 
(U.S. Department of Health & Human Services, 2016b). Prior to the passage of the ACA, 
an estimated 30% (380,000) of PLWHA did not have health insurance and relied solely 
on support from the RWHAP (Rozin et al., 2015). Improved access under the ACA was 
achieved through the creation of state health care exchanges to sell insurance policies to 
consumers, the expansion of Medicaid coverage, and the elimination of insurance 
companies having the ability to deny coverage due to preexisting conditions (U.S. 




HIV-related care and support services on an outpatient basis, the ACA expanded the 
benefits offered to PLWHA by including access to physicians for preventive and 
subspecialty care and hospitalization, eliminated financial lifetime limits on covered 
claims, and improved the coordination and delivery of care (Dawson & Kates, 2015; U.S. 
Department of Health & Human Services, 2016b). To minimize monthly premium costs, 
ACA health insurance plans include large patient out-of-pocket expenses due to 
copayments, coinsurance, and deductibles. Researchers have shown that allocating 
greater financial costs to people enrolled in high-deductible health plans reduces the 
utilization of needed health care services resulting in a delayed diagnosis and increased 
rate of suffering and mortality for many chronic diseases including HIV/AIDS, cancer, 
and diabetes (Kannan & Veazie, 2014; Taber, Leyva, & Persoskie, 2015). To eliminate 
the burden of these out-of-pocket expenses, the HRSA (2014) approved the use of 
RWHAP funds to support the enrollment of their ACA-eligible consumers to an ACA 
Silver level plan by paying for insurance premiums, deductibles, copayments, and other 
out-of-pocket health care expenses.  
Despite the creation of the RWHAP to provide PLWHA with HIV/AIDS-related 
care, PLWHA have not achieved the necessary level of viral suppression. It is unclear 
whether the transition to ACA health insurance coverage for PLWHA in Florida has 
resulted in improved health outcomes as measured by an increase in the viral suppression 
among PLWHA. This quantitative correlational cross-sectional study was conducted to 
review de-identified patient data obtained from the Florida Department of Health to 




achieved improved health status compared to PLWHA enrolled in the RWHAP. The 
results may lead to individuals afflicted with HIV/AIDS benefiting from improved health 
status by availing themselves of the subsidies offered to purchase ACA health insurance 
coverage. Chapter 1 includes the study background, problem statement, purpose, research 
questions and hypotheses, theoretical framework, nature of study, term definitions, 
assumptions, limitations, scope, delimitations, and significance of the study.  
Background 
Prior to the passage of the ACA in 2010, millions of Americans did not have 
health insurance coverage. The uninsured rate among the nonelderly population surged in 
the years immediately preceding the passage of this important legislation (The Henry J. 
Kaiser Family Foundation, 2016b). During calendar year 2010, more than 47 million 
people representing over 18% of the population of the United States did not have health 
insurance (Garfield, Majerol, Damico, & Foutz, 2016; The Henry J. Kaiser Family 
Foundation, 2016b). The health insurance coverage status of an individual is an important 
determinant in their overall health. Individuals with health insurance are generally 
healthier and experience lower disease and overall mortality rates than those without 
health insurance coverage (Wilper et al, 2009). Wilper et al. (2009) indicated that nearly 
45,000 people die annually due to the lack of health insurance coverage. If the dearth of 
health insurance were considered an illness or disease, it would be ranked as the 10th 
leading cause of death in the United States (Centers for Disease Control and Prevention 
[CDC], 2017c). Work-aged people without health insurance experience a risk of death 




al., 2009). Health insurance coverage has been found to be associated with the improved 
diagnosis, treatment, management, and mortality rate for people afflicted with numerous 
chronic medical conditions (Hogan et al., 2015; Yehia et al., 2014). Individuals covered 
with health insurance experienced a 14% increase in the frequency of being diagnosed 
with diabetes and high cholesterol and a 9% increase in the rate of diagnosis for high 
blood pressure (Hogan et al., 2015).  People with health insurance were also more likely 
to have a lower blood pressure, total cholesterol, and hemoglobin A1C (Hogan et al., 
2015). Health insurance coverage is also associated with prolonged viral suppression, 
reduced likelihood of HIV progressing to AIDS, and reduced likelihood of premature 
death (Bradley et al., 2016; Dawson and Kates, 2019; McManus et al., 2016; McManus et 
al., 2018; Raifman et al., 2019; Yehia et al., 2014). 
To reduce the number of people without health insurance coverage and improve 
overall health, the ACA was passed into law in 2010. Numerous provisions were written 
into the law to achieve health-related goals. First, the ACA includes an individual 
mandate that requires all U.S. citizens and legal residents to obtain health insurance 
coverage or pay a fine (Kates, Dawson, Undem, & Perry, 2014; Westmoreland, 2016). 
The fine serves as an inducement to encourage people to sign up for health insurance 
coverage. The penalty for not enrolling in a health insurance plan in 2018 was the greater 
of 2.5% of annual household income, or a per person charge of $695 per adult with a 
maximum of $2,085 per family per year (Internal Revenue Service, 2017b). 
Consumer protections were included in the ACA to ensure that insurance 




an enrollee become afflicted with a medical problem. For example, provisions of the 
ACA preclude insurance companies from denying coverage or raising the premium rates 
for people with preexisting medical conditions, establishing annual or lifetime financial 
coverage limits, and retroactively cancelling coverage after a person gets sick if they are 
found to have made inconsequential or irrelevant mistakes on an enrollment application 
form (Hellinger, 2015; Rozin et al., 2015; U.S. Department of Health & Human Services, 
2017n; Viall, McCray, Mermin, & Wortley, 2016). Prior to the passage of the ACA, 
insurance companies used these strategies to minimize their claims exposure for PLWHA 
and other high-cost medical conditions. Additional requirements of the ACA include 
coverage for preventive health care services and the creation of a minimum medical loss 
ratio mandating the insurance companies spend between 80% and 85% of their premium 
dollars collected on health care claims (Kantarjian, 2017; The Henry J. Kaiser Family 
Foundation, 2015). 
The federal governmental has made a substantial financial investment to subsidize 
the costs associated with purchasing ACA health insurance. The Congressional Budget 
Office (as cited in Ferris, 2016) estimated that ACA subsidies cost the federal 
government approximately $660 billion in 2016 and will cost an estimated $1.1 trillion 
over the next 10 years. Because of this financial investment, the number of people 
without health insurance has dramatically declined. From 2010 to 2016, the number of 
people without health insurance coverage decreased from 47 million to 27 million (The 
Henry J. Kaiser Family Foundation, 2016b, 2017a). Although the ACA reduced the 




rising health care costs resulting in the proliferation of high-deductible health plans. 
Patients enrolled in health insurance plans with high deductibles avoid seeking needed 
medical care. To minimize paying out-of-pocket financial costs, patients with high 
deductibles avoid getting physician-recommended diagnostic tests or procedures. 
Medical care avoidance delays disease diagnosis; reduces treatment options and health 
outcomes for a wide variety of health ailments including several types of cancer, heart 
disease, stroke, and arthritis; and increases overall suffering and the rate of mortality 
(Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 2016; Taber et al., 2015). 
Considering the large financial investment spent on the ACA, it is important to 
understand whether this legislation has enhanced the health of PLWHA. 
HIV/AIDS is a serious health problem for people living in the United States and 
specifically in the state of Florida. Nationally, there are more than 1.1 million PLWHA; 
in 2014, Florida had the third largest number of residents diagnosed and living with HIV 
at 110,000 (CDC, 2016b; Florida Department of Health, 2016b). The advent of ART 
medications turned HIV/AIDS from a fatal disease into a chronic medical condition. 
PLWHA who are compliant in taking their ART medications are more likely to become 
virally suppressed, which increases overall survival rates and reduces the spread of the 
disease (Drainoni et al., 2015; Greenberg, Purcell, Gordon, Barasky, & del Rio, 2015). 
PLWHA who are virally suppressed can experience a life expectancy similar to people 
who are not infected with the disease. Although ART medications are effective in 
slowing the progression of the disease and prolonging the lives of PLWHA, they are 




low-income underinsured or uninsured PLWHA to cover HIV/AIDS expenses related to 
medical services, food, housing, case management, support services, ART medications, 
mental health, and substance abuse treatment (McQuade et al., 2015; Weiser et al., 2015). 
As the third largest recipient of HIV/AIDS treatment funding behind Medicare and 
Medicaid, the RWHAP provides care to 66% of PLWHA in the United States (The Henry 
J. Kaiser Family Foundation, 2017b). PLWHA are more likely to become virally 
suppressed if they receive care from RWHAP facilities (Morin, 2015).  
Problem Statement 
Several researchers have studied the impact of the services provided by the 
RWHAP on the health of PLWHA. Morin (2015) and Weiser et al. (2015) demonstrated 
improved health outcomes as measured by improved viral suppression for people 
enrolled in the RWHAP. Researchers have attributed the improved health outcomes of 
Ryan White PLWHA to the additional support services provided such as case 
management and mental health (Morin, 2015). Cahill, Mayer, and Boswell (2015) found 
that 73% of PLWHA enrolled in the RWHAP received continuous care (two physician 
visits, at least 3 months apart, within the previous 12 months) as compared to 51% of 
PLWHA who were not enrolled in the program. 
Although the RWHAP has improved the health of PLWHA, the United States has 
failed to meet global health goals for the detection and treatment of HIV/AIDS set by the 
World Health Organization and the United Nations. The Joint United Nations Program on 
HIV/AIDS (UNAIDS) launched the 90-90-90 campaign to increase HIV/AIDS detection 




the detection rate of HIV to 90% of those infected, provide sustained ART treatment to 
90% of those detected, and virally suppress 90% of the cases treated (Morin, 2015; 
UNAIDS, 2018). Currently the HIV detection rate in the United States is 86%, while only 
37% of PLWHA nationally are prescribed ART medications and only 30% are virally 
suppressed (Greenberg et al., 2015; U.S. Department of Health & Human Services, 
2016b). 
Although the research regarding the health of PLWHA enrolled in the RWHAP 
provided important findings, I found only three studies in which researchers examined 
whether the comprehensive health insurance provided by the ACA improved the overall 
health status of PLWHA compared to those receiving Ryan White Care. In a study of 
PLWHA residing in Virginia who transitioned from the RWHAP to an ACAQHP, 
McManus et al. (2016) and McManus et al. (2018) reported that ACA coverage was 
associated with improved viral load suppression. Raifman et al. (2018) reported that 
among PLWHA residing in the United States in 2015, 79% who were enrolled in an 
ACAQHP were virally suppressed compared to 75% who were enrolled in the RWHAP. 
Due to the small study size and narrow geographic focus of these studies, further research 
was warranted to determine whether comprehensive health care coverage provided by the 
ACA improves the health status of PLWHA compared to PLWHA receiving Ryan White 
care. 
Purpose of the Study 
The purpose of this quantitative correlational cross-sectional research study was 




of PLWHA compared to PLWHA receiving Ryan White care. A cross-sectional design 
was employed to measure multiple independent variables including demographic factors, 
treatment compliance, and engagement in care on the health of PLWHA enrolled in an 
ACAQHP compared to PLWHA enrolled in the RWHAP. Levin (2006) wrote that cross-
sectional research is commonly used in social-science studies because it facilitates an 
understanding of the overall etiology of a disease and assists in the generation of research 
hypotheses. My study provided information on the impact that ACA health insurance 
coverage had on the health of PLWHA compared to the health of PLWHA in the 
RWHAP. Based on the substantial investment of public funds, it is important to 
understand whether PLWHA who enroll in an ACAQHP achieve improved health 
compared to PLWHA who enroll in the RWHAP. 
Research Questions and Hypotheses 
RQ1: What is the relationship between demographic factors (race, gender, age, 
education level, and federal poverty level), treatment compliance (as defined by the 
number of ART missed doses in the past 30 days), engagement in care (as defined by the 
number of HIV/AIDS-related physician visits within the previous 12 months), and 
coverage status (enrolled in the RWHAP or an ACAQHP) and the health status of 
PLWHA (as defined by viral suppression)? 
Ho1: There is no statistically significant relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 
defined by the number of ART missed doses in the past 30 days), engagement in care (as 




months), and coverage status (enrolled in the RWHAP or an ACAQHP) and the health 
status of PLWHA (as defined by viral suppression). 
Ha1: There is a statistically significant relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 
defined by the number of ART missed doses in the past 30 days), engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months), and coverage status (enrolled in the RWHAP or an ACAQHP) and the health 
status of PLWHA (as defined by viral suppression). 
RQ2: What is the difference in treatment compliance (as defined by the number of 
ART missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and 
PLWHA enrolled in the RWHAP? 
Ho2: There is no statistically significant difference in treatment compliance (as 
defined by the number of ART missed doses in the past 30 days) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
Ha2: There is a statistically significant difference in treatment compliance (as 
defined by the number of ART missed doses in the past 30 days) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
RQ3: What is the difference in engagement in care (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? 
Ho3: There is no statistically significant difference in engagement in care (as 




months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. 
Ha3: There is a statistically significant difference in engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. 
RQ4: What is the difference in health status (as defined by viral suppression) 
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? 
Ho4: There is no statistically significant difference in health status (as defined by 
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in 
the RWHAP. 
Ha4: There is a statistically significant difference in health status (as defined by 
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in 
the RWHAP. 
RQ5: What is the difference in difficulty in paying out-of-pocket medical 
expenses (as defined by problems paying for any out-of-pocket medical or health 
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP? 
Ho5: There is no statistically significant difference in difficulty in paying out-of-
pocket medical expenses (as defined by problems paying for any out-of-pocket medical 
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA 




Ha5: There is a statistically significant difference in difficulty in paying out-of-
pocket medical expenses (as defined by problems paying for any out-of-pocket medical 
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA 
enrolled in the RWHAP. 
Theoretical Framework 
The theoretical framework that I used for my study was Andersen’s behavioral 
model of health services use. Since its inception, the behavioral model of health services 
use has become widely accepted and is the most commonly used framework to predict 
and explain the factors that impact health care access, utilization, and health outcomes 
(Graham, Hasking, Brooker, Clarke, & Meadows, 2017). Andersen and Newman (2005) 
postulated that the volume of health care services consumed by an individual is 
dependent on the predisposition of a person to utilize health care services, enabling 
factors of the person that facilitate access to health care services, and the diagnosed 
illness severity of the health care consumer. These three stages of the behavioral model of 
health services use, combined with the subset of operational variables from each stage, 
thematically complemented the dependent variable, independent variables, and research 
questions in my study. The independent variables, which included gender, race, age, and 
education level, were encompassed in the demographic and social structure 
characteristics that are part of the predisposing stage of the model (see Andersen & 
Newman, 2005). Other demographic independent variables such as income and patient 
out-of-pocket medical cost sharing expenses were represented in the model as financial 




compliance and engagement of care were classified as finance and community subgroups 
of enabling characteristics (see Andersen & Newman, 2005). Finally, the dependent 
variable (health status) was represented in the model as an evaluated symptom/diagnosis, 
which is a subcomponent of illness level, the third stage of the model (see Andersen & 
Newman, 2005). 
Andersen’s behavioral model of health services use was suited to serve as a 
theoretical foundation for this study because it is regularly used to study PLWHA. 
Brennan, Morley, O’Leary, Bergin, and Horgan (2015) utilized Andersen’s model to 
examine factors that influenced the utilization of HIV outpatient services, while 
Holtzman et al. (2015) used the model to study factors that impacted treatment access, 
adherence, and compliance. Additionally, Walter et al. (2016) applied the model to 
examine the impact of decreased drug use on reduced HIV sexual risk behaviors. Ford, 
Godette, Mulatu, and Gaines (2015) used the model to study HIV testing prevalence and 
disparities among older adults in the United States. Finally, Haley et al. (2014) used  
Andersen’s model to develop retention strategies to reduce the number of missed office 
visits among low-income women residing in areas with a high prevalence of HIV. This 
model is described in greater detail in Chapter 2. 
Nature of Study 
I used a quantitative correlational cross-sectional design to examine the 
relationships between demographic factors, treatment compliance, engagement in care, 
and the health of PLWHA enrolled in the RWHAP or an ACAQHP. Levin (2006) wrote 




understanding of the overall etiology of a disease because data regarding risk exposure 
can be gathered and associations between risk factors can be determined. A cross-
sectional design is frequently used when scholars are trying to understand the impact of 
multiple independent variables on a dependent variable, when measured at a specific 
point in time (Frankfort-Nachmias, Nachmias, & DeWaard, 2015).  
There are three principal advantages of a cross-sectional research design. First, a 
cross-sectional design enables researchers to conduct studies in natural and real-world 
situations using probability samples that increase the external validity of the study 
(Frankfort-Nachmias et al., 2015). Second, the random assignment of study participants 
to a control and experimental group is not needed in a cross-sectional design (Frankfort-
Nachmias et al., 2015). This was an important consideration because the potential 
assignment of patients to either group might result in an adverse health event, which 
would be unethical because it would violate the responsibility of the researcher not to 
harm their study participants. Third, cross-sectional studies are less costly and time-
consuming to conduct than other types of studies because data are collected at only one 
point in time (Levin, 2006).  
There are several disadvantages of a cross-sectional design. First, because data in 
a cross-sectional study are collected at only one point in time, they may not be 
representative of the overall participant being studied (Sedgwick, 2014). Second, it is 
problematic to deduce a temporal relationship between an independent variable and an 
outcome; therefore, causation is unable to be determined and can only be logically or 




researchers using a cross-sectional design are unable to control for alternative analytical 
explanations, which is problematic in developing clear inferences from the data 
(Frankfort-Nachmias et al., 2015).  
A correlational design is also commonly used in social science and health care 
research when researchers are interested in understanding the relationships between 
multiple independent variables and a dependent variable in a population (Curtis, 
Comiskey, & Dempsey, 2015). A correlational design is used to measure the 
relationships between and among two or more variables (Field, 2013). One advantage of 
a correlational design is it allows researchers to inexpensively and quickly achieve a large 
sample size through the use of archived secondary data (Grand Canyon University, 
2018). A second advantage of a correlational design is researchers can study the impact 
of different independent variables in a naturally occurring event that may be unethical to 
implement in an experimentally designed study (Curtis et al., 2015; Grand Canyon 
University, 2018). For example, it would be unethical to withhold ART medications from 
PLWHA to investigate the impact on viral load suppression. One disadvantage of a 
correlational design is the inability to establish causation among the independent and 
dependent variables (Grand Canyon University, 2018). Correlational research addresses 
the strength of relationships and cannot be used to establish a cause-and-effect 
relationship (Curtis et al., 2015). Additionally, a correlational design does not allow a 
researcher to extrapolate findings to answer other research questions (Grand Canyon 




The Florida Department of Health agreed to share data from the 2018 version of 
the Medical Monitoring Project for use in the current study. This secondary data set 
provided information on PLWHA who were enrolled in the RWHAP or an ACAQHP. To 
protect the confidentiality of the study participants, all personal health data were de-
identified. Financial, clinical, and socioeconomic variables including viral load rates, 
office visit frequency, ART missed doses in the past 30 days, age, sex, race, educational 
level, federal poverty level, and difficulty in paying out-of-pocket medical expenses were 
analyzed using SPSS. 
I employed a multiple linear regression, an independent samples t test, and a chi-
square test to analyze the secondary data, A multiple linear regression analysis is used to 
measure the level of statistical significance of association between different independent 
variables and a continuous dependent variable (Field, 2013). Multiple linear regression is 
frequently used in epidemiologic or health-related studies because it is often unsafe or 
unethical to randomly assign study participants to an experimental and control group. 
Instead, researchers include different independent variables and attempt to predict the 
probability of them affecting the dependent variable. In the current study, a multiple 
linear regression analysis was employed to examine the relationship between 
demographic factors, treatment compliance, engagement in care, and coverage status and 
the health status of PLWHA. Numerous researchers have used a multiple linear 
regression analysis to study the impact of health care access on health and compliance, 
engagement, and viral suppression among PLWHA (Carrico & Moskowitz, 2014; 




Second, an independent samples t test was used to examine the difference in mean 
treatment compliance, engagement in care, and health status among PLWHA who were 
enrolled in the RWHAP or an ACAQHP. The independent samples t test is an 
appropriate statistical analysis to answer research questions because an independent 
samples t test compares differences in the means between two unrelated groups (Field, 
2013). Similar to a linear regression, an independent samples t test is commonly used in 
health care research (Pandey, 2015). Furthermore, researchers have used an independent 
samples t test to examine viral load suppression, medical care compliance, and 
engagement in care among PLWHA, and to investigate the impact of health insurance 
coverage on access to care and quality of care (Abuosi, Domfeh, Abor, & Nketiah-
Amponsah, 2016; Drachler, Drachler, Teixeira, & de Carvalho Leite, 2016; Enriquez et 
al., 2015; Maman et al., 2015). 
Third, a chi-square test was used to measure the difference in difficulty in paying 
out-of-pocket medical expenses between PLWHA enrolled in an ACAQHP and PLWHA 
enrolled in the RWHAP. A chi-square test is a suitable statistical analysis to answer 
research questions because it measures the relationship between categorical variables 
among two independent groups (Field, 2013). Researchers have used a chi-square test to 
investigate viral load suppression, medical care compliance, and engagement in care 
among PLWHA (Chang, Fleming, Nunez, & Dombrowski, 2019; Stitzer et al., 2018). 
Definitions 
90-90-90 campaign: A United Nations program to end the HIV/AIDs epidemic as 




of their diagnosis, 90% of people diagnosed with HIV regularly receive ART, and 90% of 
people on ART become virally suppressed (UNAIDS, 2018). 
ACA: An acronym for the Affordable Care Act, which was a piece of health care 
reform legislation that was enacted in March of 2010. The main goal of the ACA was to 
reduce the number of Americans without health insurance through more affordable 
insurance premiums and an expansion of the Medicaid program (U.S. Centers for 
Medicare & Medicaid Services, 2017a). 
AIDS: An acronym for acquired immunodeficiency syndrome. AIDS is the last 
phase of the HIV disease cycle. A diagnosis of AIDS is confirmed if the immune system 
of a patient is significantly weakened and the number of CD4 cells drops below 200 cells 
per cubic millimeter of blood or upon the contraction of an opportunistic infection (U.S. 
Department of Health & Human Services, 2017f). 
Antiretroviral therapy (ART): Medications taken by PLWHA to limit the HIV 
virus from reproducing, which reduces the amount of HIV virus (viral load) in the body 
and the rate of transmission to an uninfected individual (U.S. Department of Health & 
Human Services, 2017c). 
CD4 count: The number of CD4 cells in a person’s blood as measured by a 
laboratory test. CD4 cells are a form of white blood cells that safeguard the body from 
bacteria, infections, and a variety of diseases including many forms of cancer. A large 
CD4 count indicates better health. The CD4 count of a person without HIV ranges 




per cubic millimeter indicates that the HIV virus has progressed to AIDS (U.S. 
Department of Health & Human Services, 2017g) 
Coinsurance: A percentage of the costs incurred for health services or 
prescription medications for a patient with health insurance after they met their 
deductible (U.S. Centers for Medicare & Medicaid Services, 2017e). 
Copayment: The amount of money a patient with health insurance pays each time 
they consume a health care service such as a physician visit, emergency room visit, 
hospitalization, or prescription (U.S. Centers for Medicare & Medicaid Services, 2017e). 
Deductible: The amount of money a patient with health insurance pays for a 
covered health care service before their insurance company begins to make payment 
(U.S. Centers for Medicare & Medicaid Services, 2017e). 
Engagement in care: A variable in this study, which was measured by the number 
of HIV/AIDS-related physician visits within the previous 12 months. 
Health insurance premium: The financial cost to purchase a health insurance 
policy (U.S. Centers for Medicare & Medicaid Services, 2017b). 
HIV: An acronym for human immunodeficiency virus. HIV is a virus that attacks 
the body’s CD4 cells resulting in a weakened immune system, which is then unable 
combat infections and disease. There is no cure for HIV, although appropriate medical 
care and medication can control the virus and limit its transmission to other people (CDC, 
2016b). 
HIV continuum of care: A framework that depicts the successive steps of medical 




stages of the continuum of care include diagnosed, engaged in care, prescribed ART, and 
virally suppressed (CDC, 2017e). 
Out-of-pocket maximum: The annual maximum amount of money a patient with 
health insurance will spend on deductibles, copayments, and coinsurance before their 
health insurance company pays for 100% of the costs for all covered health expenses 
(U.S. Centers for Medicare & Medicaid Services, 2018b). 
Out-of-pocket medical expenses: The financial cost incurred by a patient to pay 
for medical bills, health insurance premiums, deductibles, copayments, and coinsurance 
(U.S. Centers for Medicare & Medicaid Services, 2018b). 
PLWHA: An acronym for people living with HIV/AIDS (U.S. Department of 
Health & Human Services, 2017k). 
RWHAP: An acronym for the Ryan White HIV/AIDS Program, which was 
established in 1990 when Congress passed the Ryan White Comprehensive AIDS 
Resource Emergency (CARE) Act. The RWHAP provides comprehensive medical care 
and other health care services on an outpatient basis to PLWHA who are poor, uninsured, 
or underinsured (HRSA, 2017a). 
Treatment compliance: A variable in this study, which was measured by the 
number of missed ART doses in the past 30 days. 
Viral load suppression: Viral load measures the amount of HIV particles, or 
copies, in a milliliter of blood and is determined through a laboratory test. A high viral 




become virally suppressed, which occurs when there are less than 200 copies of the HIV 
virus in a sample of blood (U.S. Department of Health & Human Services, 2015a).  
Assumptions 
There were several assumptions in this study. The first assumption was that 
comprehensive health insurance coverage would improve the health of PLWHA (see 
Wagner, Wu, & Sood, 2014). Although the scientific literature indicated the health 
benefits of having health insurance, a scarcity of information exists on the impact of the 
ACA on the health of PLWHA. The second assumption was the sample size of survey 
participants enrolled in the RWHAP and in an ACAQHP would be large enough to 
generate meaningful results and the sample would be representative of the overall Florida 
RWHAP. According to Chow, Shao, Wang, and Lokhnygina (2007), “in clinical 
research, sample size calculation plays an important role for assuring validity, accuracy, 
reliability, and integrity of the intended clinical study” (p. 1). The third assumption was 
that all Medical Monitoring Project interviewers reported the collected data accurately 
from the participants who participated in the health survey. The accuracy of the data 
collection process is an important consideration in enhancing the validity of the results of 
a study so that other researchers may replicate the study or compare the outcomes across 
multiple studies; poor clinical documentation may retard the ability to accurately measure 
treatment effectiveness and health care outcomes (De Moor et al., 2015; Springate et al., 
2014).  
The fourth assumption was that the survey participants understood the questions 




reliable, accurate, and honest. DeLamater and Plante (2015) noted that asking people 
sensitive questions about their sexuality (and associated health complications) may 
increase survey response bias due to a larger number of nonresponses or misreported 
answers motivated by social desirability to avoid overall embarrassment. The fifth and 
final assumption was that the Medical Monitoring Project database included data on all of 
the variables examined in this study. 
Scope and Delimitations 
The scope of a study indicates the topics that will be explored and the 
specifications of the data set that will be used to substantiate the analytical findings and 
study conclusions (Goes & Simon, 2013). The scope of the current study was limited to 
PLWHA residing in Florida who were surveyed as part of the Medical Monitoring 
Project and had coverage through the RWHAP or an ACAQHP. All PLWHA who met 
the selection criteria were included in this study as long as health care utilization and 
outcome data were available. Utilization and outcome data were analyzed using de-
identified personal health information obtained by the Florida Department of Health as 
part of the Medical Monitoring Project. Although the information contained in this 
database is not published or available in the public domain, it was appropriate for use in 
the current study because it contains the data needed to answer the research questions (E. 
Spencer, personal communication, March 1, 2019). Comparing the health outcomes of 
PLWHA enrolled in either the RWHAP or an ACAQHP would provide clarity on the 
impact that demographic factors, difficulty in paying out-of-pocket medical expenses, 




Delimitations occur as a result of the inclusion and exclusion criteria determined 
by the researcher (Goes & Simon, 2013). The primary delimitation of the current study 
was the focus on PLWHA who resided in Florida, participated in the Medical Monitoring 
Project survey, and were enrolled in either the RWHAP or an ACAQHP. The health 
outcomes of PLWHA who did not participate in this survey and who had other forms of 
health insurance coverage were excluded from this study. A second delimitation was the 
impact of comorbidities associated with HIV/AIDS on viral load suppression. The failure 
for PLWHA to become virally suppressed may be a result of HIV/AIDS-related 
comorbidities and not the failure of the ACA to improve the health of enrollees in the 
program (Syed et al., 2016). These delimitations may prevent the findings of the current 
study from being generalized to other populations of PLWHA. 
Limitations 
This study had several limitations. The first limitation was the potential for 
inaccurate data and/or poor data entry in the patient’s medical record. Because secondary 
data were used for this study, I was dependent on medical personnel to accurately assess, 
diagnose, and document patient findings in the medical record. The second limitation was 
weaknesses in the design of this study. A quasi-experimental design was used because it 
would have been unethical to randomly assign participants to an experimental group and 
a control group. However, the absence of adequate control over alternative explanations 
limits my to draw clear inferences from the data (Frankfort-Nachmias et al., 2015). In 
addition, the use of a correlational cross-sectional design allowed for the measurement of 




cross-sectional design is the inability to determine a cause-and-effect relationship 
between the dependent and independent variables (Curtis et al., 2015; Grand Canyon 
University, 2018; Setia, 2016; Solem, 2015). This limitation can be diminished through 
the use of statistical analysis to approximate an experimental design (Frankfort-Nachmias 
et al., 2015).  
The third limitation of this study was the use of convenience purposive sampling 
methodology. A convenience sample is a nonprobabilistic sampling strategy in which 
study participants are selected based on the ease of access for the researcher (Laerd 
Statistics, 2012a). Convenience sampling may exhibit bias, and the included participants 
may not be representative of the overall population, which may limit the generalizability 
of the findings to other populations (Laerd Statistics, 2012a). This is in contrast to 
probabilistic sampling techniques, in which the selection of units is made randomly. The 
sampling strategy used in the current study was also purposive because the inclusion 
criteria required enrollment in either the RWHAP or an ACAQHP. A purposive sampling 
strategy is also a nonprobabilistic methodology in which participants are selected based 
on qualifications or characteristics selected by the researcher, which may limit the 
generalizability of the findings due to researcher bias or a nonrepresentative sample of 
participants (Laerd Statistics, 2012d).  
Because the reasons why some PLWHA enrolled in either the RWHAP or an 
ACAQHP were unknown, the findings of this study may not be generalizable to other 
populations but may be representative of trends among PLWHA (see Etikan, Musa, & 




potential threat to external validity. Frankfort-Nachmias et al. (2015) defined external 
validity as the extent to which the findings of a research study can be generalized to other 
people or other settings. The sample of PLWHA who have ACAQHP coverage may not 
be representative of other PLWHA with ACAQHP coverage in other parts of Florida or 
throughout the United States.  
The fifth limitation was the threat to internal validity, which may have 
compromised the conclusions establishing a relationship between independent and 
dependent variables. Threats to internal validity, including include history and 
maturation, need to be controlled (Creswell, 2009). History refers to events that transpire 
during the passage of time throughout the course of the treatment period that may impact 
the results, while maturation refers to changes among study participants (Creswell, 2009).  
Significance of the Study 
A primary goal of the ACA is to improve health care outcomes for people 
enrolled in qualified health plans. The federal government is projected to spend $716 
billion annually by the year 2024 to reduce the number of people in the United States 
without health insurance and improve the overall health of the population (Jeffrey, 2014). 
There is a scarcity of research on the change in the health of people enrolled in an 
ACAQHP. Considering the substantial investment in financial resources and time, it is 
important for the federal government, politicians, public health leaders, health care 
providers, and patients to understand whether people enrolled in ACAQHP achieve 
improved health. My study provided an opportunity to examine the health of patients 




To measure the relationship between health outcomes and enrollment in an 
ACAQHP, I selected the HIV/AIDS patient population for several reasons. First, I had 
access to secondary data provided by the Florida Department of Health to assess quality 
outcomes once IRB approval was obtained. Second, people with HIV residing in the 
Florida have failed to meet the global health goals set by the World Health Organization 
and the United Nations regarding the minimum percentage being subscribed ART 
medications and becoming virally suppressed (Florida Department of Health, 2016a).  
Through examination of the impact that the ACA has on improving the health of 
PLWHA, this study has the potential to promote positive social change by assisting 
marginalized populations in understanding whether ACA health insurance coverage 
improves their overall quality of life. Marginalized populations, including African 
Americans, Hispanics, and the poor, represent the largest group of people to receive 
health care coverage through the ACA (Ferris, 2015). HIV also affects marginalized 
populations because it has disproportionately infected racial, ethnic, and sexual minorities 
and people with reduced financial means (Abara & Heiman, 2014; Yehia et al., 2014). 
Because researchers have not examined the impact of the ACA on the health of PLWHA 
in the state of Florida, the results from my study may provide important information to 
close a gap in the literature among the scientific community. Furthermore, the findings 
from my study may help raise awareness of the relationship between ACA health 
insurance coverage and enhanced quality of life for PLWHA. The results will be shared 
with Ryan White programs throughout the United States to help determine how RWHAP 





The ACA was passed in 2010 and was the most substantial piece of health care 
legislation enacted since the passage of Medicare and Medicaid in 1965. The primary 
objective of the ACA is to increase the percentage of Americans with health insurance so 
more people can access needed medical care and achieve an improved level of health. 
Although federal expenditures on the ACA will exceed $716 billion by 2024, little 
research has been conducted addressing the impact on health of this health care initiative. 
The objective of my study was to compare the health of PLWHA enrolled in either the 
RWHAP or an ACAQHP within the state of Florida. I also examined the relationships 
between demographic factors, out-of-pocket medical expenses, treatment compliance, 
and engagement in care on the health of this patient population. The results of this study 
may provide quantitative data to determine the impact on health of the ACA and provide 
strategies to optimize the percentage of PLWHA achieving viral suppression. The 
literature review in Chapter 2 provides an overview of the HIV/AIDS virus, the ACA, the 
RWHAP, and the impact that health insurance coverage has on the utilization of health 




Chapter 2: Literature Review 
Introduction 
HIV, the virus that causes AIDS, is an important global health problem. In 2015, 
2.1 million people were newly diagnosed with HIV, which increased the total number of 
infected worldwide to 36.7 million (U.S. Department of Health & Human Services, 
2017l). Nearly 60% of people with HIV worldwide are unaware of their disease status, 
and this can contribute to the spread of the disease (U.S. Department of Health & Human 
Services, 2017f; World Health Organization, 2016a). There is no cure for HIV, and if 
untreated, HIV can develop into AIDS, which damages the immune system and leads to 
the development of opportunistic infections that are often fatal (U.S. Department of 
Health & Human Services, 2017f). Approximately 35 million people globally have died 
from complications associated with the disease (World Health Organization, 2016a). In 
2015, more than 1.1 million people living with HIV died throughout the world (World 
Health Organization, 2016a). 
Since the first reported case of HIV/AIDS in the United States in 1981, an 
estimated 1.9 million people have been diagnosed with HIV (The Henry J. Kaiser Family 
Foundation, 2016a). Approximately 700,000 Americans have died from HIV/AIDS-
related complications, and an estimated 1.1 million people in the United States are 
currently infected with the disease (CDC, 2016c, 2016d; The Henry J. Kaiser Family 
Foundation, 2016a; U.S. Department of Health & Human Services, 2017m). In 2015, 
39,513 new cases of HIV were reported while 6,721 PLWHA perished from the disease 




Although HIV continues to spread, the rate of new infections in the United States 
is decreasing. From 2005 to 2014, the annual number of newly reported HIV cases 
declined by 19% (CDC, 2016d; The Henry J. Kaiser Family Foundation, 2016a; U.S. 
Department of Health & Human Services, 2017m). This decline has been attributed to the 
increased utilization of routine HIV testing and the improved efficacy of ART 
medications (Drainoni et al., 2015; The Henry J. Kaiser Family Foundation, 2016a). ART 
medications have enabled virally suppressed PLWHA to achieve a life expectancy 
comparable to the general population, rendering HIV a chronic medical condition as 
opposed to a death sentence (Doshi et al., 2015; Drainoni et al., 2015; Maulsby et al., 
2015). 
Comprehensive health insurance coverage has been found to be positively 
associated with improved health status for PLWHA. Yehia et al. (2014) stated that 
PLWHA who have health insurance coverage are less likely to develop AIDS and 
experience premature death. PLWHA are often uninsured. In 2014, an estimated 30% to 
40% of PLWHA did not have comprehensive health insurance and relied solely on 
support from the RWHAP (Rozin et al., 2015). Although the RWHAP provides needed 
HIV-related health care services to PLWHA and has been found to be related to 
improved treatment outcomes, it does not provide comprehensive health care coverage 
and is not a health insurance product (Bradley et al., 2016). The RWHAP offers HIV-
related care and support services on an outpatient basis and, as a payer of last resort, only 





To improve insurance coverage access and benefit quality for the underinsured 
and uninsured, the ACA was passed into law in 2010 (U.S. Department of Health & 
Human Services, 2016b). Extensive resources have been committed by the United States 
Federal Government to implement the ACA. However, I found no studies that addressed 
whether the comprehensive health insurance provided by the ACA has improved the 
overall health status of PLWHA compared to PLWHA who are enrolled in the RWHAP 
within the state of Florida. Further research was warranted to examine whether 
comprehensive health care coverage provided by the ACA improves the health status of 
PLWHA within Florida. The purpose of this quantitative research study was to determine 
whether the comprehensive care provided by the ACA improves the health of PLWHA 
within Florida.  
 Chapter 2 is divided into the following sections. First, I provided a description of 
the literature search strategy. Second, I provided a description and literature review of 
Andersen’s behavioral model of health services use, which served as the theoretical 
foundation for this study and a description of the appropriateness of Andersen’s model 
for use in this study. Finally, I provided a literature review addressing the dependent and 
independent variables, HIV/AIDS, the ACA, the RWHAP, and the impact that health 
insurance coverage has on the utilization of health care services and health outcomes. 
Literature Search Strategy 
I conducted an online literature review using, CINAHL, Google, Google Scholar, 
Medline, and PubMed to develop an understanding of the current information published 




Andersen’s behavioral model of health services use. The search terms included 
Affordable Care Act (ACA), ACA out-of-pocket costs, access to care, AIDS, 
Antiretroviral therapy (ART), ART adherence and viral suppression, behavioral model of 
health services use, continuum of care, health benefits of health insurance, health care 
reform, high deductible health plans, HIV, HIV engagement in care, HIV patient 
demographics, HIV physician visits, HIV prescribed ART, HIV retention in care, HIV 
treatment cost, HIV viral load suppression, Ronald Andersen, Ryan White HIV AIDS 
Program (RWHAP), and RWHAP continuum of care.  
The search terms were used individually and in combinations to narrow the search 
results. Search results were restricted to peer-reviewed journals and the websites of 
federal and state governmental agencies, international public health organizations, 
universities, health care foundations, and HIV/AIDS organizations. The time frame of the 
literature review was articles published between 2012 and 2018. Older references were 
selected if they were considered seminal studies, were included in the citation lists of 
other peer-reviewed references from within the restricted time frame, or were in other 
studies with a similar focus. 
Theoretical Foundation 
Behavioral Model of Health Services Use 
The theoretical foundation for study was Andersen’s behavioral model of health 
services use. Andersen developed the behavioral model of health services use to 
understand the factors that determine how and why health care services are utilized 




behavioral model of health services use in 1968, the model has gained widespread 
acceptance and has become the most commonly used framework for exploring the factors 
that impact health care access and utilization (Babitsch et al., 2012; Graham et al., 2017). 
The model has been used to predict and explain the use of health care services (Andersen, 
1995). Although the model has evolved since its development due to changes in the 
health care delivery system, health policy, health care financing, and feedback from 
academicians and health care professionals, the updates have expanded the scope of the 
model and have not changed any of the essential elements or relationships among the 
central variables (Andersen, 2008).  
Figure 1 shows the behavioral model of health services use as revised by 
Andersen and Newman (2005). This iteration of the model was selected because it was 
the first to include financial factors that facilitate access to care, such as income and 
patient out-of-pocket expenses, which served as independent variables in the current 
study. As shown in Figure 1, the behavioral model of health services use incorporates 
three stages including an initial predisposition to consume medical services, enabling 
circumstances that facilitate or inhibit the use of health care services, and illness level 










Figure 1. Revised behavioral model of health services use: Individual determinants of 
health services utilization. Adapted from Anderson and Newman (2005). 
 
Predisposing characteristics. Individuals consume health care services at 
differing rates. Health care services can be forecast by attributes that are present prior to 
the onset of a medical condition (Andersen, 1968). Predisposing characteristics that 




beliefs. Demographic factors include age, sex, marital status, and past illness (Andersen 
& Newman, 2005). Social structure characteristics include traits such as education, race, 
occupation, ethnicity, and religion (Andersen & Newman, 2005). Finally, health beliefs, 
represent the perception of the treatment efficacy of medical care (Andersen & Newman, 
2005). Individuals having positive feelings about their treatment plan or physician are 
more likely to use health care services, while people that have less faith in their treatment 
results are less likely to seek out medical care (Andersen, 1968). 
Predisposing characteristics are influencers and not factors that directly cause the 
use of health care services. For example, age is not a reason to use health care services, 
yet older age was associated with increased levels of illness and an increased need for 
medical care (Andersen, 1968). Social structure characteristics are correlated with 
specific lifestyle choices and are impacted by behavior and the environment in which the 
family lives, which ultimately influences the consumption of health care services 
(Andersen & Newman, 2005). Predisposing characteristics are more likely to remain 
constant over time and precede the enabling characteristics described in the second stage 
of the model. 
Enabling characteristics. Enabling characteristics, the second stage of the 
behavioral model of health services use are a set of conditions that facilitate access to 
health care services. Although an individual may be predisposed to utilize health care 
services, they must possess the resources to receive medical care. Enabling components 
include both financial and community resources (Andersen & Newman, 2005). Financial 




insurance, regular source of care, and the accessibility of care (Andersen & Newman, 
2005). Community resources that influence the utilization of health care services, include 
the quantity, quality, and sophistication of health care facilities and providers and 
locational convenience (Andersen & Newman, 2005). A community that has a physician 
shortage may experience a reduced utilization of health services due to the inability of the 
infirmed to receive or access needed care. 
Illness level. Illness level represents the third stage of the model. Presuming that 
both predisposing and enabling conditions are met, the consumption of health care 
services will occur if a perceived or evaluated illness exist combined with the individuals 
response to seek out care (Andersen & Newman, 2005). Characteristics of illness level 
attributed to the behavioral model include a self-diagnosed health level and symptoms, 
and an evaluated or clinically diagnosed medical condition.  
Model Use in Research 
The behavioral model of health services use is frequently cited as a theoretical 
framework to examine the factors that impact health care access and utilization (Babitsch 
et al., 2012; Graham et al., 2017; Holtzman, Shea, et al., 2015). The model has been 
utilized in HIV-related studies where researchers examined topics including access to 
medical care, linkage to and retention in care, and the access to and the use/adherence of 
ART medications. Anthony, Gardner, Marks, Anderson-Mahoney, and Metsch (2007) 
used the model to examine the utilization of HIV primary care services among people 
recently diagnosed with HIV. Using data obtained from the Antiretroviral Treatment 




education (predisposing factors), health insurance coverage, case management services, 
and having a usual source of medical care (enabling factors) and the existence of HIV 
symptoms (need factors) had on the probability of consuming health care services 
(Anthony et al., 2007). They found that racial disparities, education level, gender, 
insurance status, and experiencing HIV symptoms influenced the use of HIV primary 
care services. The researchers confirmed that predisposing, enabling, and need factors 
were associated with the utilization of health care services among people recently 
diagnosed with HIV (Anthony et al., 2007).  
Ulett et al. (2009) customized the model to examine the clinical outcomes 
associated with timely linkage to and early retention in HIV care. Age, race, ethnicity, 
poverty, education, mental illness, substance abuse, and stigma were categorized as 
predisposing factors (Ulett et al., 2009). Enabling factors included insurance status, 
transportation, housing, social support, and self-efficacy (Ulett et al., 2009). Symptoms 
and health beliefs were classified as need factors. The independent variables were patient 
sociodemographic information, medical history, and clinic visit utilization and the 
dependent variables included early retention in outpatient HIV care and the time it took to 
initiate ART (Ulett et al., 2009). The authors found that older patients and African 
Americans took more time to receive a HIV diagnosis and younger patients, and people 
abusing drugs and alcohol had a lower probability of being retained in care after timely 
linkage to care (Ulett et al., 2009). 
Holtzman et al. (2015) expanded the work of Ulett et al. (2009) by incorporating 




retention in care and ART adherence for PLWHA. Holtzman et al. (2015) identified five 
behavioral factors including health literacy, medication characteristics, reminder 
strategies, competing life activities, and pharmacy services that impacted retention in care 
and ART adherence that were not included in the work of (Ulett et al., 2009). Holtzman 
et al. (2015) reported that barriers and facilitators that impacted retention in care included 
transportation, clinic experiences, and appointment scheduling, while medication 
characteristics, pharmacy services, health literacy, and health beliefs influenced ART 
adherence. Factors that impacted both retention and adherence included stigma, mental 
illness, substance abuse, social support, reminder strategies, housing, insurance, 
symptoms, and competing life activities. 
The behavioral model of health services use was also used as a theoretical 
foundation for studies examining the access to and the use of ART medications. Smith 
and Kirking (1999) concluded that women and PLWHA 15 to 24 years old have reduced 
access to ART medications, while Andersen et al. (2000) reported that vulnerable 
subgroups of people living with HIV including female drug users, African Americans, 
and people with less than a high school education were less likely to receive access to 
ART medications.  
Appropriateness to Current Study 
People living with HIV must be linked, engaged, and retained in care to achieve 
viral suppression (Goldman, Juday, Linthicum, Rosenblatt, & Seekins, 2014; U.S. 
Department of Health & Human Services, 2018d). Timely and appropriate access, and 




(Goldman et al., 2014). Andersen’s behavioral model of health services use provides a 
framework that examines how patient and environmental factors impact health care 
access and outcomes (Andersen, 1968, 1995, 2008; Andersen, Davidson, & Baumeister, 
2013; Andersen & Aday, 1978; Ogunsanya, Jiang, Thatch, Bamgbade, & Brown, 2016). 
These factors represent the primary focus of this dissertation and reasons detailing the 
appropriateness of using this model are listed below. First, researchers have successfully 
used the model to predict and explain how people living with HIV access health care 
services and ART medications (Andersen et al., 2000; Bozzette et al., 1998; Holtzman, 
Shea, et al., 2015; Katz et al., 2001; Smith & Kirking, 1999). Second, the predisposing, 
enabling, and illness factors used in the model align with the topic, study variables and 
research questions I examined in this study. The key dependent and independent 
variables in this study include insurance coverage, gender, race, age, education level, 
income, out-of-pocket medical costs, access to ART medications and medical specialists, 
and evaluated and diagnosed viral load/health outcomes. These variables have been 
incorporated into previous HIV research and represent either predisposing, enabling, or 
illness/outcome factors that are the foundational tenants of Andersen’s behavioral model 
of health services use (Andersen & Newman, 2005). Ronald Andersen reviewed my 
prospectus and informed me that his model was aligned with the objectives of this 
dissertation and would be appropriate to use as a theoretical foundation (R. Andersen, 
personal communication, October 11, 2016). My study expanded Andersen’s theory 




the access to medical services and the health of PLWHA to those enrolled in the 
RWHAP. 
Literature Review Related to Key Variables and/or Concepts 
This literature review provides an overview of the key variables and concepts 
included in this study, and is organized into four sections. The first section provides an 
overview of the ACA, while the second section summarizes the HIV/AIDS disease.  The 
third section contains background information on the RWHAP, and the final portion of 
the literature review details the impact that health insurance coverage has on health care 
access, utilization, and outcomes.  
Affordable Care Act 
On March 23, 2010, President Barack Obama signed the Patient Protection and 
Affordable Care Act into law. The goals of the ACA are to reduce the number of 
uninsured or underinsured Americans and improve the affordability, accessibility, and 
quality of health care through improved coverage benefits and protections (U.S. 
Department of Health & Human Services, 2017n). Also known as Obamacare, the ACA 
was modeled after the universal coverage health reform initiative passed in 
Massachusetts in 2006, and represented the first national health reform legislation since 
the Medicare program was created in 1965 (Okoro, Dhingra, Coates, Zack, & Simoes, 
2014; Sommers, Long, & Baicker, 2014).  
Expansion of health insurance coverage. The ACA provides health insurance 
coverage to the uninsured through the expansion of Medicaid and the sale of commercial 




exchanges. As originally drafted, the ACA required states to ease eligibility requirements 
for adults to enroll in Medicaid. These new Medicaid eligibility requirements expanded 
coverage to families earning up to 138% of the federal poverty level (FPL) and removed 
the categorical eligibility requirement which limited coverage to children, parents with 
dependent children, pregnant women, and individuals with disabilities (Berry et al., 2016; 
Sommers, Musco, et al., 2014). However, the U.S. Supreme Court, in a 2012 ruling, 
declared that it was unconstitutional for the federal government to force states to expand 
their Medicaid programs (Wagner, et al., 2014). States retained the option to expand 
Medicaid eligibility if they desired and 32 states (including the District of Columbia) 
expanded their Medicaid programs, while 19 states declined to do so (Levitt, Claxton, & 
Cox, 2016; The Henry J. Kaiser Family Foundation, 2017c).  
Online state and federal exchanges were created to help individuals purchase a 
private ACA qualified health insurance plan (ACAQHP). The objective of these 
exchanges were to enhance the competitiveness in the health insurance marketplace by 
providing people greater transparency to compare the costs of the different health 
insurance plans offered by multiple insurance companies (Kates et al., 2014; 
Westmoreland, 2016).  The ACA contains an individual mandate that requires all U.S. 
citizens and legal residents, to obtain health insurance coverage or pay a fine by the year 
2014 (Kates et al., 2014; Westmoreland, 2016). The penalty for remaining uninsured in 
2017 was the greater of 2.5% of annual household income, or an annual per person 
charge of $695 per adult, $347.50 per child with a maximum of $2,085 per family per 




incentive to encourage millions of healthy Americans to sign up for ACA health 
insurance.  
The ACA created four different tiers of insurance coverage, bronze, silver, gold, 
and platinum. Each tier of health insurance provides different levels of coverage, which 
influence monthly premium amounts. Monthly health insurance premium costs are 
primarily determined based on the percent of initially covered services paid by the 
insurance company. Bronze level plans pay 60% of covered expenses, silver level plans 
70%, gold plans 80%, and platinum plans 90% (U.S. Centers for Medicare & Medicaid 
Services, 2017d). Generally, health insurance plans that pay the smallest percentage of 
initially covered medical expenses have the highest deductibles and the smallest monthly 
premiums (U.S. Centers for Medicare & Medicaid Services, 2017d). Conversely, health 
insurance plans that pay the largest percentage of initially covered expenses have the 
smallest deductibles and the highest monthly premiums. Bronze level plans typically 
have the lowest monthly premium, while platinum level plans generally are the most 
expensive (U.S. Centers for Medicare & Medicaid Services, 2017d). All ACA plans, 
regardless of tier, have the same annual out-of-pocket expense limit. An annual out-of-
pocket expense limit is the maximum cost a patient incurs for deductibles, copayments, 
and coinsurance in any plan year before the insurance company begins to pay 100% of all 
covered claims. The amount of money spent on health insurance premiums and any non-
covered health expense is not included in the annual maximum out-of-pocket expense 




plan for an individual was $7,350 and $14,700 for a family (U.S. Centers for Medicare & 
Medicaid Services, 2018b). 
Two types of tax subsidies were created to help lower income Americans 
purchase and use their ACA health insurance coverage. First, the ACA provides subsidies 
to reduce health insurance premium costs to individuals and families with incomes 
between 100% and 400% of the FPL (The Henry J. Kaiser Family Foundation, 2017d; 
Wagner et al., 2014). The amount of the premium subsidy is calculated based on a sliding 
scale, so enrollees with incomes at 100% of the FPL level receive more financial support 
than do people earning 400% of the FPL (Westmoreland, 2016). Second, the ACA 
provides additional cost sharing assistance to reduce patient out-of-pocket expenses for 
copayments, coinsurance, and deductibles for enrollees earning between 100% and 250% 
of the federal poverty level (The Henry J. Kaiser Family Foundation, 2017d). Both of 
these subsidies are classified as tax credits and are paid directly to the health insurance 
companies (Martin & Schackman, 2012). ACA subsidies are only available to enrollees 
who select silver level plans (The Henry J. Kaiser Family Foundation, 2017d).  
The subsidies provided by the ACA represent an investment to help reduce the 
number of people that do not have health insurance. Initial projections indicated that in 
2014, the federal government would spend $17 billion on subsidies for people who 
purchased insurance through the ACA exchanges (Jeffrey, 2014). In 2016, the 
nonpartisan Congressional Budget Office (as cited in Ferris, 2016) reported that subsidy 
costs increased an additional 11%.  By 2023, it is estimated that the annual subsidy cost 




Impact of the ACA on the uninsured. Prior to the implementation of the ACA 
in 2014, millions of people living in the United States did not have health insurance. In 
2013, 44 million nonelderly people were uninsured (Foutz, Squires, Garfield, & Kaiser 
Family Foundation, 2017; Garfield et al., 2016). By the end of 2016 more than 17 million 
people gained access to health insurance coverage as the number of nonelderly uninsured 
people were reduced to 27 million (Garfield et al., 2016; The Henry J. Kaiser Family 
Foundation, 2016b).  
This influx of 17 million newly covered individuals into the market due to the 
ACA has helped to reduce the disparities in health insurance coverage among low-
income people and minorities. The largest groups of newly insured include young people 
between 18 and 34 years old, poor people, Blacks, Hispanics, and people residing in rural 
communities (Ferris, 2015). The ACA reduced the uninsured rate by 4.7% for Whites, 
7.1% for Asians, 7.7% for Blacks, and 9.5% among Hispanics (Levins, 2015; The Henry 
J. Kaiser Family Foundation, 2016b). The uninsured rate declined 10.1% for people 
earning less than 100% of the FPL, 11.1% for those earning between 100% and 199%, 
and 3.0% for people with an income greater than 200% of FPL (The Henry J. Kaiser 
Family Foundation, 2016b). These demographic characteristics of the newly insured 
ACA members are also representative of the population most likely to contract 
HIV/AIDS. Zamani-Hank (2016) reported that 87% of PLWHA are young and earn less 
than 400% of the FPL. The ACA has improved the rate of health insurance coverage 
among populations that have historically been uninsured and may reduce the uninsured 




Features of the ACA. The ACA contains health insurance reforms that prevent 
private insurance companies from denying coverage to those in need. The ACA prevents 
insurance companies from denying coverage or raising the premium rates for people with 
preexisting medical conditions (U.S. Department of Health & Human Services, 2017a). 
Prior to the passage of the ACA, insurance companies could deny coverage or raise 
premium rates to people who became sick. The ACA also prohibits insurance companies 
from enacting annual or lifetime dollar limits on the payment of covered services (U.S. 
Centers for Medicare & Medicaid Services, 2018a). Insurance companies used annual 
and lifetime coverage limits to minimize their financial liability when paying claims for 
people with medical conditions that are costly to treat. Removing these financial 
coverage limits allow people in need of medical treatment to have their claims covered by 
their health insurance company. The ACA also forbids insurance companies from 
retroactively rescinding coverage due to an error or inadvertent mistake on a customer’s 
health insurance application (U.S. Centers for Medicare & Medicaid Services, 2018c). 
The ACA mandates that insurance companies extend coverage for dependent children up 
to the age of 26 (Viall et al., 2016). Finally, the ACA prevents insurance companies from 
discriminating and refusing to insure people based on their sexual orientation and gender 
identity (U.S. Department of Health & Human Services, 2017o). 
The ACA also includes mandates to improve the quality of medical care delivered 
to patients. The ACA requires insurance companies to devote a minimum percentage of 
their revenues on enrollee claims and initiatives to improve quality. The required medical 




to individuals and small businesses and 85% for large group plans (Kantarjian, 2017; 
National Association of Insurance Commissioners, 2018). To improve health, an 
adequate amount of money should be spent on health care as opposed to insurance 
company corporate expenses and profits. Prior to the passage of the ACA, insurance 
companies spent as little as 50% to 60% of their revenues on the payment of medical 
claims as compared to Medicare which spent 97% of its revenues on health care services 
(Kantarjian, 2017). Senior citizens are provided prescription drug pricing discounts of 
50% when they purchase Medicare Part D approved brand name medications (U.S. 
Department of Health & Human Services, 2017o). By 2020, the ACA will close the 
Medicare prescription drug gap, also known as the ‘donut hole’, where beneficiaries are 
required to pay the true out-of-pocket (TROOP) cost for covered medications until they 
reach the catastrophic maximum payment level and Medicare drug coverage payments 
resume (Livingston, 2017). The ACA also requires insurance companies to provide 
coverage for comprehensive health care services that will improve the quality of medical 
care offered to patients. Insurance companies under the ACA are required to provide 
enrollees free preventive care services. Preventive services that patients can access 
without cost include an assessment for obesity, blood pressure, cholesterol, depression, 
diabetes, cervical cancer, breast cancer, colorectal cancer, HIV, drug use, tobacco use, 
and sexually transmitted diseases (Han, Yabroff, Guy, Zheng, & Jemal, 2015; The Henry 
J. Kaiser Family Foundation, 2015). Researchers have shown that preventive services, 
offered to patients at no out-of-pocket cost remove barriers that inhibit utilization and 




they develop into more serious medical problems. Han et al. (2015) reported the 
utilization of preventive tests increased after the ACA eliminated patient cost sharing for 
these types of medical services. Finally, to ensure coverage consistency, access, and 
improved health outcomes, the ACA mandated that all health insurance plans provide 
coverage for a comprehensive set of ten essential health benefits including “ambulatory 
patient services, emergency services, hospitalization, maternity and newborn care, mental 
health and substance use disorder services including behavioral health treatment, 
prescription drugs, rehabilitative services, laboratory services, chronic disease 
management, and pediatric services” (U.S. Centers for Medicare & Medicaid Services, 
2017f, para. 1). As part of the prescription drug mandate, the ACA requires qualified 
health insurance plans to provide coverage for a minimum of one medication from each 
US Pharmacopeia category (U.S. Centers for Medicare & Medicaid Services, 2017f). 
This prescription mandate ensures that patients enrolled in ACA plans have access to a 
variety of medications to treat their medical conditions. 
Impact of ACA on Access to Care for PLWHA. For PLWHA, the primary 
benefit of the ACA is improved access to comprehensive care. Crowley and Garner 
(2015) reported that having health insurance enhances health security and that the 
RWHAP should not be mistaken for health insurance coverage as it only covers 
HIV/AIDS-related care on an outpatient basis and is expressly prohibited by law from 
providing inpatient HIV/AIDS care and coverage for medical issues that are not HIV-
related. PLWHA achieve overall improved health when utilizing the defined benefits of a 




difficulty obtaining health insurance coverage as an estimated 24% to 30% were 
uninsured (Rozin et al., 2015; Viall et al., 2016). The ACA improves access to health 
insurance coverage among PLWHA by establishing safeguards to ensure they will not be 
discriminated when applying for or using their health insurance benefits.  
Commercial health insurance protections. PLWHA have historically 
encountered obstacles in obtaining health insurance coverage. Provisions contained in the 
ACA prevent health insurance companies from denying coverage for preexisting medical 
conditions such as HIV/AIDS, retroactively rescinding coverage after a person becomes 
infected with HIV/AIDS, and charging higher premium costs or raising rates to PLWHA 
(Montague, 2012; U.S. Department of Health & Human Services, 2016a; Viall et al., 
2016). ACA insurance coverage must be offered to PLWHA as health care insurance 
coverage must be made available to all people, regardless of health status, as long as they 
pay their premiums. The ACA eliminates the annual and lifetime financial limits that 
insurance companies often imposed on people with chronic diseases such as HIV/AIDS 
(Abara & Heiman, 2014; U.S. Department of Health & Human Services, 2016a; Viall et 
al., 2016). This provision is beneficial to PLWHA as treatment is costly and these annual 
and lifetime were often quickly surpassed. In addition to eliminating lifetime benefit 
expense limits, the ACA health insurance plans are required to cover at least one drug 
from every US Pharmacopeia category (Abara & Heiman, 2014; U.S. Department of 
Health & Human Services, 2016a). As PLWHA are often prescribed pharmaceutical 
cocktails consisting of multiple ART medications, the ACA now ensures that at least one 





HIV and AIDS continue to be a substantial health problem for the United States 
and countries throughout the world. Thirty-six point seven million people are afflicted 
with HIV/AIDS globally, while more than 1.1 million people in the United States are 
living with the disease (The Henry J. Kaiser Family Foundation, 2017f; U.S. Department 
of Health & Human Services, 2017l). HIV is a disease that attacks a person’s immune 
system and eventually inhibits the body from fighting infections and certain types of 
cancer (CDC, 2016b; U.S. Department of Health & Human Services, 2017h). HIV 
compromises the ability of the immune system to fight infection by targeting and 
destroying CD4 cells, and over time, an infected person is unable to fight off viruses, 
bacteria, and parasites that a healthy person could (CDC, 2016b; U.S. Department of 
Health & Human Services, 2017h).   
The health problems associated with a weakened immune system for people with 
HIV are identified as opportunistic infections. A patient with HIV who develops an 
opportunistic infection is then diagnosed with AIDS (U.S. Department of Health & 
Human Services, 2017b). Opportunistic infections are the most common cause of death 
for PLWHA and frequently occur when the CD4 count drops beneath 200 cells/mm3. 
Opportunistic infections that often strike PLWHA include heart disease, tuberculosis, 
pneumonia, lung disease, weight loss, cancer, meningitis, intestinal disease, and fungal 
infections (CDC, 2016a; U.S. Department of Health & Human Services, 2017b).  
HIV stages and symptoms. Without treatment, HIV progresses through three 




disease, acute HIV infection, typically occurs 2-4 weeks after infection (U.S. Department 
of Health & Human Services, 2017i). People in the acute infection stage commonly 
experience flu-like symptoms (fever, muscle ache, sore throat) because the body is 
fighting the HIV infection. During the acute HIV infection stage, the risk of disease 
transmission and infecting others is the highest because the body is producing a high 
quantity of the virus (CDC, 2016b; U.S. Department of Health & Human Services, 
2017i). Clinical latency is the second stage of the HIV disease. During this period, the 
HIV virus continues to slowly spread throughout the body and patients may not 
experience any symptoms of the disease (CDC, 2016b). HIV is transmissible throughout 
the clinical latency stage and untreated patients will progress to aids in an average of 10 
years (CDC, 2016b), AIDS is the final stage of HIV and occurs as the result of a 
compromised immune system. Symptoms of AIDS include rapid weight loss, recurring 
fever, extreme tiredness, diarrhea, prolonged swollen glands, pneumonia, colored skin 
blotches, and neurological disorders such as memory loss and depression (U.S. 
Department of Health & Human Services, 2017e). Left untreated, people with AIDS 
survive about three years, unless they develop an opportunistic infection, which will 
shorten life-expectancy to approximately one year (U.S. Department of Health & Human 
Services, 2017i). 
People with HIV may advance through the three disease stages at different rates 
due to individualized factors. The characteristics of patients with HIV that may delay the 
onset of AIDS include regularly taking ART medications, staying in care, and eating 




an AIDS diagnoses include old age, stress, and comorbidities such as cancer, hepatitis C, 
and tuberculosis. 
HIV/AIDS testing. After a person is diagnosed with HIV, laboratory tests 
measuring CD4 cell counts and viral load are ordered every 3-6 months. A CD4 count 
measures the number of CD4 T lymphocytes in a blood sample and provides an 
indication on the overall health of the immune system (U.S. Department of Health & 
Human Services, 2017g). A higher CD4 count is indicative of a strong immune system as 
a healthy adult typically has 500 to 1,600 cells per cubic millimeter (mm3) (U.S. 
Department of Health & Human Services, 2017g). A person is diagnosed with AIDS 
when the CD4 count falls below 200 cells/mm3 (U.S. Department of Health & Human 
Services, 2017f). A viral load test measures the number of copies of HIV particles per 
milliliter of blood (U.S. Department of Health & Human Services, 2015a). The objective 
of HIV treatment is to reduce the viral load to an undetectable level, and become virally 
suppressed. PLWHA that are virally suppressed are healthier and live longer than those 
that are not virally suppressed and are less likely to transmit HIV to an uninfected sexual 
or drug partner (Goldman et al., 2014; U.S. Department of Health & Human Services, 
2018d). 
HIV treatment and cost. Although there is no cure for HIV, the disease can be 
controlled or virally suppressed with appropriate medical care and treatment (U.S. 
Department of Health & Human Services, 2017f). The primary treatment for HIV is a 
combination of antiretroviral medications. Antiretroviral therapy (ART) medications 




Department of Health & Human Services, 2017c). Prior to the development of ART 
medications in the 1990’s, people with HIV developed AIDS in just a few years (CDC, 
2016b). A person diagnosed with HIV today, who is treated with ART medications, can 
live nearly as long as a person who does not have HIV (CDC, 2016b; Drainoni et al., 
2015). To achieve the maximum health benefit, ART medications should be taken as 
soon as a person is diagnosed with HIV (U.S. Department of Health & Human Services, 
2018c). ART medications can also be taken on a preventative basis (pre-exposure 
prophylaxis) to help minimize the chances that higher risk individuals contract HIV (U.S. 
Department of Health & Human Services, 2017d). 
Although treatment with ART medications are effective in controlling the HIV 
virus, they are expensive. ART medications represent the single largest treatment expense 
for PLWHA. The lifetime cost of treatment for PLWHA ranges between $300,000 and 
$400,000 with ART medications comprising 60% to 70% of all incurred expenses 
(Nakagawa et al., 2015; Schackman et al., 2015). An early HIV diagnosis and initiation 
of treatment increases the total lifetime cost of ART medications but also improves 
quality of life and overall life expectancy (Nakagawa et al., 2015; Schackman et al., 
2015).  
Demographics of PLWHA in the United States. HIV/AIDS is a disease that 
affects Americans of diverse backgrounds. Since the initial reported case of AIDS in June 
of 1981, more than 1.9 million people in the United States have been infected with HIV, 
1.1 million people are currently living with the disease, and more than 698,000 have 




Human Services, 2017m). Among people living with HIV, 77% are male and 23% are 
female (CDC, 2017b, 2017f, 2017g). Transgendered people have a high prevalence rate 
for HIV but the exact number infected are unknown due to the lack of uniformly 
collected data (CDC, 2017d, 2017f). In 2015, males represented 81% of all people newly 
diagnosed with HIV, while females accounted for 19% (CDC, 2017f; U.S. Department of 
Health & Human Services, 2017m) 
HIV also affects Americans of all ages. Young people are most likely to become 
infected with HIV, however, teenagers and people over 60 are also contracting the 
disease (CDC, 2017a, 2018b). Of all people newly diagnosed with HIV in 2016, 66.3% 
were between 13 and 39 years old, 28.6% were between the ages of 40 and 59, and 4.9% 
were older than 60 (CDC, 2017f). 
HIV and minority communities. While HIV and AIDS effects all types of 
people, certain groups are more likely to become infected including men who have sex 
with men (MSM) and racial and ethnic minorities. MSM represent the largest group of 
people impacted by HIV and AIDS. Although MSM comprise an estimated 2% of the 
total population in the United States, they represent 55% of all people living with HIV 
(CDC, 2018a). Black and Hispanic/Latino populations also disproportionately have HIV 
as compared to people from other racial and ethnic backgrounds. In 2016, Blacks totaled 
12% of the U.S. population and 44% of all new HIV diagnoses, while Hispanics/Latinos 
comprised 18% of the U.S. population and 25% of all new cases of HIV (CDC, 2017f; 




HIV cases in 2016 per 100,000 people was 43.6 for Blacks, 17.0 for Hispanics/Latinos, 
and 5.2 for Whites (CDC, 2017f). 
Racial and ethnic minorities also represent a disparate percentage of people with 
HIV based on age, sexual orientation, and gender. Youth aged 13-24 are the most 
common age based group with HIV and 80% are MSM (CDC, 2018b). In 2015, among 
MSM aged 13-24 who were diagnosed with HIV, 58% were Black, 24% were 
Hispanic/Latino, and 18% were white (CDC, 2018b). MSM from minority ethnic and 
racial backgrounds, regardless of age, are also more likely to develop HIV. Among MSM 
who were diagnosed with HIV in 2015, 10,315 were Black, 7,570 were White, and 7,013 
were Hispanic/Latino (CDC, 2018a). HIV disproportionately affects men and women of 
color. Among women diagnosed with HIV in 2016, 62.6% were black, 17.5% were 
Hispanic/Latino and 19.9% were White (CDC, 2017f). The rate of HIV infection in 2016 
per 100,000 women was 26.2 for Blacks, 5.3 for Hispanic/Latino women, and 1.7 for 
Whites women (CDC, 2017f). Among men diagnosed with HIV in 2016, 42.5% were 
Black, 29.3% were White, and 28.3% were Hispanic/Latino (CDC, 2017f). The rate of 
HIV infection among men per 100,000 people was 24.8 for Blacks, 38.8 for 
Hispanics/Latinos, and 10.6 for Whites (CDC, 2017f). 
HIV and socioeconomic status. Socioeconomic factors including income, 
poverty level, education, and employment create inequities in access to medical care and 
treatment outcomes. Reduced socioeconomic status is associated with riskier health and 
sexual behaviors, IV drug use, and health insurance status, and is associated with an 




treatment, and an increased rate of mortality (American Psychological Association, 
2018). As part of the seminal National HIV Behavioral Surveillance System for 
Heterosexuals Round 1 (NHBS-HET-1) study conducted by the CDC in 2006-2007, 
researchers collected socioeconomic data from people diagnosed with HIV. Although the 
study was limited to heterosexual participants and included only 188 participants with 
HIV, lower socioeconomic status related to education, income, poverty, employment 
status, and homelessness was associated with an increased prevalence of HIV (Denning 
& DiNenno, 2015). The results from this research study revealed an inverse relationship 
between HIV prevalence and socioeconomic status. 
HIV continuum of care for PLWHA. The HIV continuum of care is a model 
that was developed to define the stages of HIV treatment and assist in the measurement, 
monitoring, and delivery of HIV care to PLWHA at each step in the treatment process. 
The four stages of the continuum of care include diagnosis, engagement in care, 
prescribed ART, and virally suppressed (CDC, 2017e; U.S. Department of Health & 
Human Services, 2016b). The first stage of the HIV care continuum is diagnosis. People 
who are unaware of their HIV infection status will not seek medical treatment, will more 
likely transmit the virus and infect others, and experience an increased mortality rate 
(Kay, Batey, & Mugavero, 2016; Mugavero, Amico, Horn, & Thompson, 2013). The 
second stage of the continuum of care is engagement. As there is no cure for HIV, 
treatment of the virus is a lifelong process which requires routine office visits with 
medical providers (U.S. Department of Health & Human Services, 2016b). Poor 




virally suppressed, and an increased risk of death (Crawford, Sanderson, & Thornton, 
2014; Horberg et al., 2013). The third stage of the continuum of care is access to and the 
appropriate use of ART medications. ART medications, when properly used, decrease the 
mortality rate of HIV and reduce the likelihood that the virus will be spread to uninfected 
people (Maulsby et al., 2015; Skarbinski et al., 2015). The final stage of the HIV 
continuum of care is viral suppression. PLWHA who are virally suppressed live longer 
than those that are not virally suppressed and are less likely to transmit HIV to an 
uninfected sexual or drug partner (Goldman et al., 2014; U.S. Department of Health & 
Human Services, 2018d).  
In 2011, 85% of people with HIV throughout the United States were diagnosed 
with HIV, 40% were engaged in care, 37% were prescribed ART, and 30% were virally 
suppressed (U.S. Department of Health & Human Services, 2016b). Although these 
figures show improvement from previously collected data, they still fall below the global 
health goals for the treatment and viral suppression of PLWHA set by the World Health 
Organization and the United Nations. The Joint United Nations Program on HIV/AIDS 
(UNAIDS) launched the 90-90-90 campaign to increase HIV/AIDS detection and 
treatment (Greenberg et al., 2015; Morin, 2015; UNAIDS, 2018). The objective of the 
campaign is to improve the detection rate of HIV to 90% of those infected, provide 
sustained ART treatment to 90% of those detected, and to virally suppress 90% of the 
cases treated (Morin, 2015; UNAIDS, 2018).  
Impact of care engagement on the health of PLWHA. Engagement in care is 




were engaged in care if they had a minimum of two HIV-related medical appointments 
during the previous 12 months that were separated by at least three months (CDC, 2017e; 
Kay et al., 2016). Poor engagement in care is associated with a delay in the initiation of 
ART medication, an increased rate of medication noncompliance, viral non-suppression, 
and an increased risk of death (Asamsama et al., 2017; Berg et al., 2005; Mugavero et al., 
2013). PLWHA who remain consistently engaged in care are more likely to achieve and 
maintain long-term viral suppression and experience reduced mortality rates (Crawford, 
2014; Crawford et al., 2014).  
Other researchers identified an association between the number of missed medical 
visits and viral non-suppression. Brennan, Maskew, Sanne, and Fox, (2010) found the 
failure rate to achieve viral suppression within the first six months of initiating ART 
medications was 6.6% for patients who did not miss an appointment, 6.8% for those who 
missed one appointment, 10.9% for patients who missed two appointments, and 15.1% 
for patients who missed three or more appointments. Missed clinic visits are associated 
with reduced health outcomes as each missed medical appointment increased the risk of 
delayed viral load suppression by 17% (Mugavero et al., 2012). Poor engagement in care 
increased the occurrence rate of AIDS related illness or death as the mortality rate per 
100 person-year was 2.1 for patients with no missed appointments, 5.8 for patients with 1 
missed appointment, 8.9 for patients who missed 2 appointments, and 11.7 for patients 
who missed 3 or more visits (Park et al., 2007).  
Impact of viral load suppression on the health of PLWHA. Viral load is the 




and measures the number of HIV virus particles or copies in a milliliter of blood (U.S. 
Department of Health & Human Services, 2015a). The goal of an effective HIV treatment 
plan is to suppress the viral load down to an undetectable level. A PLWHA is considered 
to be virally suppressed if their viral load is beneath 200 copies per milliliter (U.S. 
Department of Health & Human Services, 2015a). Viral load is commonly used to 
measure the health status of PLWHA. Both the World Health Organization and the CDC 
recommend using viral load levels to benchmark the degree in which ART medications 
control and suppress the HIV virus and to assess overall health status among PLWHA 
(U.S. Department of Health & Human Services, 2016c; World Health Organization, 
2016b).  
PLWHA who are virally suppressed are less likely to develop a HIV related 
opportunistic infection, transmit the virus to an uninfected sexual or drug partner, and are 
more likely to live healthier and longer lives (Goldman et al., 2014; U.S. Department of 
Health & Human Services, 2018d). Of the 1.1 million PLWHA in the United States, only 
361,764 (30%) were virally suppressed (Bradley et al., 2014). Men, Blacks and 
Hispanics/Latinos, younger PLWHA, and those with a low socioeconomic status were 
less likely to become virally suppressed then women, Whites, older PLWHA, and those 
with a higher socioeconomic standing (Adeyemi, Livak, McLoyd, Smith, & French, 
2013; Bradley et al., 2014; Crawford et al., 2014). 
Impact of ART medication adherence on the health of PLWHA. PLWHA 
require long-term therapeutic intervention with ART medications to optimize their health 




HIV/AIDS was a terminal health condition resulting in certain death (Deeks, Lewin, & 
Havlir, 2013; Goldman et al., 2014). Now, PLWHA who properly take their ART 
medications can become virally suppressed and experience a life expectancy equal to that 
of the general uninfected population (Deeks et al., 2013). ART medication adherence 
directly impacts the effectiveness of ART treatment and viral load suppression and is the 
strongest predictor of viral suppression failure (CDC, 2012). Inadequately adhering to an 
ART regimen results in an increased rate of hospitalization, viral load, morbidity and 
mortality (Olson et al., 2014). 
ART medication adherence is defined as the degree to which a PLWHA takes 
their ART medications at the correct dose and interval, and complies with other 
instructions issued by the treating medical provider (U.S. Department of Health & 
Human Services, 2018a). A sustained high level of ART medication adherence is crucial 
to becoming virally suppressed. While early researchers indicated that ART adherence 
rates of 90% were required to achieve viral suppression, due to the development of more 
effective ART medications, viral suppression can now be achieved at ART adherence 
rates as low as 80% (CDC, 2012; Kalichman et al., 2014; Machtinger & Bangsberg, 
2018; U.S. Department of Health & Human Services, 2016c).  
Holtzman, Brady, and Yehia, (2015) found that patient self-reported data over a 
30 day period was an appropriate measure to determine ART treatment compliance. This 
personal estimate of ART usage can be used to calculate the proportion of days a person 
had access to ART medications and is instrumental in evaluating non adherence due to 




Bangsberg (2018) also suggested that patient self-reported data can be used to measure 
overall treatment compliance.  
Ryan White HIV/AIDS Program 
The Ryan White HIV/AIDS program (RWHAP) was created by Congress as part 
of the Ryan White Comprehensive AIDS Resource Emergency (CARE) Act of 1990 and 
serves as a safety net by providing medical care and ART medications for lower income 
PLWHA (The Henry J. Kaiser Family Foundation, 2017b). The legislation was named 
after Ryan White, a 13 year old hemophiliac, who contracted aids in the 1980s from a 
blood transfusion (Sood et al., 2014; Zamani-Hank, 2016). The RWHAP is administered 
by the HIV/AIDS Bureau at the Health Resources and Services Administration (HRSA), 
a division of the U.S. Department of Health and Human Services (HRSA, 2017a). In 
2016, funds from the RWHAP provided comprehensive HIV/AIDS-related medical care 
and treatment to more than 535,000 PLWHA, reaching an estimated 48% of all people 
diagnosed with HIV in the United States (HRSA, 2017g; U.S. Department of Health & 
Human Services, 2017m). RWHAP eligibility guidelines require a HIV or AIDS 
diagnosis and either no health insurance coverage or limited coverage that does not fully 
pay for all HIV/AIDS-related health care services (HRSA, 2016b). There are also 
financial guidelines that regulate eligibility to enroll in the RWHAP. Although cities and 
states individually determine their own enrollment guidelines and benefits offered, 
participants must have a low annual income (Adimora, Ramirez, Schoenbach, & Cohen, 




RWHAP funding. Since the creation of the RWHAP in 1990, Congress has 
reauthorized program funding in 1996, 2000, and 2009 (Johnson & Heisler, 2015; The 
Henry J. Kaiser Family Foundation, 2017b). The most recent Congressional authorization 
for the RWHAP lapsed in 2013.  However, the original law did not contain a sunset 
provision or end date so funding for the RWHAP has been continually renewed based on 
annual appropriations from Congress (Johnson & Heisler, 2015; The Henry J. Kaiser 
Family Foundation, 2017b). Funding for the RWHAP has risen over time due to the 
treatment success and wide use of ART medications. Federal funding for the RWHAP in 
fiscal year 1991 was $257 million, $1 billion in 1998, and surpassed $2 billion in 2004 
(Johnson & Heisler, 2015). The U.S Department of Health and Human Services allocated 
$2.32 billion in funding to the RWHAP in fiscal year 2017 (HRSA, 2017h; The Henry J. 
Kaiser Family Foundation, 2017e). With an annual budget of $2.32 billion, the RWHAP 
was the largest recipient of financial resources focused exclusively on HIV/AIDS care, 
and trailed only Medicare ($10.1 billion) and Medicaid ($6.1 billion) in HIV/AIDS-
related federal spending (The Henry J. Kaiser Family Foundation, 2017e).  
RWHAP structure and covered services. The RWHAP is comprised of five 
parts (A, B, C, D, and F):  
Part A. Part A of the RWHAP provides funding grants to one of the 24 Eligible 
Metropolitan Areas (EMAs) or 28 Transitional Grant Areas (TGAs) which are located in 
the areas of the United States that are most severely affected by the HIV/AIDS epidemic 
(Crowley & Kates, 2013; HRSA, 2017b). To qualify as an EMA, an area must have a 




AIDS in the previous five years (HRSA, 2017b). TGA eligibility criteria include 1,000 to 
1,999 reported cases of AIDS over the past 5 years in an area with a population of 50,000 
people (HRSA, 2017b). The 52 EMAs and TGAs are all different sizes and are 
geographically dispersed throughout the United States. Some include only one city or 
county, while others comprise portions of multiple states (HRSA, 2016c). Part A of the 
RWHAP provides core medical and support services to PLWHA. Core medical services 
include the AIDS Drug Assistance Program (ADAP), AIDS pharmaceutical assistance, 
early intervention services, health insurance premium and cost sharing assistance for low-
income individuals, home and community-based services, home health care, hospice 
services, medical case management services, including treatment-adherence services, 
medical nutrition therapy, mental health services, oral health, outpatient and ambulatory 
medical care, and substance abuse outpatient care (HRSA, 2017b). Support medical 
services include caregiver respite care, medical transportation services, outreach services, 
and translation services (HRSA, 2017b). Fiscal year 2017 RWHAP Part A funding was 
$654.2 million (HRSA, 2017h).  
Part B. Part B of the RWHAP authorizes monetary grants to each of the 50 states, 
the District of Columbia, and all 8 U.S. Territories to improve the access and quality of 
health care for PLWHA (HRSA, 2017c). The specific services provided by Part B are 
determined by each state, and are generally similar to the core medical and support 
services provided in Part A of the RWHAP (HRSA, 2017c; The Henry J. Kaiser Family 
Foundation, 2017b). The second component of Part B funding provides RWHAP clients 




with the disease (HRSA, 2017c). Funds from the Part B ADAP may also be used to pay 
the health insurance premiums and other out-of-pocket insurance costs such as 
copayments, coinsurance, and deductibles for RWHAP clients (HRSA, 2017c; Johnson & 
Heisler, 2015). Total fiscal year 2017 Part B funding was $1.31 billion, of which $900 
million was allocated to the ADAP and the remaining $411 million was apportioned to 
pay for core medical and support services (HRSA, 2017h).  
Part C. Part C of the RWHAP provides funding for early intervention services 
and capacity development and planning grants. Early intervention services offered under 
Part C include HIV testing, case management services, and counseling to reduce risks to 
people recently diagnosed with HIV/AIDS (HRSA, 2017d; The Henry J. Kaiser Family 
Foundation, 2017b). Part C development and planning grants enable public and private 
organizations to improve their organizational infrastructure to deliver higher quality HIV 
primary health care services (HRSA, 2017d). Fiscal year 2017 Part C funding was $200.5 
million (HRSA, 2017h). 
Part D. Part D grants authorize funding to public and private nonprofit 
organizations to provide HIV/AIDS health care services to women, infants, children, and 
youth. Services offered under Part D include outpatient health care, case management, 
referrals, clinical trials, and additional support services (HRSA, 2017e). The 2017 fiscal 
year allocation to Part D was $74.9 million (HRSA, 2017h).  
Part F. Finally, funding from Part F of the RWHAP supports AIDS education and 
training centers, dental reimbursement programs, and special projects of national 




professional development educational services to health care providers who treat patients 
with HIV in clinics, hospitals, addiction treatment centers, mental health facilities, and 
health departments. Dental schools and dentists are provided reimbursement for non-
compensated oral health care services provided to PLWHA and additional funds are 
allocated to support special projects of national significance to assist in the creation of 
alternative models of HIV care delivery that enhance quality, reduce costs, and help 
develop the health information systems within the RWHAP (HRSA, 2017f, 2018b). The 
total grant awarded under Part F in fiscal year 2017 was $71.5 million (HRSA, 2017h). 
RWHAP coverage status. The services provided to PLWHA by the RWHAP are 
dissimilar to those provided by a health insurance company. The RWHAP does not 
provide coverage for comprehensive health care services. The RWHAP covers only 
outpatient HIV/AIDS-related medical care and treatment (Crowley & Garner, 2015; 
Emory Health care, 2017; Westmoreland, 2016). Specifically excluded from coverage 
under the RWHAP are medical services provided in an emergency room or a hospital 
inpatient setting, medical care by general physicians and subspecialists, and prescription 
medications unrelated to the treatment of the HIV/AIDS virus (Crowley & Garner, 2015; 
Emory Health care, 2017). Unlike a health insurance company, the RWHAP does not 
serve as the primary payer of HIV/AIDS-related medical claims. Federal statutes classify 
the RWHAP as a payer of last resort.  Funds from the RWHAP may not be used to pay 
for any health care service in which payment has been rendered, or is expected to be 
rendered, from any health insurance policy or federal or state health benefits program 




required to access alternative sources of funds whenever possible and are required by law 
to attempt to enroll their clients into alternative health care programs that they may be 
eligible for, including private health insurance, Medicare, and Medicaid (HRSA, 2014; 
Johnson & Heisler, 2015). 
RWHAP insurance purchasing and cost sharing assistance. Increasing 
numbers of PLWHA are obtaining health insurance coverage through ACA qualified 
health plans (ACAQHP). Private health insurance coverage is expensive as enrollees are 
often faced with large monthly premiums and high out-of-pocket expenses including 
copayments, coinsurance, and deductibles. Provisions of the RWHAP permit the use of 
RWHAP funds to cover ACA health insurance coverage premiums and any associated 
out-of-pocket expenses (Eaton & Mugavero, 2016; Zamani-Hank, 2016). The HIV/AIDS 
Bureau has authorized the use of RWHAP funds to purchase health insurance coverage 
since its initial passage in 1990 (Dawson & Kates, 2015).  
While language in the original CARE Act focused on maintaining continual 
insurance coverage for PLWHA, updated policy guidelines and the 2006 reauthorization 
legislation specifically affirmed that funds could be used for purchasing new health 
insurance (Dawson & Kates, 2015). Although health insurance premium and cost sharing 
assistance is allowable under multiple sections of the RWHAP (Parts A, B, C, and D) the 
principal funding source is derived from the Part B ADAP (Dawson & Kates, 2015; 
HRSA, 2014). Although Part B of the RWHAP was initially intended (and continues) to 
provide medications for PLWHA, a greater emphasis has been placed on insurance 




health insurance coverage and provide cost sharing assistance to 6% of clients 
nationwide, compared to 35% in 2013 (Dawson & Kates, 2015). 
The proliferation of ACAQHPs has increased the complexity and importance of 
insurance purchasing and cost sharing subsidies to PLWHA. HRSA issued guidance 
notices to grantees strongly encouraging them to use RWHAP funds to help clients 
purchase health insurance through ACAQHPs (Dawson & Kates, 2015). The Centers for 
Medicare and Medicaid Services (CMS) also support the use of RWHAP funds to 
purchase ACAQHPs. In response to a lawsuit against an insurer in Louisiana who refused 
to accept RWHAP funds as payment for health insurance coverage, the CMS in 2014 
issued interim final rule CMS-9943-IFC which required insurance companies 
participating in the ACA to accept third party payments from the RWHAP for insurance 
premiums and cost sharing assistance (Dawson & Kates, 2015). As of June 2014, the 
RWHAP has facilitated the enrollment of 16,000 people into ACAQHPs (Dawson & 
Kates, 2015). 
RWHAP client demographics. In 2016, the RWHAP provided services to more 
than half a million PLWHA who were generally older, male, from a racial or ethnic 
minority population, and poor. At that time, 44.9% of PLWHA served by the RWHAP 
were older than age 50 and an additional 23.9% were between the ages of 40 and 49, 
while only 12.9% were younger than 30 years of age (HRSA, 2017g). Among the 
PLWHA served by the RWHAP in 2016, 71.7% were male, 27.0% were female, and 
1.3% were transgendered (HRSA, 2017g). Racial and ethnic minorities were also more 




clients served. In 2016, 46.9% of RWHAP clients with HIV/AIDS were black, 23.2% 
were Hispanic/Latino, 26.8% were white, and the remaining 3.1% were American Indian, 
Alaska Native, Asian, Native Hawaiian/Pacific Islander, and persons of multiple races 
(HRSA, 2017g). 
RWHAP clients with HIV/AIDS that used services in 2016 had low annual 
incomes as 62.7% earned less than 100% of the FPL, while an additional 28.4% of clients 
earned between 101% and 250% of the FPL. In 2016, only 8.9% of RWHAP clients 
earned more than 251% of the FPL (HRSA, 2017g). Although RWHAP clients had low 
annual incomes, approximately 80% had health insurance coverage. Among PLWHA 
using RWHAP services in 2016, 32.4% had health insurance coverage through Medicaid, 
16.5% were covered by a commercial carrier, 10.6% were insured through Medicare, 
10.1% had several forms of coverage, and 20.5% were uninsured (HRSA, 2017g).  
Impact of the RWHAP on care engagement and viral suppression rates. 
RWHAP clients achieve increased rate of engagement in care, access to ART 
medications, and viral suppression compared to PLWHA who do not receive services 
through the program. Among PLWHA throughout the United States, 40% are engaged in 
care, 37% are prescribed ART, and 30% are virally suppressed (U.S. Department of 
Health & Human Services, 2016b). Among PLWHA enrolled in the RWHAP 81% are 
engaged in care and 84% are virally suppressed (HRSA, 2016c). 
Relationships Between Health Coverage and Outcomes for PLWHA 
Health insurance provides a way to finance health care expenses and protects a 




exchange for a predetermined premium cost, a health insurer is contractually obligated to 
pay a defined portion of covered medical expenses. Health insurance coverage enhances 
health outcomes by decreasing disparities in access to health care services. Diminished 
access to medical services reduces overall health and increases the mortality rate. Wilper 
et al. (2009) determined that the lack of health insurance is a contributing factor in death 
as the mortality rate was 40% lower for people with insurance coverage compared to 
people without insurance coverage. In 2015, the lack of health insurance contributed to 
the deaths of 44,789 Americans between 18 and 64 years old and would have been the 
10th leading cause of mortality in the United States if classified as a medical disorder 
(CDC, 2017c; Wilper et al., 2009). Health insurance coverage provides improved clinical 
outcomes for patients with HIV/AIDS. Goldman et al. (2001) concluded that health 
insurance reduced the 6-month baseline mortality rate by 71% and 85% at follow-up, 
compared to those who were uninsured. Patients with commercial health insurance 
coverage more frequently achieved sustained viral suppression compared to participants 
who were uninsured (Yehia, Fleishman, Metlay, Moore, & Gebo, 2012) and health 
insurance coverage for PLWHA has been associated with prolonged viral suppression 
and a reduction in the progression of HIV to AIDS and premature death (Yehia et al., 
2014). 
ACA coverage and outcomes. Three important changes have been identified in 
the impact of the ACA on the health of PLWHA. First, provider-initiated HIV screenings 
have increased due to improved access to care (Carter, Owens, & Lin, 2017). Second, 




Kates (2019) reported that the viral load suppression rate for PLWHA enrolled in an 
ACAQHP was the same or higher than the viral load suppression rate for PLWHA 
enrolled in the RWHAP. Third, Simon, Soni, and Cawley (2017) reported the expansion 
of health insurance coverage due to the ACA increased the probability of having a HIV 
test by 5%. HIV testing is essential to diagnose HIV and achieve viral load suppression, 
which results in an improved overall health status and mortality rate.  
The rate of hospitalization for PLWHA was higher in states that did not expand 
Medicaid as part of the ACA compared to states that did expand their Medicaid 
programs. The hospitalization rate of uninsured PLWHA dropped in ACA Medicaid 
expansion states from 13.7% to 5.5%, while the hospitalization rate in non-Medicaid 
expansion states increased from 14.5% to 15.7% (Hellinger, 2015). PLWHA who 
enrolled in Medicaid coverage provided through the ACA were less likely to die during 
their hospitalization as uninsured PLWHA experienced a 41% higher mortality rate while 
in the hospital compared to patients with insurance (Hellinger, 2015). Finally, low 
income adults with chronic medical conditions who enrolled in Medicaid coverage 
provided through the ACA reported enhanced access to care, medication adherence, and 
self-reported health (Simon et al., 2017; Sommers, Maylone, Blendon, Orav, & Epstein, 
2017) 
Health coverage, out-of-pocket expenses, and outcomes. The failure of the 
federal government and the Affordable Care Act to include mechanisms to regulate 
health care costs and decrease health care expenditures have compelled issuers of 




insurance premiums (Wharam, Ross-Degnan, & Rosenthal, 2013). Insurance policies 
with high deductibles generally cost less than traditional health insurance, however, they 
burden patients with considerable out-of-pocket medical expenses (Bebinger & Murphy, 
2015; Wharam, Zhang, Landon, Soumerai, & Ross-Degnan, 2013). For calendar year 
2018, the Internal Revenue Service set the minimum deductible for a high deductible 
health plan at $1,350 for an individual and $2,700 for a family, while the maximum out-
of-pocket expense for an individual was $6,650 and $13,300 for a family (Internal 
Revenue Service, 2017a).  
As the cost of health insurance continues to increase, more people are selecting 
health policies that contain high deductibles. Created in 2003, millions of people with 
health insurance are now enrolled in high deductible health plans (Dolan, 2014; Grens, 
2013). In 2009, 21% of people with group health insurance coverage and 47% of people 
who purchased individual health policies enrolled in plans with high deductibles 
(Beeuwkes-Buntin, Haviland, McDevitt, & Sood, 2011). By 2016, 35% of people with 
employer sponsored group health insurance and 54% of people who purchased individual 
health policies were enrolled in high deductible health plans (U.S. Department of Health 
& Human Services, Cohen, & Zammitti, 2017). Nearly 90% of people who purchased 
individual ACA policies through the marketplace were enrolled in a health insurance plan 
with a large deductible (Murphy, 2016).  
Health insurance plans with high deductibles adversely impact two important 
principles of insurance coverage; to defend against large costs after needed medical 




maximize health status (U.S. Department of Health & Human Services et al., 2017). 
Researchers have shown that allocating greater financial costs to people enrolled in high 
deductible health plans results in medical care avoidance and an overall reduction in the 
utilization of medical care (Taber et al., 2015; U.S. Department of Health & Human 
Services et al., 2017). Medical care avoidance is characterized as an intentional failure to 
obtain timely treatment for a medical condition (Taber et al., 2015; U.S. Department of 
Health & Human Services et al., 2017). Multiple researchers indicated that between 33% 
and 43% of patients enrolled in a high deductible health plan deferred or skipped 
physician recommended diagnostic tests or procedures due to large out-of-pocket 
expenses and that adults with high deductibles were 2.7 times more like to delay or forgo 
care than were adults with traditional health insurance (Galbraith et al., 2012; Kannan & 
Veazie, 2014; Murphy, 2016).  
The ability of a patient to afford medical care is impaired when the deductible 
amount increases as a percentage of annual income. Murphy (2016) reported that patients 
chose to avoid seeking needed medical care when deductibles reached 5% of their annual 
income. Deductibles under the ACA are often greater than this threshold. In 2018 a 
family of four enrolled in a high deductible health plan earning 200% of the FPL 
($50,200 annually) would spend 26.5% of their annual household income on out-of-
pocket payments for medical expenses before their insurance company began fully 
paying for all covered claims (U.S. Department of Health & Human Services, 2018b). 
The same sized family earning 300% of the FPL ($75,300 annually) would consume 




Services, 2018b). Individuals with an annual income of less than $19,999 and between 
$20,000 and $34,999 were 4.85 and 5.22 times more likely to avoid seeking medical care 
due to cost than were people earning more than $100,000 per year (Galbraith et al., 2012; 
Kannan & Veazie, 2014).  Forty percent of families earning less than 400% of the FPL 
with a high deductible health plan delayed or refused needed medical care, compared to 
15% of people with similar annual income who had traditional health insurance coverage 
(Galbraith et al., 2012; Kannan & Veazie, 2014) 
Delayed access to care and outcomes. Severe health consequences can occur 
when people avoid obtaining needed medical care when they are sick. Delayed care 
results in a delayed diagnosis, an increase in overall suffering, reduced treatment options 
for a wide variety of health diseases including HIV, cancer, heart disease, stroke, and 
arthritis, and a rise in overall mortality (Kannan & Veazie, 2014; Taber et al., 2015). For 
PLWHA, delayed engagement in HIV medical care or the start of ART medications 
reduces the chances of viral load suppression and increases the overall rate of mortality 
and the chances of transmitting the disease to non-infected people (Fatukasi et al., 2017; 
U.S. Department of Health & Human Services, 2016b, 2018c). Patients with other 
treatable chronic conditions also experience increased mortality rates due to delayed 
access to medical care. Among patients with oral cancer, nearly 40% postponed seeing a 
physician until the disease had progressed to stage 3 or 4, while 50% of patients 
diagnosed with rectal cancer delayed seeking medical care for at least 6 months (Kannan 
& Veazie, 2015). Finally, patients with curable illnesses that are not promptly treated 




longer lengths of stay. Murphy (2016) stated that nearly 80% of emergency room 
physicians reported treating patients for a preventable medical condition because they 
delayed seeking care due to out-of-pocket costs that were unaffordable. 
Summary and Conclusions 
HIV and AIDS continues to be a considerable health problem in the United States 
as more than 1.1 million people are living with the disease (The Henry J. Kaiser Family 
Foundation, 2017f; U.S. Department of Health & Human Services, 2017l). HIV and 
AIDS disproportionately impacts marginalized members of society including men who 
have sex with men (MSM), racial and ethnic minorities, and people of lower 
socioeconomic status (CDC, 2018a; Denning & DiNenno, 2015; U.S. Department of 
Health & Human Services, 2017m). Viral load suppression is a commonly used measure 
to assess the overall health status of a PLWHA (U.S. Department of Health & Human 
Services, 2016c; World Health Organization, 2016b). PLWHA who are virally 
suppressed live healthier and longer lives and are less likely to transmit the virus to others 
(Goldman et al., 2014; U.S. Department of Health & Human Services, 2018d). Key 
factors in becoming virally suppressed include engagement in care and ART medication 
adherence. PLWHA who remain consistently engaged in care and properly take their 
ART medications are more likely to achieve and maintain long term viral suppression, 
experience reduced mortality rates, and experience a life expectancy equal to that of the 





For PLWHA, health insurance coverage is associated with viral load suppression 
and a reduced likelihood of premature death (Goldman et al., 2001; Yehia et al., 2012, 
2014). Prior to the passage of the ACA in 2010, between 30% and 40% of PLWHA did 
not have comprehensive health insurance and received care solely provided by the 
RWHAP (Rozin et al., 2015). The RWHAP was created in 1990 and provides 
comprehensive HIV/AIDS-related medical care and support services on an outpatient 
basis to approximately 48% of all people diagnosed with HIV in the United States 
(HRSA, 2017g). RWHAP participants must be diagnosed with HIV or AIDS and either 
have no health insurance coverage or limited coverage that does not fully pay for all 
HIV/AIDS-related health care services (HRSA, 2016b). Although PLWHA who receive 
care provided by the RWHAP are more likely to become virally suppressed than are 
uninsured PLWHA who are not enrolled in the program, the RWHAP is not a health 
insurance product, as it does not provide coverage for comprehensive health care 
services. The RWHAP only provides outpatient HIV/AIDS-related medical care and 
treatment and excludes coverage for medical services provided in an emergency room, 
inpatient hospital setting, or for any other medical condition or medications unrelated to 
the treatment of HIV/AIDS (Crowley & Garner, 2015; Dawson & Kates, 2015; Emory 
Health care, 2017). Consequently, the health benefits associated with the comprehensive 
care provided by an ACAQHP may improve the health of PLWHA. In addition, the ACA 
provides several protections that will benefit PLWHA including the inability for 




and the elimination of annual or lifetime dollar limits on the payment of covered services 
(U.S. Centers for Medicare & Medicaid Services, 2018a).  
Little is known about the relationship between the ACA and the health of 
PLWHA. I have found only five studies in which researchers examined whether the 
comprehensive health insurance provided by the ACA has improved the overall health 
status of PLWHA compared to those receiving Ryan White Care.  Bradley et al. (2016) 
found that PLWHA enrolled in an ACAQHP were 5% less likely to be virally suppressed 
then those enrolled in the RWHAP.  Dawson and Kates (2019) found the viral load 
suppression rate was the same for PLWHA enrolled in the RWHAP and in an ACAQHP.  
However, McManus et al. (2016), McManus et al. (2018), and Raifman et al. (2018) 
reported the viral load suppression rate was higher for PLWHA enrolled in an ACAQHP 
compared to those enrolled in the RWHAP. My study will help close a gap in the 
research and expand scientific knowledge by providing seminal data on the relationship 
between the RWHAP, the ACA, and the health of PLWHA in the state of Florida. 
The next chapter, Chapter 3, provides an explanation of the research design that 
will be used to help close the gap in this subject matter. Initially, the methodology of the 
study will be described including an overview of the study population, study sampling 
procedures, power analysis, sample size, data collection process, statistical assumptions, 
and data analysis. Finally, the threats to the validity of this study and the ethical 




Chapter 3: Research Method 
Introduction 
HIV and AIDS are significant health problems in the United States as 1.1 million 
people are living with the disease (CDC, 2016d; U.S. Department of Health & Human 
Services, 2017m). It is important for PLWHA, health care providers, and health policy 
makers to understand the impact on HIV/AIDS health outcomes (viral load) when 
comparing the care provided by the RWHAP to the care received from an ACAQHP. The 
purpose of this quantitative correlational cross-sectional study was to explore the 
relationship between demographic factors, treatment compliance, and engagement in care 
on the health status (viral suppression) of PLWHA who were enrolled in the RWHAP 
compared to those who were enrolled in an ACAQHP.  
Both descriptive and inferential statistical measurements were used. Descriptive 
statistics such as mean and percentages were used to measure categorical and continuous 
independent variables. Three inferential statistical methodologies were used to analyze 
the relationship and differences between the health of PLWHA who were enrolled in the 
RWHAP and those who were enrolled in an ACAQHP: multiple linear regression, chi-
square, and an independent samples t test. Field (2013) recommended a multiple linear 
regression model to establish the statistical significance of association between multiple 
independent variables and one continuous dependent variable, and recommended an 
independent samples t test to compare differences in the means of two categorical 
unrelated groups. Field (2013) also recommended a chi-square test to determine whether 




Chapter 3 presents the research approach used in this study. A detailed description 
of the research design and rationale is provided, followed by the methodology of the 
study including the study population and setting, sampling procedures, data collection, 
variable description, variable operationalization, power analysis and sample size, 
statistical analysis and assumptions, and data analysis. The final sections include a 
description of the potential threats to validity, protection of participants, and a transition 
to Chapter 4. 
Research Design and Rationale 
This study addressed the relationships between independent and dependent 
variables of PLWHA enrolled in the RWHAP and in an ACAQHP, as well as differences 
in dependent variables between groups. The independent variables in the first research 
question were gender, race, age, education level, federal poverty level, coverage status, 
treatment compliance, and engagement in care, while the dependent variable was health 
status. The independent variable in the second research question was coverage status, 
while the dependent variable was treatment compliance. The independent variable in the 
third research question was coverage status, while the dependent variable was 
engagement in care. The independent variable in the fourth research question was 
coverage status, while the dependent variable was health status. The independent variable 
in the fifth research question was coverage status, while the dependent variable was the 
difference in difficulty in paying out-of-pocket medical expenses.  
A quantitative design was appropriate because numerical data were used to 




well as differences between dependent variables across groups. Additional elements of 
this study that justified a quantitative approach included the use of a structured research 
instrument to collect data and the development of research questions with fixed 
responses, which were objectively answered (see Labaree, 2017). A quantitative design is 
a suitable choice when the objective of the study is to generalize the findings to larger 
populations (Creswell, 2009; Labaree, 2017).  
Frankfort-Nachmias et al. (2015) noted that a cross-sectional design is frequently 
used in public health and social science research, while Levin (2006) and Setia (2016) 
indicated that a cross-sectional design is helpful in public health planning and enhancing 
the understanding of disease etiology. A cross-sectional study is observational, and a 
researcher can compare multiple variables and health outcomes simultaneously at a single 
point (Setia, 2016). This approach matched the current study objectives in measuring the 
relationships between independent variables and the viral load of PLWHA who receive 
care from the RWHAP and those who receive care from an ACAQHP as well as 
differences in the dependent variables between groups. This design does not require 
participants to be randomly assigned to control or comparison groups, which is often 
considered unethical in public health research due to the serious nature of withholding 
treatments/interventions (Frankfort-Nachmias et al., 2015). Cross-sectional studies can be 
both descriptive in examining disease frequency and distribution in a population and 
analytical in investigating the association among multiple factors and health outcomes 
(Barratt & Kirwan, 2010). The three primary disadvantages of a cross-sectional study 




establish a cause-and-effect relationship, and the lack of generalizability of findings to 
other points in time (Frankfort-Nachmias et al., 2015; Setia, 2016).  
A correlational design is used to determine whether a relationship exists between 
two or more variables. Advantages of a correlational design include the ability to collect 
data on a large number of participants and to study a diverse set of variables and their 
interrelations (Field, 2013). A correlational design offers a researcher the ability to 
measure variables in health science studies that cannot be manipulated due to ethical 
reasons (Field, 2013). The primary disadvantage of a correlational study is that it only 
reveals the existence of a relationship and cannot provide a definitive reason for why the 
relationship exists (Frankfort-Nachmias et al., 2015). A correlational study cannot be 
used to draw inferences about the causal relationships between and among variables 
(Frankfort-Nachmias et al., 2015). 
A correlational cross-sectional design provides a low level of internal validity and 
a high level of external validity, while the generalizability of the results may be limited 
due to the sampling methodology (Carlson & Morrison, 2009). Additionally, a 
correlational cross-sectional design provides a greater level of reliability than an editorial 
or a case report, yet is less reliable than a case control study or a randomized controlled 
study (Berezow, 2017). Reliability in a cross-sectional study is impacted by the inability 
of the researcher to control for the impact of competing alternative explanations on the 






The study population was PLWHA residing in Florida who participated in the 
2015–2017 Medical Monitoring Project surveys, and were enrolled in the RWHAP or an 
ACAQHP. 
Sampling and Sampling Procedures  
Sampling strategy. Because secondary data were collected in this study, a 
purposive convenience sampling strategy was used. A purposive sampling strategy is a 
nonprobabilistic methodology in which participants are selected based on qualifications 
or characteristics selected by the researcher, while a convenience sample is a 
nonprobabilistic sampling strategy in which participants are selected based on the ease of 
access and inclusion for the researcher (Laerd Statistics, 2012a, 2012d). Advantages of a 
purposive sampling strategy include the ability to quickly reach a targeted population and 
cost effectiveness (Laerd Statistics, 2012d). Disadvantages of purposive sampling are a 
vulnerability to errors in judgement by the researcher, researcher bias (which could 
reduce the internal validity and reliability of the study), and a potentially reduced level of 
external validity in that research findings may not be generalizable to other populations 
(Barrat, Ferris, & Lenton, 2015; Laerd Statistics, 2012d).  
The benefits of a convenience sampling methodology include the ease of 
implementation and the ability to quickly achieve the needed sample size in a cost-
effective manner while (Laerd Statistics, 2012a). Disadvantages of a convenience 




internal validity and reliability of the study, the possibility of a sampling error, and 
reduced external validity in that the study results may not be generalizable to other 
populations (Laerd Statistics, 2012a). 
Sampling frame. All patients who have had continual RWHAP coverage for a 
minimum of one year and patients who have had coverage through an ACAQHP for at 
least one year (without any lapse in care enrollment) and have available medical and 
sociodemographic data will be included in this study. The one-year threshold of 
continuous insurance coverage for both groups of PLWHA was selected based on the 
results of other similar studies.  Baicker et al. (2013) found one-year of continuous health 
insurance coverage was an appropriate length of time to measure whether patients 
achieved improved health (as measured by blood pressure, cholesterol, and glycated 
hemoglobin) due to their new insurance coverage. Sommers, Gawande, and Baicker 
(2017) reported the impact of health insurance coverage on life-threatening conditions 
such as HIV/AIDS may take at least one year to occur. The availability of medical and 
sociodemographic data will also determine eligibility for participation in this study. 
Patient data specific to the focus of each individual research question was also required 
and only PLWHA with the needed information for each individual research question was 
included in this study.  
RQ1: The intent of the first research question is to analyze the relationship 
between demographic factors, treatment compliance, engagement in care, coverage 
status, and the health status of PLWHA. Necessary data for participant inclusion for this 




and federal poverty level, and medical record data from PLWHA who had either one year 
of continuous coverage from the RWHAP or from an ACAQHP, the number of ART 
missed doses in the past 30 days and physician office visit dates for a minimum of 12 
months. PLWHA without this information were excluded from participation in this study.  
RQ2: The aim of the second research question is to examine the difference in 
treatment compliance between PLWHA enrolled in an ACAQHP and PLWHA enrolled 
in the RWHAP. Participant inclusion criteria required documentation of either one year 
of continuous coverage from the RWHAP or from an ACAQHP and the number of ART 
missed doses in the past 30 days. PLWHA without this information were excluded from 
participation in this study.  
RQ3: The goal of the third research question is to examine the difference in 
engagement in care between PLWHA enrolled in an ACAQHP and PLWHA enrolled in 
the RWHAP. Participant inclusion criteria required documentation of either one year of 
continuous coverage from the RWHAP or from an ACAQHP and physician office visit 
dates for a minimum of 12 consecutive months. PLWHA without this information were 
excluded from participation in this study.  
RQ 4: The focus of the fourth research question is to examine the difference in 
health status between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP.  Participant inclusion criteria required documentation of either one year of 
continuous coverage from the RWHAP or from an ACAQHP and viral load test results 
(to measure health status). PLWHA without this information were excluded from 




RQ5: Finally, the objective of the fifth research question is to examine the 
difference in difficulty in paying out-of-pocket medical expenses between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. Participant inclusion 
criteria required documentation of either one year of continuous coverage from the 
RWHAP or from an ACAQHP and documentation of the difficulty in paying out-of- 
pocket medical expenses. PLWHA without this information were excluded from 
participation in this study.  
Power analysis and sample size. An accurate sample size is needed to generate 
reliable study findings that can be generalized to a larger population. Sample size in a  
study is determined by three factors: effect size, alpha level, and statistical power (Field, 
2013; Frankfort-Nachmias et al., 2015). Effect size is a numerical value that identifies the 
strength of the differences or relationships among multiple variables in a research study 
(Creswell, 2009). A larger effect size requires a smaller sample size to identify the 
strength of the relationships among study variables, while a smaller effect size 
necessitates a larger sample size to reveal the magnitude of the relationships among the 
same variables (Creswell, 2009). While effect size values are classified as small, medium, 
or large, Cohen (1988) suggested that social science researchers use  a medium effect 
size. For a multiple linear regression, Cohen (1988) defined a value of 0.15 as a medium 
effect size. Alpha (α), the second determinant of sample size, should be set at a low level 
in order to minimize the chances of a type 1 error. A type 1 error (false positive) occurs 
when a researcher perceives there is a statistically significant impact on a study 




null hypothesis (Field, 2013). An Alpha level of .05 was used in this research study. Both 
Field (2013) and Frankfort-Nachmias et al. (2015) recommended that the alpha level be 
set at .05 signifying that the probability of incorrectly rejecting a true null hypothesis will 
occur 5% of the time.  
Power is inversely related with the probability of committing a type II error. A 
type II error (false negative) occurs when a researcher deems there is not a statistical 
significance when it actually does exist, resulting in the incorrect rejection of the null 
hypothesis (Field, 2013). The formula to determine power is 1- Beta (β). As power 
increases, the likelihood of committing a type II error decreases (Cohen, 1988). The 
Pennsylvania State University Eberly College of Science (2017) recommended a power 
level between 80% and 95% in order to identify a precise effect in clinical research. 
Therefore, β in this research study will be set at .20 resulting in a power level of 80%, 
signifying an 80% probability of avoiding a type II error. 
Sample size calculation. The required sample size for each research question was 
calculated using GPower version 3.1.9.2. GPower is a commonly used free software 
application designed to calculate sample size (Faul, Erdfelder, Lang, & Buchner, 2007).  
The first research question was: What is the relationship between demographic 
factors (race, gender, age, education level, and federal poverty level), treatment 
compliance (as defined by the number of ART missed doses in the past 30 days), 
engagement in care (as defined by the number of HIV/AIDS-related physician visits 
within the previous 12 months), coverage status (enrolled in the RWHAP or an 




suppression)? This research question will be analyzed using a multiple linear regression. 
The GPower parameters for these research questions are: Test family = F test, Statistical 
test = Linear multiple regression: Fixed model, R2 deviation from zero, Type of power 
analysis = A priori: compute required sample size given alpha, power, and effect size, 
Effect size = 0.15, Alpha = 0.05, power = 0.80, and Number of predictors = 8. Based on 
the aforementioned sampling criteria, the minimum total sample size needed was 109 
participants. Research questions two, three, and four will be analyzed using an 
independent samples t test. The GPower parameters for these research questions are: Test 
family = t test, Statistical test = Means: Difference between two independent means (two 
groups), Type of power analysis = A priori: Compute required sample size given alpha, 
power, and effect size, Tails = 2, Effect size = 0.50, Alpha = 0.05, Power = 0.80, and 
Allocation ratio (n2/n1) =.20 (D. Segal, personal communication, May 19, 2018). The 
sample size for each research question is listed below. 
The second research question was: What is the difference in treatment compliance 
(as defined by the number of ART missed doses in the past 30 days) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? Based on the 
aforementioned sampling criteria for an independent samples t test, the minimum total 
sample size needed was 228, of which 190 participants were enrolled in the RWHAP and 
38 participants were enrolled in an ACAQHP. 
The third research question was: What is the difference in engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 




RWHAP? The results of the aforementioned sampling criteria for an independent 
samples t test required a minimum total sample size of 228, of which 190 participants 
were enrolled in the RWHAP and 38 participants were enrolled in an ACAQHP. 
The fourth research question was: What is the difference in health status (as 
defined by viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA 
enrolled in the RWHAP? Based on the aforementioned sampling criteria for an 
independent samples t test, the minimum total sample size needed was 228, of which 190 
participants were enrolled in the RWHAP and 38 participants were in enrolled in an 
ACAQHP.  
Finally, the fifth research question was: What is the difference in difficulty in 
paying out-of-pocket medical expenses (as defined by problems paying for any out-of- 
pocket medical or health insurance costs) between PLWHA enrolled in an ACAQHP and 
PLWHA enrolled in the RWHAP? This research question was analyzed using a chi-
square test. The GPower parameters for these research questions are: Test family = z 
tests, Statistical test = Proportions: Difference between two independent proportions, 
Type of power analysis = A priori: compute required sample size given alpha, power, and 
effect size, Tails = 2, Proportion p2 = .40, proportion p1 = .15 (Galbraith et al., 2012), 
Alpha = 0.05, power = 0.80, and Allocation ratio (n2/n1) =.20 (D. Segal, personal 
communication, May 19, 2018). Based on the aforementioned sampling criteria, the 
minimum total sample size needed was 157 participants, of which 131 participants were 




The minimum sample size for this research study was 228. This minimum sample 
size was selected because it represented the largest number generated by GPower for all 
five of the research questions and was the appropriate number when utilizing a multiple 
linear regression, an independent samples t test, and a chi-square test. Additionally, when 
conducting the independent samples t test analysis, the sample population required a 
minimum of 190 participants who were enrolled in the RWHAP and 38 participants were 
enrolled in an ACAQHP. 
Weighted data. The Florida Department of Health required the use of individual 
case weighted data in this study. For each study participant, the CDC weighted the 
individual response based upon demographic variables including age, birth gender, and 
race in order to ensure that survey participants were representative of PLWHA 
throughout the state of Florida (CDC, 2020). The primary benefit of using weighted data 
in my study was to enhance external validity. The results of my study are now 
generalizable to all PLWHA residing in Florida. 
Data Collection Procedures 
My dissertation used secondary data, which was made available from the Florida 
Department of Health after IRB approval was granted by Walden University. Study 
participants did not need to sign informed consent for their data to be included in this 
study. Individual level demographic, financial and health outcome data was obtained 
from the 2018 version of the Medical Monitoring Project survey for use in this study. 
This survey compiled HIV service care data for PLWHA enrolled in the RWHAP and in 




ART medication compliance, and information identifying the difficulty PLWHA had in 
paying out-of-pocket medical expenses.  
I considered the dataset as secondary data because I did not personally collect the 
information that I analyzed. Boslaugh (2007) wrote that secondary data including clinical 
information obtained from surveys and medical records is commonly used in public 
health research. The use of secondary research offers numerous advantages to public 
health researchers. Frankfort-Nachmias et al. (2015) stated secondary data may provide a 
conceptual-substantive advantage in that it may be the only data available to use in a 
research study. This was the case for my study. The only data available to examine the 
health of PLWHA in Florida enrolled in the RWHAP and enrolled in an ACAQHP was 
collected by the HIV/AIDS Section, Bureau of Communicable Diseases, Florida 
Department of Health. Reliable and accurate data obtained from secondary sources 
allows other researchers an opportunity to replicate the findings of a study (Frankfort-
Nachmias et al., 2015). The findings of a scientific study are enhanced when other 
researchers are able to obtain similar results when using the same dataset. A final 
advantage of using secondary data is the realization of improved efficiencies, which 
result in savings of both time and money (Boslaugh, 2007). An added benefit was the de-
identified dataset was provided to me in an electronic format, which minimized my time 
spent digitizing the information and maximized my time spent analyzing the data.  
There are three principal limitations in using secondary data in scientific research 
and each of these limitations has been minimized in the design of this study. The first 




Nachmias et al., 2015). Fortunately, this obstacle was removed, as Emma Spencer, Ph.D., 
Surveillance Program Manager, HIV/AIDS Section, Bureau of Communicable Diseases, 
Florida Department of Health executed a Data Use Agreement and provided me the de-
identified, blinded secondary dataset that I used in this study.  A second limitation in 
using secondary data in a research study is the information was collected by other 
individuals to answer their own specific research questions and may not be completely 
applicable or transferable for use in other research settings (Frankfort-Nachmias et al., 
2015). This potential limitation in the use of secondary data in this study was addressed, 
as the Florida Department of Health collected this data to monitor client-level outcomes 
for evaluation of disease status and health outcomes and would benefit from 
understanding the impact that the ACA has on the health of PLWHA. A third and final 
limitation of the use of secondary data is the researcher generally does not know how 
well the data was collected or the accuracy of the data entry process (Frankfort-Nachmias 
et al., 2015). Although I did not know the individuals collecting and entering data from 
the participants in the Medical Monitoring Project, clinical guidelines established by 
HRSA and the Florida Department of Health both required the documentation of all 
patient information without personal bias or error.  
Instrumentation and Operationalization of Constructs  
As shown in Table 1, I used four dependent variables in this study.  The first, 
health status, was measured by viral load.  The second, treatment compliance, was 
measured by the number of missed ART doses in the past 30 days.  The third, 




visits within the previous 12 months.  The fourth, difficulty in paying out-of-pocket 
medical expenses, was measured by the self-reported financial affordability data 
collected from study participants.   
I also used four independent variables in this study.  The first independent 
variable, demographic factors, included gender, race, age, education level, and federal 
poverty level. The second, treatment compliance, was measured by the number of missed 
ART doses in the past 30 days.  The third, engagement in care, was measured by the total 
number of HIV/AIDS-related physician visits within the previous 12 months.  The fourth, 
coverage status, was determined based on whether care was provided by the RWHAP or 
from an ACAQHP. 
Viral load was selected as the determinant of health status for PLWHA for several 
reasons. First, the RWHAP, in November of 2013, identified viral load as a core 
performance measure that should be used to evaluate the care and treatment of PLWHA 
(U.S. Department of Health & Human Services, 2017j). Consequently, the HIV/AIDS 
Bureau recommends the use of viral load in the assessment of clinical outcomes and 
overall improvement in health (U.S. Department of Health & Human Services, 2017j). As 
the examination of changes in health among PLWHA was an integral component of this 
research study, the use of viral load was an appropriate proxy for health outcomes. 
Second, viral load has been used in other similar research studies by Crawford et al. 
(2014) and Mugavero et al. (2012) to assess the health status of PLWHA.  
Viral load. Viral load, a continuous variable, was the dependent variable in this 




load count results were identified in the dataset as “Viral Load Count Date” and “Viral 
Load Count”. To simplify the nomenclature I renamed these study variables in SPSS, as 
“VLCOUNT” and “VLDATE”. I entered VLCOUNT into SPSS as a numerical value, 
while I entered VLDATE into SPSS using the mm/dd/yyyy format. I named the 
difference in viral load results “VLCHANGE”. I recoded study participants with 
unknown or missing viral load data in the SPSS data set as missing and excluded these 
participants from this study. 
Gender. Gender, a categorical independent variable was identified in the dataset 
as “BIRTGEN”. In SPSS, I renamed this variable “GENDER” and coded 1 = Male, 2 = 
Female, 3 = Intersex/Ambiguous. I recoded study participants with unknown or missing 
gender data in the SPSS data set as missing and excluded these participants from this 
study.  
Race. Race is also a categorical independent variable and was identified in the 
dataset as “HISPA_13” = Hispanic or Latino, “Race 9A” = American Indian or Alaska 
Native, “Race 9B” = Asian, “Race 9C” = Black or African American, “Race 9D” = 
Native Hawaiian or Other Pacific Islander, and “Race 9E” = White. To simplify the 
dataset codes, I renamed these variables in SPSS as “RACE” and will be coded as 0 = 
White, 1 = Black of African American, 2 = Hispanic or Latino, 3 = Asian, 4 = Native 
Hawaiian/Other Pacific Islander, 5 = American Indian/Alaska Native, 6= Multiracial. 
After I reviewed the racial identity of each study participant, I recoded 0 = each 
individual racial group and 1= white to create a dichotomous variable to focus on the 




missing racial data in the SPSS data set as missing and excluded these participants from 
this study. 
Age. Age is a continuous ratio independent variable designated as “DOB_13” in 
the dataset. I retitled Age in SPSS as “AGE” and recorded the number as a numerical 
value. I recoded study participants with unknown or missing age data in the SPSS data set 
as missing and excluded these participants from this study.  
Education. Education is an ordinal independent variable, referenced in the dataset 
as “EDUC” I renamed this variable in SPSS as “EDUCATION” and coded the responses 
as 1 = Never attended school, 2 = Grades 1 through 8, 3 = Grades 9 through 11, 4 = 
Grade 12 or GED, 5 = Some college, associate’s degree, or technical degree, 6 = 
Bachelor’s degree, 7 = Any post-graduate studies. I recoded study participants with 
unknown or missing education data in the SPSS data set as missing and excluded these 
participants from this study.  
Federal poverty level. Federal poverty level is an additional ordinal independent 
variable that was used in this research study. Termed “INCOME_8” in the dataset, I 
renamed this variable “POVERTY” in the SPSS data set and coded as data as 1 = below 
100% of the federal poverty level, 2 = 100-139% of the federal poverty level, 3 = 139-
400% of the federal poverty level, 4 = more than 400% of the federal poverty level. I 
coded study participants with unknown or missing federal poverty level data as missing 
and excluded these participants from this study.   
Difficulty in paying out-of-pocket medical expenses. Difficulty in paying out-




“PAY_N5” in the dataset. I renamed this variable in SPSS as “Financial” and coded the 
data 0 = no, 1 = yes as a numerical value. I coded study participants with unknown or 
missing data on difficulty in paying out-of-pocket medical expenses as missing and 
excluded these participants from the study.  
Treatment compliance. Treatment compliance in this study is a continuous ratio 
variable that was assessed based on the number of missed ART doses in the past 30 days. 
The number of missed ART doses in the past 30 days was identified as “ADH1_N5” in 
the data set, which I renamed as “ARTMissed”. I coded study participants with unknown 
or missing treatment compliance data indicating the number of days missed taking ART 
as missing and excluded these participants from the study.   
Engagement in care. Engagement in care, a continuous ratio variable was 
measured in this research study as the total number of HIV/AIDS-Related physician visits 
within the previous 12 months. The dataset contained the field named “ApptDate” and 
“ApptType” which track appointment frequency. The number of these appointments from 
the calendar year prior to the year the participant completed the MMP survey were 
entered as a numerical value into SPSS in a field that I appropriately named “HIVVisits”. 
I recoded study participants with unknown or missing engagement in care data as missing 
and excluded these participants from the study.  
Table 1 
Summary of Research Variables 
Research 
Question 




1 Health Status Dependent 
Variable 
Numerical result of most 
recent viral load test 
results less viral load test 
results at time 0. 
    
 
Demographic 








Race - 0 = White, 1 = 
Black of African 
American, 2 = Hispanic or 
Latino, 3 = Asian, 4 = 
Native Hawaiian/Other 
Pacific Islander, 5 = 
American Indian/Alaska 
Native, 6 = Multiracial 
    
   
Gender - 1 = Male, 2 = 
Female, 3 = Intersex or 
Ambiguous 
    
   
Age - as a numerical 
value     
   
Education - 1 = Never 
attended school, 2 = 
Grades 1 through 8, 3 = 
Grades 9 through 11, 4 = 
Grade 12 or GED, 5 = 
Some college, associate’s 
degree, or technical 
degree, 6 = Bachelor’s 
degree, 7 = Any post-
graduate studies 




   
Federal poverty level - 1 = 
below 100% of the federal 
poverty level, 2 = 100 -
139% of the federal 
poverty level, 3 = 139 - 
400% of the federal 
poverty level, 4 = more 
than 400% of the federal 






Numerical value for the 
number of missed ART 
doses in the past 30 days 






Numerical value for the 
number of HIV/AIDS- 
related physician visits in 
the past 12 months 
    
 
Coverage Status Independent 
Variable 
PLWHA enrolled in the 
RWHAP or in an 





Numerical value for the 
number of missed ART 
doses in the past 30 days 
    
 
Coverage Status Independent 
Variable 
PLWHA enrolled in the 
RWHAP or in an 
ACAQHP     




Numerical value for the 
number of HIV/AIDS- 
related physician visits in 
the past 12 months 
    
 
Coverage Status Independent 
Variable 
PLWHA enrolled in the 
RWHAP or in an 




4 Health Status Dependent 
Variable 
Numerical result of most 
recent viral load test 
results less viral load test 
results at time 0. 
    
 
Coverage Status Independent 
Variable 
PLWHA enrolled in the 
RWHAP or in an 
ACAQHP     






Difficulty in paying out-
of-pocket medical 
expenses - 0 = no, 1 = yes 
    
  Coverage Status Independent 
Variable 
PLWHA enrolled in the 




Data Analysis Plan  
I used the Statistical Package for the Social Sciences (SPSS) version 25 to 
complete the descriptive and inferential statistical analysis. The descriptive analysis I 
conducted included measures of central tendencies (mean and standard deviation) for all 
independent continuous variables and frequency distributions and percentage 
distributions for all independent categorical variables. Inferential statistical analysis is 
conducted to test hypotheses to derive answers to research questions based on study 
participants or populations. The objective of this research study was to understand the 
relationship between the health status of PLWHA enrolled in an ACAQHP and the health 
status of PLWHA enrolled in the RWHAP. To elucidate this impact, statistical analysis 




RQ1: What is the relationship between demographic factors (race, gender, age, 
education level, and federal poverty level), treatment compliance (as defined by the 
number of ART missed doses in the past 30 days), engagement in care (as defined by the 
number of HIV/AIDS-related physician visits within the previous 12 months), coverage 
status (enrolled in the RWHAP or an ACAQHP and the health status of PLWHA (as 
defined by viral suppression)? 
Ho1: There is no statistically significant relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 
defined by the number of ART missed doses in the past 30 days), engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status 
of PLWHA (as defined by viral suppression) 
Ha1: There is a statistically significant relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 
defined by the number of ART missed doses in the past 30 days), engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status 
of PLWHA (as defined by viral suppression). 
 A multiple linear regression was used to analyze the data output from research 
question one. A multiple linear regression is used to examine if relationships exist 
between one continuous dependent variable and multiple independent variables (Field, 




among the independent variables (Boston University School of Public Health, 2013). By 
estimating the relationship between a single independent variable, while holding other 
independent variables constant, a multiple linear regression can control for confounding 
variables in a model and allow a researcher to better understand the impact that one or 
more independent variables have on a dependent variable (Boston University School of 
Public Health, 2013). A multiple linear regression was the appropriate statistic to use  
because the dependent variable in this research question is continuous (Field, 2013). 
RQ2: What is the difference in treatment compliance (as defined by the number of 
ART missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and 
PLWHA enrolled in the RWHAP? 
Ho2: There is no statistically significant difference in treatment compliance (as 
defined by the number of ART missed doses in the past 30 days between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
Ha2: There is a statistically significant difference in treatment compliance (as 
defined by the number of ART missed doses in the past 30 days) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
An independent samples t test was used to analyze research question two. This 
test was appropriate to answer this research question because an independent samples t 
test compares differences in the means between two unrelated groups while a dependent t 
test measures related groups and indicates that the same participants are included in both 




dependent variable is continuous and the independent variable has two different 
categorical groups (Laerd Statistics, 2018b). 
RQ3: What is the difference in engagement in care (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? 
Ho3: There is no statistically significant difference in engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. 
Ha3: There is a statistically significant difference in engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. 
An independent samples t test was used to analyze research question three. This 
test was an appropriate statistical analysis to answer this research question because an 
independent samples t test compares differences in the means between two unrelated 
groups while a dependent t test measures related groups and indicates that the same 
participants are included in both groups (Field, 2013). This statistical test was suitable for 
this research question as the dependent variable is continuous and the independent 
variable has two different categorical groups (Laerd Statistics, 2018b). 
RQ4: What is the difference in health status (as defined by viral suppression) 




Ho4: There is no statistically significant difference in health status (as defined by 
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in 
the RWHAP. 
Ha4: There is a statistically significant difference in health status (as defined by 
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in 
the RWHAP. 
An independent samples t test was used to analyze the fourth research question. 
This test was an appropriate statistical analysis to answer this research question because 
an independent samples t test compares differences in the means between two unrelated 
groups while a dependent t test measures related groups and indicates that the same 
participants are included in both groups (Field, 2013). This statistical test was suitable for 
this research question as the dependent variable is continuous and the independent 
variable has two different categorical groups (Laerd Statistics, 2018b). 
RQ5: What is the difference in difficulty in paying out-of-pocket medical 
expenses (as defined by problems paying for any out-of-pocket medical or health 
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP? 
Ho5: There is no statistically significant difference in difficulty in paying out-of-
pocket medical expenses (as defined by problems paying for any out-of-pocket medical 
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA 




Ha5: There is a statistically significant difference in difficulty in paying out-of-
pocket medical expenses (as defined by problems paying for any out-of-pocket medical 
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA 
enrolled in the RWHAP. 
 A chi-square was used to analyze the fifth research question. This test was an 
appropriate statistical analysis to answer this research question because both the 
dependent and independent variables are categorical and are being measured among two 
independent groups (Laerd Statistics, 2018a).  
Threats to Validity 
Validity is an indication that the results of a study measure what is purported to be 
measured (Field, 2013). The two primary types of validity are external validity and 
internal validity. External validity represents the extent to which study findings can be 
generalized to other broader populations (Frankfort-Nachmias et al., 2015). The results of 
this study may be generalizable to PLWHA enrolled in the RWHAP and enrolled in an 
ACAQHP throughout the United States as the benefits provided by ACA plans are 
uniform regardless of geographic locale. However, the findings of this study are not 
generalizable to people with other types of insurance coverage and consequently, the 
impact on overall health may be dissimilar between these different types of patient 
populations. 
Internal validity is affected by the methods in which the research data is collected 
and the design of the research study. The impact on internal validity from the collection 




and HIV office visit dates were transactional in nature, contained in lab reports and 
insurance claims forms, and were less likely to be impacted by bias or input error. 
However, due to the increased complexity of the data entry process, patient demographic 
information may have been less accurate than the clinical information contained in the 
medical record. The design of the research study also impacted internal validity as the 
observed variances in the dependent variable must be caused by the independent variable 
and not by another unintended, confounding, or covariate variable (Trochim, 2006). 
Before conducting multiple linear regression analyses, correlations were conducted to 
determine if any variables were highly correlated.  If any variables were highly 
correlated, one or more of them would have been removed from the model to avoid 
multicollinearity. 
Two additional factors associated with the individual participants in this research 
study that may have reduced internal validity include maturation and experimental 
mortality. Maturation occurs when there is a change in the health of study participants 
over time, while experimental mortality refers to participants that drop out of an ongoing 
study and are no longer included (Laerd Statistics, 2012b, 2012c). Maturation may have 
occurred in this study if the health of a participant changed and they no longer felt the 
need to engage in care or remain compliant in care. Finally, experimental mortality may 
have transpired among a study participant if they no longer desired to participate in the 






Obtaining informed consent from the study participants was not necessary due to 
the absence of any direct or indirect communication or interaction. Walden University 
required IRB approval to be obtained before accessing secondary data. The data set was 
not accessed until this approval was received. Finally, the data used to conduct this 
research study as well as the findings of this research study will be stored for seven years 
on a password protected computer network that is monitored by virus scanning software 
and secured by both a hardware and software firewall. At the conclusion of the seven-
year data retention period, the electronic information will be erased using commercially 
available software such as Eraser or Cyberscrub.  
I received the de-identified secondary data from the Florida Department of Health 
after Walden IRB approval was granted. I will provide documentation of this approval to 
the organization for their records. The dataset used in this study was supplied in a HIPAA 
approved de-identified format. Data that is de-identified per HIPAA guidelines does not 
contain any personal identifiers such as name, address, telephone number, social security 
number, date of birth, email address, medical record number, or another number or code 
that could be used to identify the study participant (U.S. Department of Health & Human 
Services, 2015b). Medical information that is de-identified per HIPAA guidelines is not 
considered protected health information and can be shared and/or used without restriction 





Chapter 3 provided an overview of this quantitative correlational cross-sectional 
designed study. The research design and rationale, methodology, threats to validity, and 
ethical procedures used to examine the relationships between the independent and 
dependent variables were described in significant detail. The next chapter, Chapter 4, will 




Chapter 4: Results  
Introduction 
The purpose of this quantitative study was to determine the relationship between 
demographic factors (race, gender, age, education level, and federal poverty level), 
treatment compliance (as defined by the number of ART missed doses in the past 30 
days), engagement in care (as defined by the number of HIV/AIDS-related physician 
visits within the previous 12 months), and coverage status (enrolled in the RWHAP or an 
ACAQHP) and the health status of PLWHA (as defined by viral suppression). I also 
examined the difference in treatment compliance, engagement in care, and coverage 
status between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
The research questions and hypotheses were developed to determine whether a 
relationship existed between the health of PLWHA, the ACA, and the RWHAP. The 
research questions and hypotheses were the following: 
RQ1: What is the relationship between demographic factors (race, gender, age, 
education level, and federal poverty level), treatment compliance (as defined by the 
number of ART missed doses in the past 30 days), engagement in care (as defined by the 
number of HIV/AIDS-related physician visits within the previous 12 months), coverage 
status (enrolled in the RWHAP or an ACAQHP) and the health status of PLWHA (as 
defined by viral suppression)? 
Ho1: There is no statistically significant relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 




defined by the number of HIV/AIDS-related physician visits within the previous 12 
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status 
of PLWHA (as defined by viral suppression) 
Ha1: There is a statistically significant relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 
defined by the number of ART missed doses in the past 30 days), engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status 
of PLWHA (as defined by viral suppression). 
The independent variables for this research question were demographic factors, 
treatment compliance, engagement in care, and coverage status. The dependent variable 
was health status. 
RQ2: What is the difference in treatment compliance (as defined by the number of 
ART missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and 
PLWHA enrolled in the RWHAP? 
Ho2: There is no statistically significant difference in treatment compliance (as 
defined by the number of ART missed doses in the past 30 days) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
Ha2: There is a statistically significant difference in treatment compliance (as 
defined by the number of ART missed doses in the past 30 days) between PLWHA 




The independent variable for this research question was coverage status, and the 
dependent variable was treatment compliance. 
RQ3: What is the difference in engagement in care (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? 
Ho3: There is no statistically significant difference in engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. 
Ha3: There is a statistically significant difference in engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. 
The independent variable for this research question was coverage status, and the 
dependent variable was engagement in care. 
RQ4: What is the difference in health status (as defined by viral suppression) 
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? 
Ho4: There is no statistically significant difference in health status (as defined by 





Ha4: There is a statistically significant difference in health status (as defined by 
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in 
the RWHAP. 
The independent variable for this research question was coverage status, and the 
dependent variable was health status. 
RQ5: What is the difference in difficulty in paying out-of-pocket medical 
expenses (as defined by problems paying for any out-of-pocket medical or health 
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP? 
Ho5: There is no statistically significant difference in difficulty in paying out-of- 
pocket medical expenses (as defined by problems paying for any out-of-pocket medical 
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA 
enrolled in the RWHAP. 
Ha5: There is a statistically significant difference in difficulty in paying out-of-
pocket medical expenses (as defined by problems paying for any out-of-pocket medical 
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA 
enrolled in the RWHAP. 
The independent variable for this research question was coverage status, and the 
dependent variable was difficulty in paying out-of-pocket medical expenses. Chapter 4 
includes the data collection methodology, a discussion of the statistical results, and a 





 Approval to conduct the study (IRB Number 03-28-19-0573087) was granted by 
Walden University on October 1, 2019. Data were requested from the Florida Department 
of Health on February 8, 2019 and were received on December 2, 2019. On January 15, 
2020, the Florida Department of Health resent the same data set that included a new case 
weight variable for each individual respondent who participated in the study.  
Initial Collection of Secondary Data 
The data used were provided by the Florida Department of Health and were 
originally collected by the Centers for Disease Control and Prevention in conjunction 
with the Florida Department of Health as part of the Medical Monitoring Project in the 
2015, 2016, and 2017 cycle years. In each of these 3 years, the Centers for Disease 
Control and Prevention randomly selected 800 PLWHA residing in Florida from the 
enhanced HIV/AIDS reporting system database. The overall response rate for the survey 
varied from year to year (2015 = 37.4%; 2016 = 41.6%; 2016 = 36.5%; U.S. Department 
of Health & Human Services, 2019). The number of cases that were provided for each 
year and the total number of cases are presented in Table 2.  
Table 2 
    
Number of Responses by Year 
    
 Included in Data set 
 2015 2016 2017 Total 
Original data set cases 299 333 292 924 
Original data set RWHAP 179 192 152 523 






Of the 924 cases provided, some needed to be removed from the data set before 
conducting further analyses. Six were eliminated because the respondents lived outside 
the state of Florida. Three hundred and sixty eight were excluded because the respondents 
did not have coverage from the RWHAP or an ACAQHP. Three were omitted because 
they were duplicates completed by the same individual. Two hundred and sixty four were 
removed because data were missing from one or more of the variables. 
After cleaning the data set, I determined that 283 individual cases were eligible 
for inclusion. Among the 283 individual cases, 238 were participants enrolled in the 
RWHAP and 45 were participants with coverage from an ACAQHP. According to the 
statistical power analyses, to reach the appropriate statistical power for each of the 
research questions, 228 cases were needed with 190 from participants enrolled in the 
RWHAP and 38 from participants enrolled in an ACAQHP. The calculated power 
requirements were met.  
Required Use of Weighted Secondary Data 
After cleaning the secondary data and reducing the number of individual cases to 
283, I was notified by the Florida Department of Health that the data set they sent to me 
did not include the individual case weighting variable that was required for me to include 
in my analysis. For each participant in the study, the Centers for Disease Control and 
Prevention (2020) weighted the individual response based on demographic variables 
including age, birth gender, and race to ensure the survey participants were representative 




statistical analysis in SPSS with the individual case weighting variable included in the 
data set, I determined that the number of participants increased to 30,670. Among these 
30,670 participants, 25,834 were enrolled in the RWHAP and 4,836 were enrolled in an 
ACAQHP (see Table 3). The primary benefit of using the weighted data was an 
enhancement in external validity. The results were now generalizable to all PLWHA 
residing in Florida. A post hoc power analysis was completed using the sample of 30,670 
participants that was generated from the weighted sample size. As shown in Appendix C, 
the power achieved in this study was 100%, which meant there was a 100% probability of 




Weighted Data Sample Size 
 Weighted 
 N 
Sample Size 30670 
 
Data Collection Discrepancies 
There were some discrepancies between what was planned in Chapter 3 and what 
occurred during data collection. The individual data set cases provided by the Florida 
Department of Health were weighted by the Centers for Disease Control and Prevention 
based upon demographic variables including age, birth gender, and race (S. Geary, 




data in this study was an enhancement in external validity. The results were now 
generalizable to all PLWHA residing in Florida.  
Several clarifications in the coding and analysis of the operationalized data were 
necessary. First, multiracial was added as an additional code in the race/ethnicity 
descriptors. Second, federal poverty level was coded as 1 = below 100% of the federal 
poverty level, 2 = 100-139% of the federal poverty level, 3 = 139-400% of the federal 
poverty level, and 4 = more than 400% of the federal poverty level. Third, all surveys 
were coded as completed on July 1 of each response year. Fourth, an ACAQHP was 
coded as the primary health care coverage for all PLWHA who had both ACAQHP and 
RWHAP coverage. 
Results 
Demographics of Sample 
As can be seen in Table 4, a majority of survey respondents were Black or 
African American (55.6%, n = 17,050) and male (68.0%, n = 20,859). Additionally, most 
respondents were between 40 and 59 years old (60.2%, n = 18,411) and the majority 
attended some college or received an Associate or Technical degree, received a 
bachelor’s degree, or participated in any Post-Graduate studies (52.8%, n = 16,193). 
Finally, most respondents had an annual household income of less than 139% of the FPL 
(63.7%, n = 19,536). Among the survey participants, 84.2% (n = 25,834) had RWHAP 
coverage while 15.8% (n= 4,836) had coverage through an ACAQHP. Additionally, 




paying out-of-pocket medical expenses while 26.4% (n = 8,103) did have financial 
difficulty in paying out-of-pocket medical expenses.  
Table 4 
    
Variable Descriptives – Demographic and Financial Difficulty        
 
RQ Associated Variable Category 
Weighted 
N Percent 





  Hispanic/Latino - - 










  Multiracial 5662 18.5 
     
1 (IV - Demographic) Gender Male 20859 68.0 
  Female 9811 32.0 
  Intersex/Ambiguous - - 
     
1 (IV - Demographic) Age (Mean = 49.2) Under 30 1571 5.1 
  30-39 5245 17.1 
  40-49 7105 23.2 
  50-59 11306 37.0 
  60-69 4430 14.5 
  70+ 940 3.1 





  Grades 1-8 1642 5.4 
  Grades 9-11 4151 13.5 







or Technical Degree 
11578 37.8 





     




< 100% FPL 15488 50.5 
  100% - 139% FPL 4048 13.2 
  
> 139% - 400% 
FPL 
10919 35.6 
  > 400% FPL 216 0.7 
     
1 through 5 Coverage Status RWHAP 25834 84.2 
(IV - Demographic)  ACA 4836 15.8 
1 (IV) & 5 (DV) 
 
 
Difficulty in paying 
out-of-pocket 
medical expenses 
Yes 8103 26.4 
 
 No 22567 73.6 
 
As shown in Table 5, the change in viral load suppression mean (n = 30,670) was 
-24.956 (s = 121,073), while the number of ART missed doses mean in the past 30 days 
(n = 30,670) was 1.6 doses (s = 4.5), and the average number of HIV/AIDS-related 





     
Variable Descriptives - Health Status, Treatment Compliance, and Engagement in Care 










30670 -24956.4 121073 




in Past 30 
Days 
30670 1.6 4.5 





Visits in Past 
12 Months 
30670 3.5 2.3 
 
Sample Representativeness of Population 
As shown in Table 6, data in the PLWHA sample were comparable to the national 
2017 Cycle HIV Surveillance Report (CDC, 2019). In my study, Whites represented 
25.0% of the sample size, while the remaining 75.0% of participants were people of 
color. Nationally, Whites represent 28.8% of PLWHA, while people of color account for 
the remaining 71.2% (CDC, 2019). Among study participants in my research study, 
68.0% were male and 32% were female, compared to 74.6% male and 23.6% female 
nationally (CDC, 2019). In my study, 22.2% of participants were between the ages of 18-
39, 60.2% were aged 40-59, and 17.6% were over 60 years old. Nationally, 26.0% of 
PLWHA are between the ages of 18-39, 55.7% are aged 40-59, and 18.3% were are 60 




school education compared to 16.6% nationally, 27.4% had a high school diploma or 
GED compared to 27.3% nationally, and 52.7% had more than a high school degree 
compared to 56.1% nationally (CDC, 2019). Finally, in my study, 50.5% of participants 
lived at or below the FPL and the remaining 49.5% lived above the FPL threshold. 
Nationally, 41.6% of PLWHA live at or below the federal poverty level and 58.4% live 
above (CDC, 2019). 
The clinical data from my research study was also comparable to the national data 
reported in the 2017 Cycle HIV Surveillance Report (CDC, 2019). First, 68.3% of 
participants in my study achieved sustained viral suppression (all viral load results were 
less than 200 copies/ML) compared to 63.2% nationally (CDC, 2019). Second, 60.5% of 
participants in my study reported not missing an ART dose in the past 30 days compared 
to 60.8% nationally (CDC, 2019). Third, 83.3% of participants in my study reported 
having 2 or more HIV related medical appointments in the past twelve months compared 
to 78.0% nationally (CDC, 2019). Fourth, 73.6% of participants in my study reported no 
problems in paying out-of-pocket medical expenses, however, the CDC (2019) failed to 
include this data point in their report the results, so no comparative national benchmark 
exists. Finally, 15.8% of participants in my study reported having coverage from an 







Sample Representativeness of Population     
 Study National 
  Data Data 
Whites 25.0 28.8 
People of Color  75.0 71.2 
Male 68.0 74.6 
Female 32.0 23.6 
Age - 18-39 22.2 26.0 
Age - 40-59 60.2 55.7 
Age - 60+ 17.6 18.3 
Education - < High School 19.9 16.6 
Education - High School Diploma/GED 27.4 27.3 
Education - > High School 52.7 56.1 
Poverty Level - Equal to or Below 50.5 41.6 
Poverty Level – Above 49.5 58.4 
Viral Load Suppression Achieved 68.3 63.2 
ART Doses - None Missed in Past 30 Days 60.5 60.8 
HIV Visits - 2+ in Past 12 Months 83.3 78.0 
PLWHA with ACA Coverage 15.8 20.0 
 
Assumptions 
Multiple linear regression (RQ 1). I used a multiple linear regression to examine 
the relationship between demographic factors (race, gender, age, education level, and 
federal poverty level), treatment compliance (as defined by the number of ART missed 
doses in the past 30 days), engagement in care (as defined by the number of HIV/AIDS- 
related physician visits within the previous 12 months), coverage status (enrolled in the 
RWHAP or an ACAQHP) and the health status of PLWHA (as defined by viral 
suppression). There are eight assumptions that need to be considered when completing a 




variable, 2) two or more continuous or categorical independent variables, 3) an 
independence of observations/residual values, 4) a linear relationship between the 
independent and dependent variables (collectively and individually), 5) homoscedasticity 
of the data, 6) no multicollinearity, 7) no significant outliers, and 8) residuals that are 
approximately normally distributed (Laerd Statistics, 2018d). 
The first two assumptions (1, 2) have been met as the dependent variable in this 
research question, viral load change, is continuous, while the independent variables 
including race, gender, age, education level, federal poverty level, treatment compliance, 
engagement in care, and coverage status are all either continuous or categorical variables. 
The third assumption, independence of observations/residual was confirmed as the use of 
weighted data in this study eliminated the possibility of autocorrelation between the 
variables (Laerd Statistics, 2018d). The fourth assumption, the verification of linearity 
between the dependent variable and the independent variables, was confirmed by visual 
evaluation of the scatterplot of the studentized residuals against the unstandardized 
predicted value (Laerd Statistics, 2018d). The fifth assumption, homoscedasticity of the 
residuals, was also confirmed by visual evaluation of the scatterplot of the studentized 
residuals against the unstandardized predicted value (Laerd Statistics, 2018d). The sixth 
assumption, a lack of multicollinearity, was confirmed after removing the multiracial 
variable from the analysis. After the removal of this variable, Pearson correlation values 
for all remaining variables were less than .80, tolerance values for all variables were 
greater than 0.1 and VIF values for all variables were all less than 10 (Laerd Statistics, 




the studentized deleted residuals revealed data points greater than ±3 standard deviations. 
As these data points represented the change in viral load among PLWHA and were not 
abnormal outliers, they were appropriate to leave in the study when completing the 
statistical analysis (Laerd Statistics, 2018d). The eighth and final assumption, the 
normality of the distributions of residuals, was met as assessed by visual evaluation of the 
Q-Q Plot (Laerd Statistics, 2018d). Additional information on the analysis of these 
assumptions is provided in Exhibit D. 
Independent samples t test (RQ 2). I used an independent samples t test to 
analyze the second, third, and fourth research questions. In the second research question, 
I examined the difference in treatment compliance (as defined by the number of ART 
missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and 
PLWHA enrolled in the RWHAP. There are six assumptions that must be satisfied to run 
an independent samples t test. These assumptions include 1) a dependent variable that is 
continuous, 2) an independent variable that consists of two independent categorical 
groups, 3) an independence of observations, 4) a homogeneity of variances, 5) normality 
in the distribution of the dependent variable around the independent variables, and 6) no 
significant outliers (Laerd Statistics, 2018b).  
The first three assumptions (1, 2, 3) for this research question were met through 
the overall design of the research study. The dependent variable, number of ART 
prescription refills is continuous.  The independent variable is comprised of two 
independent categorical groups and an independence of observations has been achieved 




coverage from either the RWHAP or the ACA. The fourth assumption, a homogeneity of 
variances, was not confirmed based on visual evaluation of the results of the Levene’s 
test (Laerd Statistics, 2018b). The fifth assumption, the normality of the distributions of 
residuals, was not met as assessed by visual evaluation of all Q-Q Plots (Laerd Statistics, 
2018d). The sixth assumption, the lack of outliers, was not met, as assessed by inspection 
of the boxplot output (Laerd Statistics, 2018b).  
Due to violations of the assumptions of homogeneity, normality of the 
distributions, and outliers, I used a Mann-Whitney U to analyze the data instead of an 
independent samples t test (Laerd Statistics, 2018b). The Mann-Whitney U test is a 
nonparametric test used to determine if statistically significant differences exist between 
two groups when data from an independent samples t fails to meet the required 
assumptions (Laerd Statistics, 2018c). The Mann-Whitney U test has three assumptions 
that must be met which include a continuous or ordinal dependent variable, a categorical 
independent variable with two groups, and an independence of observations (Laerd 
Statistics, 2018c). As all three of these assumptions were met based on the design of my 
study, I ran a Mann-Whitney U test to determine if there were differences in treatment 
compliance (as defined by the number of ART missed doses in the past 30 days) between 
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. Additional 
information on the analysis of these assumptions can be found in Appendix E. 
Independent samples t test (RQ 3). I used an independent samples t test to 
assess the difference in engagement in care (as defined by the number of HIV/AIDS-




ACAQHP and PLWHA enrolled in the RWHAP. The same six assumptions of an 
independent samples t-test that were previously discussed must also be met in this 
research question. The initial three assumptions (a dependent variable that is continuous, 
an independent variable that consists of two independent categorical groups, and an 
independence of observations) were met through the overall design of the research study. 
The fourth assumption, a homogeneity of variances, was not confirmed based on visual 
evaluation of the results of the Levene’s test (Laerd Statistics, 2018b). The fifth 
assumption, the normality of the distributions of residuals, was not met as assessed by 
visual evaluation of all Q-Q Plots (Laerd Statistics, 2018d). The sixth assumption, the 
lack of outliers, was not met, as assessed by inspection of the boxplot output (Laerd 
Statistics, 2018b).  
Due to violations of the assumptions of homogeneity, normality of the 
distributions, and outliers, I used a Mann-Whitney U to analyze the data instead of an 
independent samples t test (Laerd Statistics, 2018b). The Mann-Whitney U test is a 
nonparametric test that is used to determine if statistically significant differences exist 
between two groups when data from an independent samples t fails to meet the required 
assumptions (Laerd Statistics, 2018c). The Mann-Whitney U test has three assumptions 
that must be met prior to running the statistical test which include a continuous or ordinal 
dependent variable, a categorical independent variable with two groups, and an 
independence of observations (Laerd Statistics, 2018c). As all three of these assumptions 
were met based on the design of this research study, I ran Mann-Whitney U test to 




HIV/AIDS-related physician visits within the previous 12 months) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. Additional information 
on the analysis of these assumptions can be found in Appendix F. 
Independent samples t test (RQ 4). I used an independent samples t test to 
assess the difference in health status (as defined by viral suppression) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. The same six 
assumptions of an independent samples t-test that were previously discussed must also be 
met in this research question. The initial three assumptions (a dependent variable that is 
continuous, an independent variable that consists of two independent categorical groups, 
and an independence of observations) were met through the overall design of the research 
study. The fourth assumption, a homogeneity of variances, was not confirmed based on 
visual evaluation of the results of the Levene’s test (Laerd Statistics, 2018b). The fifth 
assumption, the normality of the distributions of residuals, was not met as assessed by 
visual evaluation of all Q-Q Plots (Laerd Statistics, 2018b). The sixth assumption, the 
lack of outliers, was not met, as assessed by inspection of the boxplot output (Laerd 
Statistics, 2018b).  
Due to violations of the assumptions of homogeneity, normality of the 
distributions, and outliers, I used a Mann-Whitney U to analyze the data instead of an 
independent samples t test (Laerd Statistics, 2018b). The Mann-Whitney U test is a 
nonparametric test that is used to determine if statistically significant differences exist 
between two groups when data from an independent samples t fails to meet the required 




that must be met prior to running the statistical test which include a continuous or ordinal 
dependent variable, a categorical independent variable with two groups, and an 
independence of observations (Laerd Statistics, 2018c). As all three of these assumptions 
were met based on the design of this research study, I ran a Mann-Whitney U test to 
determine if there were differences in health status (as defined by viral suppression) 
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. 
Additional information on the analysis of these assumptions can be found in Appendix G. 
Chi-square (RQ 5). I used a chi-squared test to examine the difference in 
difficulty in paying for out-of-pocket medical expenses (as defined by problems paying 
for any out-of-pocket medical or health insurance costs) between PLWHA enrolled in the 
RWHAP and PLWHA enrolled in an ACAQHP. A chi-square test has three assumptions 
that must be satisfied to run this test. The first two assumptions (categorical variables and 
an independence of observations) were met based on the design of the study. The third 
assumption of a chi-square test is that all cells in the SPSS cross-tabulation output table 
must have expected counts that are greater than five (Field, 2013). Additional information 
on the analysis of these assumptions can be found in Appendix H.  
Research Question Results 
Research Question 1. What is the relationship between demographic factors 
(race, gender, age, education level, and federal poverty level), treatment compliance (as 
defined by the number of ART missed doses in the past 30 days), engagement in care (as 




months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status 
of PLWHA (as defined by viral suppression)? 
As shown in Table 7, the adjusted R2 value (.050) for the model indicated that 
only 5.0% of the dependent variable was related to the independent variables, which 
suggests there are other factors that need to be considered. In future studies, researchers 
may want to employ a different statistical model that may provide an enhanced level of 
predictive ability.  
Table 7 











Change df1 df2 
Sig. F 
Change  
1 .278a .077 .050 1230444.526 .077 2.868 8 274 .004  
a. Predictors: (Constant), Insurance. Age, GENDER, ARTMissed, EDUCATION, 
HIVVisits, RACE, PovertyLevel 
b. Dependent Variable: VLCHANGE 
c. Weighted Least Squares Regression - Weighted by Weight 
d. The enter method was used to conduct this analysis. Entering all independent variables into 
the model simultaneously is appropriate when there is uncertainty in understanding which 
variables will generate the best regression equation and the research desires to see how all of 
the variable interact with one another (Statistics Solutions, 2020).  
 
A multiple linear regression was conducted and, as shown in Table 8, only 
engagement in care (as defined by the number of HIV/AIDS-related physician visits 
within the previous 12 months) was related at a statistically significant level to viral load 
change (β = -9774.960, t = -3.141, p = < .05). Based on these results, the null hypothesis 




dependent variable at a statistically significant level when all variables were included in 
the model.  
Table 8 
     







Coefficients   
Variable B Std. Error Beta t Sig. 
Constant -63246.110 52742.879  -1.199 0.232 
Race -24193.849 16648.524 -0.089 -1.453 0.147 
Gender -2055.865 15884.668 -0.008 -0.129 0.897 
Age 1090.960 621.554 0.103 1.755 0.080 
Education 3250.199 6246.503 0.033 0.520 0.603 
Poverty Level 15880.569 8392.543 0.122 1.892 0.060 
ART Missed -217.72 1622.718 -0.008 -0.134 0.893 
HIV Visits -9774.96 3112.364 -0.187 -3.141 0.002 
Insurance -5448.301 20119.053 -0.016 -0.271 0.787 
a. Dependent Variable: VL Change    
b. Weighted Least Squares Regression - Weighted by Weight   
 
Research Question 2: What is the difference in treatment compliance (as defined by 
the number of ART missed doses in the past 30 days) between PLWHA enrolled in an 
ACAQHP and PLWHA enrolled in the RWHAP? 
A Mann-Whitney U test was run to determine if there was a statistically 
significant difference in treatment compliance (as defined by the number of ART missed 
doses in the past 30 days) between PLWHA enrolled in the RWHAP and PLWHA 
enrolled in an ACAQHP. Distributions of the ART missed doses in the past 30 days for 




similar, as assessed by visual inspection of the SPSS output. As depicted in Table 9, the 
mean number of missed ART doses was higher for RWHAP clients (mean = 1.72) when 
compared to PLWHA enrolled in an ACAQHP (mean = 0.81). This is a statistically 
significant difference (p = .000), so the null hypothesis is rejected and the alternative 
accepted. 
Table 9 
Mann Whitney U Results – Treatment Compliance 
Treatment Compliance for PLWHA Enrolled in the RWHAP and an ACAQHP 
 
  N Mean U Z p 
Treatment Compliance - ACAQHP 4836 0.81    
Treatment Compliance - RWHAP 25834 1.72    
Treatment Compliance     53404348.500 -18.121 .000 
 
Research Question 3. What is the difference in engagement in care (as defined 
by the number of HIV/AIDS-related physician visits within the previous 12 months) 
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? 
A Mann-Whitney U test was run to determine if there was a statistically 
significant difference in engagement in care (as defined by the number of HIV/AIDS- 
related physician visits within the previous 12 months) between PLWHA enrolled in the 
RWHAP and PLWHA enrolled in an ACAQHP. Distributions of the number of 
HIV/AIDS-related physician visits within the previous 12 months were not similar, as 
assessed by visual inspection of the SPSS output. As seen in Table 10, the mean number 
of HIV/AIDS-related physician visits was higher for RWHAP clients (mean = 3.56) 




significant difference (p = .000), so the null hypothesis is rejected and the alternative 
accepted. 
Table 10 
Mann Whitney U Results – Engagement in Care 
Engagement in Care for PLWHA Enrolled in the RWHAP and an ACAQHP 
 
  N Mean U Z p 
Engagement in Care - ACAQHP 4836 3.19    
Engagement in Care - RWHAP 25834 3.56    
Engagement in Care     59708211.500 -4.843 .000 
 
Research Question 4. What is the difference in health status (as defined by viral 
suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP? 
A Mann-Whitney U test was run to determine if there was a statistically 
significant difference in health status (as defined by viral suppression) between PLWHA 
enrolled in the RWHAP and PLWHA enrolled in an ACAQHP. Distributions of viral 
load suppression were not similar, as assessed by visual inspection of the SPSS output. 
As shown in Table 11, the change in viral load was greater for PLWHA enrolled in an 
ACAQHP (mean = -28661.290) when compared to RWHAP clients (mean = -5165.271). 






Mann Whitney U Results – Viral Load Change 
Viral Load Change for PLWHA Enrolled in the RWHAP and an ACAQHP 
 
  N Mean U z P 
Viral Load Change - ACAQHP 4836 -5165.271    
Viral Load Change – RWHAP 25834 -28661.290    
Viral Load Change     62187443.000 -.391 .696 
 
Research Question 5. What is the difference in difficulty in paying out-of-pocket 
medical expenses (as defined by problems paying for any out-of-pocket medical or health 
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP? 
A chi-square test was conducted in order to determine if there was a statistically 
significant difference in difficulty in paying out-of-pocket medical expenses (as defined 
by problems paying for any out-of-pocket medical or health insurance costs) between 
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. As shown in 
Table 12, there was a statistically significant difference between the two groups in 
relation to being able to pay for out-of-pocket medical expenses (p=.000) with a higher 
percentage in the RWHAP group (28.9%, n = 25,843) reporting difficulty than the 
ACAQHP group (13.1%, n = 4,835). Therefore, the null hypothesis is rejected and the 





Chi-square Results- Financial Difficulty 
Financial Difficulty in Paying Out-of-Pocket Medical Expenses 
  
Value Df Asymptotic Significance (2-sided) 
Pearson Chi-Square 521.577a 1 .000 




This chapter provided the statistical results for the research questions included in 
this study. A multiple linear regression was used to test the hypothesis in the first 
research question and only engagement in care (as defined by the number of HIV/AIDS- 
related physician visits within the previous 12 months) was related at a statistically 
significant level to viral load change (β = -9774.960, t = -3.141, p = < .05). The adjusted 
R2 value (.050) indicated that only 5.0% of the dependent variable was related to the 
independent variables, which suggests there are other factors that need to be considered. 
A Mann-Whitney U test was run on the second, third, and fourth research questions. The 
results of the Mann-Whitney U test indicated a statistically significant relationship in 
treatment compliance (p = .000) as the mean number of missed ART doses was higher for 
RWHAP clients (mean = 1.72) compared to PLWHA enrolled in an ACAQHP (mean = 
0.81). Additionally, the Mann-Whitney U test also showed a statistically significant 
relationship in engagement in care (p = .000) as the mean number of HIV/AIDS-related 
physician visits was higher for RWHAP clients (mean = 3.56) compared to PLWHA 




statistically significantly difference in viral load change (p = .696) between PLWHA 
enrolled in an ACAQHP (mean = -28661.29) and PLWHA enrolled in the RWHAP 
(mean = -5165.27). Finally, a chi-square test was run on the fifth research question to 
determine if there was a significant association between financial difficulty in paying for 
out-of-pocket medical expenses and health coverage status. The results of the chi-square 
test revealed a statistically significant association between these variables, χ2(1) = 
521.577, p = .001. 
In Chapter 5, the final chapter of this study, I will provide an interpretation of the 
statistical findings and a review of the limitations of the study. I will also discuss 
recommendations for further research as well as the implications of study findings. 
Finally, I will discuss the impact of the study findings on social change, community 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of my study was to determine the relationship between demographic 
factors (race, gender, age, education level, and federal poverty level), treatment 
compliance (as defined by the number of ART missed doses in the past 30 days), 
engagement in care (as defined by the number of HIV/AIDS-related physician visits 
within the previous 12 months), and coverage status (enrolled in the RWHAP or an 
ACAQHP) and the health status of PLWHA (as defined by viral suppression). 
Additionally, I examined the difference in treatment compliance, engagement in care, and 
coverage status between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. I provided information on the relationship between ACA health insurance 
coverage and the health of PLWHA compared to the relationship between RWHAP 
coverage and the health of PLWHA. Based on the substantial investment of resources and 
public funds on the ACA, it is important to understand whether care provided by an 
ACAQHP is related to better health outcomes of plan participants (Ferris, 2016). Five 
research questions were addressed in my study. Using secondary data provided by the 
Florida Department of Health, I analyzed the data for each of the five research questions. 
For RQ1, a multiple linear regression was conducted and only engagement in care 
(as defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) was related at a statistically significant level to viral load change (β = -9774.960, 




only one of the independent variables was related to the dependent variable at a 
statistically significant level when all variables were included in the model.  
For RQ2, a Mann-Whitney U test was run to determine whether there was a 
statistically significant difference in treatment compliance (as defined by the number of 
ART missed doses in the past 30 days) between PLWHA enrolled in the RWHAP and 
PLWHA enrolled in an ACAQHP. The mean number of missed ART doses was higher 
for RWHAP clients (mean = 1.72) when compared to PLWHA enrolled in an ACAQHP 
(mean = 0.81). This was a statistically significant difference (p = .000), so the null 
hypothesis was rejected and the alternative hypothesis was accepted. 
For RQ3, a Mann-Whitney U test was run to determine whether there was a 
statistically significant difference in engagement in care (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA 
enrolled in the RWHAP and PLWHA enrolled in an ACAQHP. The mean number of 
HIV/AIDS-related physician visits was higher for RWHAP clients (mean = 3.56) when 
compared to PLWHA enrolled in an ACAQHP (mean = 3.19). This was a statistically 
significant difference (p = .000), so the null hypothesis was rejected and the alternative 
hypothesis was accepted. 
For RQ4, a Mann-Whitney U test was run to determine whether there was a 
statistically significant difference in health status (as defined by viral suppression) 
between PLWHA enrolled in the RWHAP and PLWHA enrolled in an ACAQHP. The 




28661.290) when compared to RWHAP clients (mean = -5165.271). This was not a 
statistically significant difference (p = .696), so the null hypothesis was retained. 
For RQ5, a chi-square test was conducted to determine whether there was a 
statistically significant difference in difficulty in paying out-of-pocket medical expenses 
(as defined by problems paying for any out-of-pocket medical or health insurance costs) 
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. There 
was a statistically significant difference between the two groups in relation to being able 
to pay for out-of-pocket medical expenses (p = .000) with a higher percentage in the 
RWHAP group (28.9%, n = 25,843) reporting difficulty than the ACAQHP group 
(13.1%, n = 4,835). Therefore, the null hypothesis was rejected and the alternative 
hypothesis was accepted.  
Chapter 5 includes a discussion of the findings. First, I interpret the findings of 
each research question by comparing the results to current peer-reviewed literature and to 
Andersen’s behavioral model of health services use, which was the theoretical framework 
used in this study. Second, I describe the limitations of this study with respect to 
generalizability, trustworthiness, validity, and reliability. Third, I provide 
recommendations for further study on this topic that are grounded in the strengths and 
limitations of this study as well as the literature reviewed in Chapter 2. Fourth, I explain 
the potential social change impact and practical implications of the findings of this study. 




Interpretation of the Findings 
Research Question 1 
The first research question addressed the relationship between demographic 
factors (race, gender, age, education level, and federal poverty level), treatment 
compliance (as defined by the number of ART missed doses in the past 30 days), 
engagement in care (as defined by the number of HIV/AIDS-related physician visits 
within the previous 12 months), and coverage status (enrolled in the RWHAP or an 
ACAQHP) and the health status of PLWHA (as defined by viral suppression). Only 
engagement in care was related at a statistically significant level to viral load change. 
Engagement in care is an important determinant of the health of PLWHA (U.S. 
Department of Health & Human Services, 2016b). There is currently no cure for HIV, 
and treatment for the virus is a lifelong process that requires routine office visits with 
medical providers (U.S. Department of Health & Human Services, 2016b). PLWHA who 
remain consistently engaged in care are more likely to achieve and maintain long-term 
viral suppression and experience reduced mortality rates (Crawford, 2014; Crawford et 
al., 2014). In my study, 83.7% of PLWHA enrolled in the RWHAP and 81.0% of 
PLWHA enrolled in an ACAQHP were engaged in care. The results were favorable 
compared to Cahill et al. (2015) who found that 73% of PLWHA enrolled in the RWHAP 
and 51% of PLWHA not enrolled in the RWHAP were engaged in care. Current study 
findings were also favorable compared to the United States government report that 81% 
of RWHAP clients were engaged in care compared to 40% of PLWHA throughout the 




Research Question 2 
The second research question addressed the difference in treatment compliance 
(as defined by the number of ART missed doses in the past 30 days) between PLWHA 
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. There was a statistically 
significant difference in treatment compliance as the mean number of missed ART doses 
for RWHAP clients (1.72) was higher than the mean number for PLWHA enrolled in an 
ACAQHP (0.81). A sustained high level of ART medication adherence is crucial for 
virus suppression; inadequately adhering to an ART regimen results in an increased rate 
of hospitalization, viral load, morbidity, and mortality (Olson et al., 2014). The results of 
my study compared favorably to the work of other researchers who estimated that 45% of 
PLWHA in North America were not adherent to their prescription regimen (Gardner, 
McLees, Steiner, del Rio, C., & Burman, 2011; Kay et al., 2006). I found that 31.0% of 
PLWHA enrolled in an ACAQHP and 41.1% of PLWHA enrolled in the RWHAP were 
not adherent to their prescription regimen. Because little is known about the overall ART 
medication adherence rate among PLWHA enrolled in an ACAQHP, my findings may 
extend the knowledge related to ART medication adherence. 
Research Question 3 
The third research question addressed the difference with engagement in care (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. There is no cure for HIV and treatment of the virus is a lifelong process which 




Human Services, 2016b). PLWHA who remain consistently engaged in care are more 
likely to achieve and maintain long term viral suppression and experience reduced 
mortality rates (Crawford, 2014; Crawford et al., 2014). Previous studies by Cahill et al., 
(2015) found that 73% of PLWHA enrolled in the RWHAP and 51% of PLWHA who 
were not enrolled in the RWHAP were engaged in care while the United States 
government reported that 81% of RWHAP clients were engaged in care compared to 
40% of PLWHA throughout the United States (HRSA, 2016c; U.S. Department of Health 
& Human Services, 2016b). My study results compared favorably to these researchers as 
83.7% of PLWHA enrolled in the RWHAP and 81.0% of PLWHA enrolled in an 
ACAQHP were engaged in care. My results also expand upon the findings of other 
research studies by demonstrating significantly higher engagement in care for PLWHA 
enrolled in RWHAP (3.56 average visits) compared to PLWHA enrolled in an ACAQHP 
(3.19 average visits).  
Research Question 4 
The fourth research question addressed the difference in health status (as defined 
by viral suppression) between PLWHA enrolled in the RWHAP and PLWHA enrolled in 
an ACAQHP. I found no statistically significant difference in viral load between 
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. I found that 
66.8% of PLWHA enrolled in the RWHAP and 66.7% of PLWHA enrolled in an 
ACAQHP were virally suppressed. The goal of HIV treatment is to reduce viral load to 
an undetectable level and become virally suppressed (U.S. Department of Health & 




expectancy equal to that of the general uninfected population and are less likely to 
transmit HIV to an uninfected sexual or drug partner (Deeks et al., 2013; Goldman et al., 
2014; U.S. Department of Health & Human Services, 2018d). Bradley et al. (2016) 
examined the viral load suppression rates by coverage status of 18,095 participants from 
the 2009 – 2013 Medical Monitoring Project survey and found that PLWHA enrolled in 
an ACAQHP were 5% less likely to be virally suppressed then those enrolled in the 
RWHAP. 
While Bradley et al. (2016) reported that PLWHA enrolled in the RWHAP were 
more likely to be virally suppressed than PLWHA enrolled in an ACAQHP, McManus et 
al. (2018), Raifman et al. (2018), and Dawson and Kates (2019) reached an alternative 
conclusion. McManus et al. (2018) reported that among PLWHA residing in Virginia in 
2015, 83.3% who were enrolled in an ACAQHP were virally suppressed compared to 
79.9% who were enrolled in the RWHAP. Raifman et al. (2018) reported that among 
PLWHA residing in the United States in 2015, 79% who were enrolled in an ACAQHP 
were virally suppressed compared to 75% who were enrolled in the RWHAP. Although 
there was an improvement in viral load suppression among PLWHA enrolled in an 
ACAQHP type insurance plan, the results were not statistically significant and they 
concluded that transitioning from the RWHAP to an ACAQHP type insurance plan was 
not associated with a change in viral load suppression (Raifman et al., 2018). Dawson 
and Kates (2019) explored viral load suppression and insurance coverage among 3,645 




Monitoring Project survey and found that 66% of study participants enrolled in the 
RWHAP and in an ACAQHP were virally suppressed. 
My study results were consistent with McManus et al. (2018), Raifman et al. 
(2018), and Dawson and Kates (2019) who reported that viral load suppression rates 
among PLWHA enrolled in an ACAQHP were equal to or better than PLWHA enrolled 
in the RWHAP. However, the findings of my study were inconsistent with the results of 
Bradley et al. (2016) who reported reduced viral load suppression rates among PLWHA 
enrolled in an ACAQHP compared to PLWHA enrolled in the RWHAP. My results may 
have been comparable to the findings of McManus et al. (2018), Raifman et al. (2018), 
and Dawson and Kates (2019) because these studies compared the viral load suppression 
rate of PLWHA enrolled in the RWHAP to the viral load suppression rate of PLWHA 
enrolled in the ACA after it was fully enacted in 2014. My study results may have been 
dissimilar to the findings reported by Bradley et al. (2016) because they examined viral 
load suppression rates from PLWHA enrolled in the RWHAP and ACA during 2009 to 
2013, prior to full ACA implementation. An analysis of viral load suppression rates 
among PLWHA enrolled in the ACA prior to its full implementation in 2014, may have 
under reported the actual health benefits of this comprehensive insurance coverage. My 
results are important because they show PLWHA living in Florida can gain access to the 
comprehensive services provided by the ACA, while simultaneously maintaining their 




Research Question 5 
The fifth research question addressed the difference in difficulty in paying for out-
of-pocket medical expenses (as defined by problems paying for any out-of-pocket 
medical or health insurance costs) between PLWHA enrolled in an ACAQHP and 
PLWHA enrolled in the RWHAP. I found a statistically significant difference as 
PLWHA enrolled in the RWHAP were 2.690 times more likely of having difficulty in 
paying out-of-pocket medical expenses than PLWHA enrolled in an ACAQHP. The 
ability of PLWHA to pay out-of-pocket medical expenses is an important consideration 
in becoming virally suppressed as higher out-of-pocket costs results in medical care 
avoidance, and an overall reduction in the use of health care services and in overall health 
(Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 2016). 
Multiple researchers indicated that between 33% and 43% of patients enrolled in a 
high deductible health plan deferred needed medical care and that adults with high 
deductibles were 2.7 times more like to delay or forgo care than were adults with 
traditional health insurance (Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 
2016). Severe health consequences can occur when people avoid obtaining needed 
medical care when they are sick (Galbraith et al., 2012; Kannan & Veazie, 2014; 
Murphy, 2016). Delayed care can result in an increase in overall suffering and reduced 
treatment options and health outcomes (Kannan & Veazie, 2014; Taber et al., 2015). For 
PLWHA, delayed access to care that hinders the timely engagement in HIV medical care 




and increases the overall rate of mortality (Fatukasi et al., 2017; U.S. Department of 
Health & Human Services, 2016b, 2018c). 
Researchers have identified health care related expenses as an impediment to 
accessing care (Dombrowski, Simoni, Katz, & Golden, 2015; Yehia et al., 2015). Yehia 
et al. (2015) found that out-of-pocket medical expenses deterred study participants from 
seeking care while Dombrowksi et al. (2015) reported that health care costs, or the 
perception of those costs resulted in a barrier to care among insured PLWHA. I have been 
unable to find quantitative data comparing the difficulty in paying for out-of-pocket 
medical expenses between PLWHA enrolled in the RWHAP and PLWHA enrolled in an 
ACAQHP. Gardner et al. (2011) reported that few researchers have evaluated the degree 
to which health care expenses have inhibited access to care for PLWHA. As little is 
known about the financial difficulty that PLWHA have in paying out-of-pocket medical 
expenses, my study results are the first to quantify financial burden and may extend the 
overall knowledge related to potential financial barriers that PLWHA face when seeking 
medical care. 
Interpretation of the Findings in Relation to the Theoretical Framework 
The theoretical framework I used in this study was the behavioral model of health 
services use. Andersen developed the behavioral model of health services use to explain 
the factors that determine how and why health care services are utilized (Babitsch et al., 
2012; Graham et al., 2017). Predisposing characteristics related to health care utilization 
include age, sex, marital status, past illness, education, race, occupation, ethnicity, 




2005). Andersen et al. (2000) found that PLWHA with predisposing characteristics 
associated with vulnerable and marginalized groups were less likely to have access to 
medical care and ART medications, and become virally suppressed. My study results 
showed participants who were male, white, older, more educated, and had higher annual 
income were more likely to access care and become virally suppressed (Andersen et al., 
2000). My study findings followed the relationship patterns of predisposing 
characteristics represented in the behavioral model of health services use. In my study, 
health status for PLWHA was better for whites compared to non-whites, males compared 
to females, older compared to younger, more educated compared to the less educated, and 
participants with higher income levels compared to those with lower income levels.  
The second stage of the behavioral model of health services is enabling 
characteristics which are a set of conditions that facilitate access to health care services 
(Andersen & Newman, 2005). Although an individual may be predisposed to utilize 
health care services, they must possess the needed resources to receive medical care. 
Enabling components are characterized by financial attributes that facilitate access to care 
including income, savings, health insurance, and the accessibility of care (Andersen & 
Newman, 2005). The ability of PLWHA to pay out-of-pocket medical expenses is an 
enabling characteristic and is an important consideration in an individual’s ability to 
become virally suppressed (Andersen & Newman, 2005). Yehia et al. (2015) found that 
out-of-pocket medical expenses deterred individuals from seeking care, while 
Dombrowksi et al. (2015) reported that health care costs, or the perception of what those 




even when insured. For PLWHA, a delay in seeking care or the start of ART medications 
reduces the probability of viral load suppression and increases the overall rate of 
mortality and morbidity (Fatukasi et al., 2017; U.S. Department of Health & Human 
Services, 2016b, 2018c). I found that PLWHA enrolled in the RWHAP were 2.69 times 
more likely to have financial difficulty in paying for out-of-pocket medical expenses than 
were PLWHA enrolled in an ACAQHP. PLWHA enrolled in the RWHAP are more 
likely to face real or perceived financial barriers to accessing necessary health care, 
which are representative of the enabling characteristic as described in the model. 
The third and final stage of the behavioral model of health services use is illness 
level, which can influence an individual’s belief that they need to pursue medical care 
(Andersen & Newman, 2005). A medical diagnosis is needed for an individual to have a 
perceived or evaluated illness that would influence the use of health care services 
(Andersen & Newman, 2005). Engagement in care (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) is an important 
determinant of health, as PLWHA who remain consistently engaged in care are more 
likely to achieve and maintain long term viral suppression and experience reduced 
mortality rates (Crawford, 2014; Crawford et al., 2014). My study showed that PLWHA 
who were enrolled in the RWHAP (mean = 3.56) had a greater number of HIV/AIDS-
related physician visits than were PLWHA enrolled in an ACAQHP (mean = 3.19).  
However, PLWHA enrolled in the RWHAP or an ACAQHP exceeded the recommended 
minimum of 2 HIV/AIDS-related physician visits within the previous 12 months (Cahill 




aligned with the relationship patterns of illness level characteristics espoused by the 
behavioral model of health services use.  
Limitations of the Study 
The limitations that I raised earlier in this study were successfully resolved. First, 
I assumed that comprehensive health insurance would improve the health of PLWHA. 
The results of my study and the findings of other researchers including McManus et al. 
(2018), Raifman et al. (2018), and Dawson and Kates (2019) confirmed that 
comprehensive health insurance is associated with improved health for PLWHA. Second, 
I assumed the sample size of participants would be large enough to generate meaningful 
study results. I met this assumption as the weighted sample size of sample size 30,670 
participants exceeded the 228 participants needed to meet the desired statistical power of 
the study. Third, I assumed that the data set would contain the data points needed to 
answer the research questions in this study.  This assumption was confirmed after I 
received the data set from the Florida Department of Health and verified the needed 
information was included. Fourth, my use of a purposeful convenience sampling 
methodology could have reduced the external validity of the study and the potential 
generalizability of the results (Laerd Statistics, 2012a). However, the provision of 
weighted data by the organization enhanced the external validity, so the results can be 
generalizable to all PLWHA residing in Florida.  
Fifth, challenges with the internal validity of my study could have compromised 
the conclusions establishing a relationship between independent and dependent variables 




internal validity is selection bias which occurs when the study sample is not 
representative of the overall population (Creswell, 2009; Labaree, 2017). I maintained the 
internal validity of my study by using weighted data that was representative of all 
PLWHA residing in Florida. Sixth, my study used secondary data that was amassed as 
part of the Medical Monitoring Project survey, which was collected from survey 
participants directly, and from data abstracted directly from the participant’s medical 
records. I assumed that survey participants understood the questions being asked of them 
by the survey data collectors, and provided answers that were reliable, accurate, and 
honest. While DeLamater and Plante (2015) noted that asking people sensitive questions 
about their sexuality (and associated health complications) may increase survey response 
bias due to a larger number of nonresponses, or misreported answers motivated by social 
desirability to avoid overall embarrassment, Conway, Jako, and Goodman (1995) found 
that the use of standardized questions while collecting data provided the highest overall 
reliability. Additionally, I assumed that the data collectors accurately completed the data 
collection process. Mi, Collins, Lerner, Losina, and Katz (2013) found that data 
abstracted by non-physicians from a medical record resulted in excellent reliability. 
Recommendations 
The data I used in this research study was collected from respondents who resided 
in the state of Florida. As HIV/AIDS are diseases of national concern, additional research 
is needed to compare the relationship between the health of PLWHA, the ACA, and the 
RWHAP within different states and regions from across the United States. It is important 




which would provide PLWHA a better awareness of potential changes in health outcomes 
by transitioning care from the RWHAP to an ACAQHP. 
Additional research also needs to be conducted examining the relationship that the 
duration of enrollment in the RWHAP or an ACAQHP has on engagement in care, 
treatment compliance, and viral load suppression. Participants in my study were enrolled 
in the RWHAP or an ACAQHP for a minimum of 12 months, yet the actual duration of 
coverage was unknown. Although Sommers et al., (2017) stated the impact of health 
insurance coverage on life-threatening conditions such as HIV/AIDS may take at least 
one year to occur, it would be important to understand how the results of this study would 
have differed based on the number of years of ACAQHP or RWHAP coverage. Further 
research may need to be delayed for several years to allow enough time to pass so a 
greater volume of ACAQHP data can be collected to assess changes in engagement in 
care, treatment compliance, and viral load suppression. 
Future researchers should study the relationship that the RWHAP has on the 
engagement in care, treatment compliance, and viral load suppression of PLWHA who 
are also enrolled in an ACAQHP. A considerable number of PLWHA enrolled in an 
ACAQHP also continue to receive services through the RWHAP (Adamson, Lipira, & 
Katz, 2019; Bradley et al., 2016; Furl, Watanabe-Galloway, Lyden, & Swindells, 2018; 
McManus et al., 2018; Raifman et al., 2018). The RWHAP services provided to PLWHA 
enrolled in an ACAQHP include financial support for insurance premiums and cost 
sharing assistance for other out-of-pocket financial costs including deductibles, 




2018; McManus et al., 2018; Raifman et al., 2018). The RWHAP also provides wrap 
around services not typically covered by commercial health insurance carriers including 
mental health counseling and treatment, substance abuse counseling and treatment, dental 
care, housing assistance, and transportation services. Consequently, continued research is 
needed to understand how to maximize the effectiveness of the RWHAP post ACA 
implementation. 
My recommendations for future research are similar to the recommendations 
proposed by other authors who have conducted similar studies. Bradley et al. (2016), 
suggested that additional information about the RWHAP support services PLWHA 
enrolled in the ACA receive is needed to understand the relationship between coverage 
status and health status. McManus et al. (2018) also recommended that future researchers 
examine the role that RWHAP wrap around services have on health outcomes for 
PLWHA enrolled in an ACAQHP and that studies should be conducted throughout the 
country so health outcomes could be understood on a larger scale. Raifman et al. (2018) 
advised that future researchers should assess how financial considerations and the length 
(in years) of insurance coverage influence viral load suppression. Finally, Ginossar et al. 
(2019) recommended additional information is needed to assess health outcomes for 
PLWHA enrolled in an ACAQHP. 
Implications 
Implications for Social Change  
My study results may promote social change as PLWHA who enroll in an 




insurance coverage while simultaneously maintaining a high viral load suppression rate. 
PLWHA that are virally suppressed are generally healthier and live longer than those that 
are not virally suppressed HIV (CDC, 2016b; Drainoni et al., 2015; Goldman et al., 2014; 
U.S. Department of Health & Human Services, 2018d). Furthermore, the lifespan of a 
person with HIV who is treated with ART medications is nearly the same as a person 
who does not have HIV (CDC, 2016b; Drainoni et al., 2015; Goldman et al., 2014; U.S. 
Department of Health & Human Services, 2018d) so having access to information and 
services that promote viral suppression would be desirable. My study results may also 
promote social change by encouraging PLWHA to enroll in an ACAQHP, as PLWHA 
who receive care from the RWHAP were more likely of having a greater difficulty in 
paying out-of-pocket medical expenses than those enrolled in an ACAQHP. The ability 
of PLWHA to pay out-of-pocket medical expenses is an important consideration in 
becoming virally suppressed as higher out-of-pocket costs results in medical care 
avoidance, an overall reduction in the utilization of medical care, and in overall health 
(Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 2016). For PLWHA, delayed 
access to care that hinders the timely engagement in HIV medical care and the start of an 
ART medication regimen reduces the chances of viral load suppression and increases the 
overall rate of mortality (Fatukasi et al., 2017; U.S. Department of Health & Human 
Services, 2016b, 2018c).  
Implications for Practice 
I found that PLWHA enrolled in an ACAQHP were statistically more likely to 




have financial problems in paying for out-of-pocket medical expenses than were PLWHA 
enrolled in the RWHAP. I also found no statistically significant differences in change in 
viral load suppression between PLWHA enrolled in the RWHAP or enrolled in an 
ACAQHP. These findings are important as they show that ACAQHP coverage may offer 
PLWHA a viable treatment alternative beyond the care that is provided by the RWHAP. 
In an era of the ACA, there is some uncertainty with respect to the future of the RWHAP. 
Numerous researchers including Cahill et al. (2015), Crowley and Garner (2015), 
Dawson and Kates (2015) Johnson and Heisler (2015), and Morin (2015), have advocated 
for changes in the RWHAP to ensure its survival post ACA implementation. As the most 
recent Congressional authorization for the RWHAP lapsed in 2013, there is no guarantee 
the funding that has been renewed based on annual appropriations from Congress will 
continue (Johnson & Heisler, 2015; The Henry J. Kaiser Family Foundation, 2017b).  
In an era of the ACA, it may be beneficial for administrators from the Health 
Resources and Services Administration and the Florida Department of Health to refocus 
the RWHAP in Florida from funding care to subsidizing the costs of ACAQHP health 
insurance premiums and other out-of-pocket expenses such as coinsurance, copayments, 
and deductibles. Subsidizing health care costs associated with enrollment in an ACAQHP 
will help PLWHA gain access to the comprehensive services provided by the ACA, while 
simultaneously maintaining their rate of viral load suppression achieved from care 
provided by the RWHAP (Bradley et al., 2016; Furl et al., 2018; McManus et al., 2018; 
U.S. Centers for Medicare & Medicaid Services, 2018a). The RWHAP should also 




health insurance carriers such as mental health care, substance abuse treatment, dental 
care, housing assistance, and transportation services because access to these supplemental 
services help PLWHA become virally suppressed (Berry et al., 2016; Morin, 2015). 
PLWHA who enroll in an ACAQHP and lose access to these services may experience a 
decline in health status (Berry et al., 2016; Morin, 2015). Finally, Ginossar et al. (2019) 
noted that by enrolling PLWHA into an ACAQHP, Virginia reduced their health care 
expenses nearly 50% compared to keeping the patients in the RWHAP. Similar financial 
savings in Florida could be used to help an even greater number of PLWHA become 
virally suppressed. 
Practitioners including physicians, social workers, and public health workers 
could use this information to encourage PLWHA to enroll in an ACAQHP, which would 
provide the comprehensive health care benefits associated with health insurance coverage 
while also achieving viral load suppression rates comparable to that of the RWHAP. 
PLWHA who enroll in an ACAQHP will receive access to health care services that are 
specifically excluded from coverage under the RWHAP including hospital care provided 
in an emergency room or inpatient setting, and medical care by physicians for services 
unrelated to the treatment of the HIV/AIDS (Crowley & Garner, 2015; Emory Health 
care, 2017). Access to comprehensive health care as part of the ACA is becoming more 
important for virally suppressed PLWHA as they now live long enough to encounter 
other chronic conditions unrelated to HIV that are not covered by the RWHAP (Deeks et 





Advances in ART medications have increased the viral load suppression rate and 
PLWHA that are virally suppressed experience a life expectancy equal to that of the 
general uninfected population (Deeks et al., 2013; Goldman et al., 2014; U.S. Department 
of Health & Human Services, 2018d). Although the RWHAP is not an insurance 
company and only covers outpatient HIV/AIDS-related medical care and treatment, it has 
served as a safety net by providing medical care and ART medications for lower income 
PLWHA that were uninsured or underinsured (HRSA, 2016b; The Henry J. Kaiser 
Family Foundation, 2017b). RWHAP clients have been more likely to be engaged in 
care, have access to ART medications, and become virally supressed than were PLWHA 
who have not received services through the program (U.S. Department of Health & 
Human Services, 2016b).  
The passage of the ACA offered PLWHA enrolled in the RWHAP an opportunity 
to maintain and potentially enhance their rate of viral load suppression and receive 
comprehensive health insurance that may improve overall health and life expectancy. I 
found a statistically significant difference in treatment compliance and difficulty in 
paying for out-of-pocket medical expenses between PLWHA enrolled in an ACAQHP 
and PLWHA enrolled in the RWHAP. PLWHA enrolled in the RWHAP missed a greater 
number of ART doses in the past 30 days than did PLWHA enrolled in an ACAQHP. I 
also found that PLWHA enrolled in the RWHAP were more likely to have financial 
difficulties in paying out-of-pocket medical expenses than those enrolled in an ACAQHP. 
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Appendix A: G Power Sample Size Calculation 
  
[1] -- Saturday, August 31, 2019 -- 11:13:11 
F tests - Linear multiple regression: Fixed model, R² deviation from zero 
Analysis: A priori: Compute required sample size  
Input: Effect size f² = 0.15 
 α err prob = 0.05 
 Power (1-β err prob) = .8 
 Number of predictors = 8 
Output: Noncentrality parameter λ = 16.3500000 
 Critical F = 2.0323276 
 Numerator df = 8 
 Denominator df = 100 
 Total sample size = 109 
 Actual power = 0.8040987 
 
[2] -- Saturday, August 31, 2019 -- 11:15:57 
t tests - Means: Difference between two independent means (two groups) 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = Two 
 Effect size d = 0.5 
 α err prob = 0.05 
 Power (1-β err prob) = .80 
 Allocation ratio N2/N1 = .2 
Output: Noncentrality parameter δ = 2.8136572 
 Critical t = 1.9705162 
 Df = 226 
 Sample size group 1 = 190 
 Sample size group 2 = 38 
 Total sample size = 228 
 Actual power = 0.8000279 
 
[3] -- Saturday, August 31, 2019 -- 11:16:07 
t tests - Means: Difference between two independent means (two groups) 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = Two 
 Effect size d = 0.5 
 α err prob = 0.05 
 Power (1-β err prob) = .80 
 Allocation ratio N2/N1 = .2 
Output: Noncentrality parameter δ = 2.8136572 
 Critical t = 1.9705162 
 Df = 226 
 Sample size group 1 = 190 




 Total sample size = 228 
 Actual power = 0.8000279 
 
[4] -- Saturday, August 31, 2019 -- 11:16:09 
t tests - Means: Difference between two independent means (two groups) 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = Two 
 Effect size d = 0.5 
 α err prob = 0.05 
 Power (1-β err prob) = .80 
 Allocation ratio N2/N1 = .2 
Output: Noncentrality parameter δ = 2.8136572 
 Critical t = 1.9705162 
 Df = 226 
 Sample size group 1 = 190 
 Sample size group 2 = 38 
 Total sample size = 228 
 Actual power = 0.8000279 
 
[5] -- Saturday, August 31, 2019 -- 11:29:08 
z tests - Proportions: Difference between two independent proportions 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = Two 
 Proportion p2 = .4 
 Proportion p1 = .15 
 α err prob = 0.05 
 Power (1-β err prob) = .8 
 Allocation ratio N2/N1 = .2 
Output: Critical z = 1.9599640 
 Sample size group 1 = 131 
 Sample size group 2 = 26 
 Total sample size = 157 





Appendix B: Data Use Agreement 
See the attached data use agreement, which has been executed by the Florida 














































































Appendix C: Post Hoc Power Analysis 
 
[1] – Saturday, February 01, 2020 – 23:59:33 
t tests – Means: Difference between two independent means (two groups) 
Analysis: Post hoc: Compute achieved power  
Input: Tail(s) = Two 
 Effect size d = 0.5 
 α err prob = 0.05 
 Sample size group 1 = 25834 
 Sample size group 2 = 4836 
Output: Noncentrality parameter δ = 31.9118579 
 Critical t = 1.9600413 
 Df = 30668 






Appendix D: Research Question 1 - Multiple Linear Regression Assumptions 
In the first research question, I addressed the relationship between demographic 
factors (race, gender, age, education level, and federal poverty level), treatment 
compliance (as defined by the number of ART missed doses in the past 30 days, 
engagement in care (as defined by the number of HIV/AIDS-related physician visits, 
within the previous 12 months), coverage status (enrolled in the RWHAP or an 
ACAQHP) and the health status of PLWHA (as defined by viral suppression). I used a 
multiple linear regression to analyze this research question. There are eight assumptions 
that need to be considered when completing a multiple linear regression analysis. These 
assumptions include 1) a continuous dependent variable, 2) two or more continuous or 
categorical independent variables, 3) an independence of observations/residual values, 4) 
a linear relationship between the independent and dependent variables (collectively and 
individually), 5) homoscedasticity of the data, 6) no multicollinearity, 7) no significant 
outliers, and 8) residuals that are approximately normally distributed (Laerd Statistics, 
2018d). 
I met the first two assumptions (1, 2) as the dependent variable in this research 
question, viral load change is continuous, while the independent variables including race, 
gender, age, federal poverty level, out-of-pocket medical expenses, treatment compliance, 
and engagement in care are all continuous or categorical variables. The third assumption, 
an independence of observations/residual values can be checked using the Durbin-
Watson statistic. Although the Durbin-Watson statistic can range from between 0 and 4, a 




the residual values (Laerd Statistics, 2018d). As I used weighted data in this study, the 
Durbin-Watson statistic for this research question was not generated by SPSS and I was 
unable to assess the independence of observations/residual.  However, the Durbin-
Watson statistic was not needed because the use of weighted data eliminated the 
possibility of autocorrelation between the variables in the study. 
The fourth assumption, the verification of linearity between the dependent 
variable and the independent variables can be checked by examining a scatterplot of the 
studentized residuals against the unstandardized predicted value and by reviewing the 
partial regression plots between the dependent variable and each independent variable 
(Laerd Statistics, 2018d). I visually evaluated the scatterplot and confirmed there was a 
linear relationship between the variables. However, as weighted data was used in this 
research study, SPSS did not produce partial regression plots. Consequently, I confirmed 
the assumption of linearity based solely on the visual examination of the scatterplot. 
I also used the simple scatter plot of studentized residuals by unstandardized 
predicted values presented in Figure 2 to assess the fifth assumption, the 
homoscedasticity of the residuals. Homoscedasticity is achieved when the variance is the 
same for all values of the predicted dependent variable (Laerd Statistics, 2018d).  I 
confirmed homoscedasticity by visually evaluating the scatterplot of studentized residuals 





Figure 2. Scatter plot of the studentized residuals against the unstandardized predictive 
values depicting linearity of the dependent variable and all independent variables.  
 
 The sixth assumption of a multiple linear regression is the data must not 
demonstrate multicollinearity, which occurs when multiple independent variables are 
correlated with one another (Laerd Statistics, 2018d). The existence of multicollinearity 
is determined by reviewing the Pearson correlation results in the correlations table and 
the tolerance and VIF statistics in the coefficients table generated by SPSS. 
Multicollinearity is present if the Pearson correlation values are equal to or greater than 
0.80 (Field, 2013) and if the tolerance value is less than 0.1 or the VIF is greater than 10 
(Laerd Statistics, 2018d). I confirmed there was no multicollinearity as all tolerance 
values were less than 0.1, all VIF values were less than 10, and the Pearson correlation 






Pearson Correlation Values 
 VLCHG Race Gender Age Education 
VLCHANGE 1.000 -0.101 -0.073 0.077 0.068 
Race -0.101 1.000 0.165 0.040 0.051 
Gender -0.073 0.165 1.000 0.035 -0.176 
Age 0.077 0.040 0.035 1.000 -0.029 
Education 0.068 0.051 -0.176 -0.029 1.000 
Poverty Level 0.165 -0.062 -0.236 -0.009 0.338 
ART Missed 0.032 0.118 -0.067 0.044 0.057 
HIV Visits -0.195 0.024 0.104 0.104 0.001 







Visits Insurance  
VLCHANGE 0.165 0.032 -0.195 -0.071  
Race -0.062 0.118 0.024 0.229  
Gender -0.236 -0.067 0.104 0.032  
Age -0.009 0.044 0.104 -0.020  
Education 0.338 0.057 0.001 -0.063  
Poverty Level 1.000 0.178 -0.128 -0.148  
ART Missed 0.178 1.000 -0.125 0.073  
HIV Visits -0.128 -0.125 1.000 0.058  
Insurance -0.148 0.073 0.058 1.000  
 
The seventh assumption of a multiple linear regression test is there should be no 
significant outliers or extreme values in the dataset. The presence of data outliers can be 
determined by inspecting the casewise diagnostics and studentized deleted residuals for 
values great than ±3 standard deviations (Laerd Statistics, 2018d). Upon visual evaluation 
of the casewise diagnostics and studentized deleted residuals values, I confirmed the 




deviations. Although outlier data should be removed if caused by a data entry error, the 
data may remain in the study if valid (Laerd Statistics, 2018d). As the data points 
represent the change in viral load among PLWHA and are not abnormal outliers, I 
purposely did not remove them when I ran the analysis. These outlier data points 
demonstrated large changes in viral load and eliminating them would bias the study 
against PLWHA who realized significant viral load changes.  
The eighth and final assumption of a multiple linear regression test is a normal 
distribution of residuals, which can be evaluated using a normal Q-Q plot of studentized 
residuals. Normally distributed residuals are confirmed when the data points are closely 
proximate to the diagonal line (Laerd Statistics, 2018d). As can be seen in figure 3, the 
assumption of normally distributed residuals was met, as assessed by a Q-Q Plot. 
 






Appendix E: Research Question 2 - Independent Samples t test Assumptions 
In the second research question, I used an independent samples t test to address 
the difference in treatment compliance (as defined by the number of ART missed doses in 
the past 30 days) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the 
RWHAP. There are six assumptions that must be satisfied to run an independent samples 
t test. These assumptions include: a dependent variable that is continuous, an independent 
variable that consists of two independent categorical groups, an independence of 
observations, a homogeneity of variances, normality in the distribution of the dependent 
variable around the independent variables, and no significant outliers (Laerd Statistics, 
2018b). I met the first three assumptions for this research question based on the overall 
design of the research study. The dependent variable, number of ART prescription refills 
is continuous, the independent variable is comprised of two independent categorical 
groups and an independence of observations has been achieved by ensuring that each 
study participant has been assigned to a group of PLWHA that have coverage from either 
the RWHAP or the ACA.  
I used SPSS to determine if the final three assumptions of an independent samples 
t test were met. First, a Levene’s test of equality of error variances was run to determine 
if there was homogeneity of variances. A homogeneity of variance exists when the 
variance within each group in the independent variable is equal (Field, 2013). 
Homogeneity is confirmed if the Levene’s test produces a non-statistically significant 
result which occurs when the p-value (significance level) is greater than .05 (Field, 2013). 




variances in treatment compliance between PLWHA enrolled in the RWHAP and 
PLWHA enrolled in an ACAQHP as F(1,9461.358) = 310.602, p < .001.  
Table 14    
Levene’s Test for Equality of Variances – Treatment Compliance 
  F Sig. t df 
Treatment 
Compliance 
Equal variances not assumed  310.602 .000 -16.883 9461.358 
 
Second, I used SPSS to confirm the normal distribution of the data which occurs when 
the dependent variable is normally distributed by each level of the independent variable 
(Field, 2013). Two methodologies were used to determine if the study data was normally 
distributed. These two approaches included analyzing the results of the Shapiro-Wilk’s 
test and interpreting the shape of the Normal Q-Q Plots (Laerd Statistics, 2018b). The 
Shapiro-Wilk’s test confirms normality of distribution when the result is not statistically 
significant (Field, 2013). As I used weighted data in this study, SPSS did not generate the 
Shapiro-Wilk’s test for this research question, so it was not used to assess the normality 
of distribution. Instead, I used the Normal Q-Q Plot output from SPSS for PLWHA 
enrolled in the RWHAP and enrolled in an ACAQHP to graphically assess the normality 
of the data distribution. Normally distributed data will appear as round dots located near 
the diagonal line (Laerd Statistics, 2018b). Based on my graphical assessment of the 
Normal Q-Q Plots presented in Figure 4 and Figure 5, treatment compliance (as defined 




in the RWHAP and in an ACAQHP was not normally distributed. 
 
Figure 4. Scatter plot depicting treatment compliance data (as defined by the number of 
ART missed doses in the past 30 days) that is not normally distributed for PLWHA 
enrolled in an ACAQHP.  
 
 
Figure 5. Scatter plot depicting treatment compliance data (as defined by the number of 
ART missed doses in the past 30 days) that is not normally distributed for PLWHA 





Finally, I used SPSS to determine if the dataset contained a significant number of 
outliers. Outliers are single data points that vary from the others and can reduce the 
validity of the test results and were assessed by examining the box-whisker plot produced 
from SPSS (Field, 2013). Outliers are data points plotted above the top whisker or below 
the bottom whisker (Laerd Statistics, 2012e). Based on my visual inspection of the 
boxplot shown in Figure 6, I confirmed outliers were present in the data for PLWHA who 
were enrolled in the RWHAP and enrolled in an ACAQHP.  
 
Figure 6. Box plot showing the presence of outliers for treatment compliance data (as 
defined by the number of ART missed doses in the past 30 days) for PLWHA enrolled in 
the RWHAP and enrolled in an ACAQHP.  
 
Due to heterogeneity in the equality of variances, violations in the assumptions of 
normality in the distribution of the dependent variable around the independent variables, 
and the presence of significant outliers in the dataset, I used a Mann-Whitney U to 




Mann-Whitney U test is a nonparametric test used to determine if statistically 
significance differences exist between two groups when an independent samples t test 
when data fails to meet the required assumptions (Laerd Statistics, 2018c). The Mann-
Whitney U test has three assumptions that must be met prior to running the statistical test 
which include a continuous or ordinal dependent variable, a categorical independent 
variable with two groups, and an independence of observations (Laerd Statistics, 2018c). 
As I met all three assumptions based on the design of my study, I used a Mann-Whitney 
U test to determine if there were differences in treatment compliance (as defined by the 
number of ART missed doses in the past 30 days) between PLWHA enrolled in an 




Appendix F: Research Question 3 - Independent Samples t test Assumptions 
In the third research question, I used an independent samples t test to address the 
difference in engagement in care (as defined by the number of HIV/AIDS-related 
physician visits within the previous 12 months) between PLWHA enrolled in an 
ACAQHP and PLWHA enrolled in the RWHAP. The same six assumptions must also be 
met in this research question which include a dependent variable that is continuous, an 
independent variable that consists of two independent categorical groups, an 
independence of observations, a homogeneity of variances, normality in the distribution 
of the dependent variable around the independent variables, and no significant outliers 
(Laerd Statistics, 2018b).  
I met the initial three assumptions (a dependent variable that is continuous, an 
independent variable that consists of two independent categorical groups and an 
independence of observations) based on the overall design of the research study. I used 
SPSS to determine if the three remaining assumptions (a homogeneity of variances, 
normality in the distribution of the dependent variable around the independent variables, 
and no significant outliers) were met. First, I ran a Levene’s test of equality of error 
variances to determine if there was a homogeneity of variances. A homogeneity of 
variance exists when the variance within each group in the independent variable is equal 
(Field, 2013). Homogeneity is confirmed if the Levene’s test produces a non-statistically 
significant result which occurs when the p-value (significance level) is greater than .05 




difference in the variances in engagement in care between PLWHA enrolled in the 
RWHAP and PLWHA enrolled in an ACAQHP as F(1,9621.887) = 258.616, p < .001.  
Table 15    
Levene’s Test for Equality of Variances - Engagement in Care 
  F Sig. t Df 
Engagement in 
Care 
Equal variances not assumed  258.616 .000 -13.542 9621.887 
 
Second, I used SPSS to confirm the normal distribution of the data which occurs 
when the dependent variable is normally distributed by each level of the independent 
variable (Field, 2013).  As I used weighted data in this study, SPSS did not generate the 
Shapiro-Wilk’s test for this research question, so it was not used to assess the normality 
of distribution. Instead, I used the Normal Q-Q Plot output from SPSS for PLWHA 
enrolled in the RWHAP and in an ACAQHP to graphically assess the normality of the 
data distribution. Normally distributed data will appear as round dots located near the 
diagonal line (Laerd Statistics, 2018b). Based on my graphical assessment of the Normal 
Q-Q Plots presented in Figure 7 and Figure 8, engagement in care data (as defined by the 
number of HIV/AIDS-related physician visits within the previous 12 months) for 





Figure 7. Scatter plot depicting engagement in care data (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) that is normally 
distributed for PLWHA enrolled in an ACAQHP.  
 
 
Figure 8. Scatter plot depicting engagement in care data (as defined by the number of 
HIV/AIDS-related physician visits within the previous 12 months) that is not normally 





Finally, I used SPSS to generate a box-whisker plot to determine the presence of 
any data outliers. Outliers are data points plotted above the top whisker or below the 
bottom whisker (Laerd Statistics, 2012e). Based on my visual inspection of the boxplot 
shown in Figure 9, I confirmed outliers were present in the data for PLWHA who were 
enrolled in the RWHAP and not in the data for PLWHA enrolled in an ACAQHP.  
 
 
Figure 9. Box plot showing the presence of outliers for engagement in care data (as 
defined by the number of HIV/AIDS-related physician visits within the previous 12 
months) for PLWHA enrolled in the RWHAP and no outliers for PLWHA enrolled in an 
ACAQHP.  
 
Due to heterogeneity in the equality of variances, violations in the assumptions of 
normality in the distribution of the dependent variable around the independent variables, 




analyze the data instead of an independent samples t test (Laerd Statistics, 2018c). The 
Mann-Whitney U test is a nonparametric test used to determine if statistically 
significance differences exist between two groups when an independent samples t test 
when data fails to meet the required assumptions (Laerd Statistics, 2018c). The Mann-
Whitney U test has three assumptions that must be met prior to running the statistical test 
which include a continuous or ordinal dependent variable, a categorical independent 
variable with two groups, and an independence of observations (Laerd Statistics, 2018c). 
As I met all three assumptions based on the design of my study, I used a Mann-Whitney 
U test to determine if there were differences in engagement in care (as defined by the 
number of HIV/AIDS-related physician visits within the previous 12 months) between 




Appendix G: Research Question 4 - Independent Samples t test Assumptions 
In the fourth research question, I used an independent samples t test to address the 
difference in health status (as defined by viral suppression) between PLWHA enrolled in 
an ACAQHP and PLWHA enrolled in the RWHAP. The same six assumptions must also 
be met in this research question which include a dependent variable that is continuous, an 
independent variable that consists of two independent categorical groups, an 
independence of observations, a homogeneity of variances, normality in the distribution 
of the dependent variable around the independent variables, and no significant outliers 
(Laerd Statistics, 2018b).  
The same six assumptions must also be met in this research question which 
include a dependent variable that is continuous, an independent variable that consists of 
two independent categorical groups, an independence of observations, a homogeneity of 
variances, normality in the distribution of the dependent variable around the independent 
variables, and no significant outliers (Laerd Statistics, 2018b).  
I met the initial three assumptions (a dependent variable that is continuous, an 
independent variable that consists of two independent categorical groups and an 
independence of observations) based on the overall design of the research study. I used 
SPSS to determine if the three remaining assumptions (a homogeneity of variances, 
normality in the distribution of the dependent variable around the independent variables, 
and no significant outliers) were met. First, I ran a Levene’s test of equality of error 
variances to determine if there was a homogeneity of variances. A homogeneity of 




(Field, 2013). Homogeneity is confirmed if the Levene’s test produces a non-statistically 
significant result which occurs when the p-value (significance level) is greater than .05 
(Field, 2013). The results of the Levene’s test shown in Table 16 revealed there was a 
difference in the variances in health status between PLWHA enrolled in the RWHAP and 
PLWHA enrolled in an ACAQHP as F(1,30566.262) = 583.703, p < .001.  
Table 16    
Levene’s Test for Equality of Variances – Health Status 
  F Sig. t Df 
Health Status Equal variances not 
assumed 
 583.703 .000 26.740 30566.262 
 
Second, I used SPSS to confirm the normal distribution of the data which occurs 
when the dependent variable is normally distributed by each level of the independent 
variable (Field, 2013).  As I used weighted data in this study, SPSS did not generate the 
Shapiro-Wilk’s test for this research question, so it was not used to assess the normality 
of distribution. Instead, I used the Normal Q-Q Plot output from SPSS for PLWHA 
enrolled in the RWHAP and in an ACAQHP to graphically assess the normality of the 
data distribution. Normally distributed data will appear as round dots located near the 
diagonal line (Laerd Statistics, 2018b). Based on my graphical assessment of the Normal 
Q-Q Plots presented in Figure 10 and Figure 11, health status (as defined by viral load 
suppression) for both PLWHA enrolled in the RWHAP and enrolled in an ACAQHP 






Figure 10. Scatter plot depicting health status data (as defined by viral load suppression) 
that is not normally distributed for PLWHA enrolled in an ACAQHP.  
 
 
Figure 11. Scatter plot depicting health status data (as defined by viral load suppression) 




 Finally, I used SPSS to determine if the dataset contained a significant number of 
outliers. Outliers are single data points that vary from the others and can reduce the 
validity of the test results and were assessed by examining the box-whisker plot produced 
from SPSS (Field, 2013). Outliers are data points plotted above the top whisker or below 
the bottom whisker (Laerd Statistics, 2012e). Based on my visual inspection of the 
boxplot shown in Figure 12, I confirmed outliers were present in the data for PLWHA 
who were enrolled in the RWHAP and enrolled in an ACAQHP.  
 
 
Figure 12. Box plot showing the presence of outliers for health status data (as defined by 
viral load suppression) for PLWHA enrolled in the RWHAP and for PLWHA enrolled in 







Due to heterogeneity in the equality of variances, violations in the assumptions of 
normality in the distribution of the dependent variable around the independent variables, 
and the presence of significant outliers in the dataset, I used a Mann-Whitney U to 
analyze the data instead of an independent samples t test (Laerd Statistics, 2018c). The 
Mann-Whitney U test is a nonparametric test used to determine if statistically 
significance differences exist between two groups when an independent samples t test 
when data fails to meet the required assumptions (Laerd Statistics, 2018c). The Mann-
Whitney U test has three assumptions that must be met prior to running the statistical test 
which include a continuous or ordinal dependent variable, a categorical independent 
variable with two groups, and an independence of observations (Laerd Statistics, 2018c). 
As I met all three assumptions based on the design of my study, I used a Mann-Whitney 
U test to determine if there were differences in health status (as defined by viral load 





Appendix H: Research Question 5 – Chi-Square Assumptions 
In the fifth research question, I used a chi-square to address the difference ins 
difficulty in paying out-of-pocket medical expenses (as defined by problems paying for 
any out-of-pocket medical or health insurance costs) between PLWHA enrolled in the 
RWHAP and PLWHA enrolled in an ACAQHP. There are three assumptions that must 
be satisfied to run this test. I met the first two assumptions (variables must be categorical 
and an independence of observations) based on the design of my study. The third 
assumption of a chi-square test is that all cells in the SPSS cross-tabulation output table 
must have expected counts that are greater than five (Field, 2013). As can be seen in 
Table 17, I met this assumption as all cell counts for the expected count were greater than 
five.  
Table 17 
    






ACA Count 4201 635 4836 
 Expected Count 3558.3 1277.7 4836 
     
RWHAP Count 18366 7468 25834 
 Expected Count 19008.7 6825.3 25834 
     
Total Count 22567 8103 30670 
 Expected Count 22567 8103 30670 
 
As I met all three assumptions of a chi-square test, I used this test to examine the 




paying for any out-of-pocket medical or health insurance costs) between PLWHA 
enrolled in the RWHAP and PLWHA enrolled in an ACAQHP.   
